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Summary 
The keystone periodontal pathogen, P. gingivalis, is a Gram-negative oral anaerobe that is 
strongly implicated as the prime etiological agent in the initiation and progression of 
periodontal disease. P. gingivalis contains a plethora of virulence factors, including 
fimbriae, proteases, lipopolysaccharides and outer membrane proteins that contribute to 
the pathogenesis of the disease. The bacterium also displays the ability to interact with host 
cells through the adherence and invasion both in vitro and in vivo. In this thesis new light 
has been shed on the role of the heterotrimeric outer membrane protein A (OmpA). 
Through the creation of ompA mutants and recombinant complementation plasmids, 
alongside the use of standard antibiotic protection assays in an oral epithelial cell line, this 
research has demonstrated the importance of OmpA, specifically the OmpA2 subunit, in the 
invasion of the host and in the ability of the bacteria to form biofilms. Structural analysis of 
the protein identified extracellular loops, which when synthetic versions were applied to 
host cells, demonstrated successful interruption of wild-type P. gingivalis adherence and 
invasion of the host, indicating a direct interaction of OmpA2 with oral epithelial cells. In 
particular, this research demonstrates that OmpA2-loop 4 plays an important role in the 
interaction with the host through significantly increased binding to host cells when applied 
to fluorescent latex beads. 
This work also characterised the putative periplasmic chaperone protein OmpH, identifying 
potential proteins that act as clients to this chaperone, including OmpA. Through the 
creation of an ompH1H2 knock out mutant, enzymatic analysis of various virulence factors 
was assessed, demonstrating a loss of gingipain activity, whilst also identifying a loss of 
membrane stability through the observation of an increase in outer membrane vesicle 
formation. Evidence is also presented for the role of OmpH protein in chaperoning OmpA 
across the periplasm to the outer membrane and this work has opened up the potential for 
novel work identifying other clients of this chaperone system.  
Overall, the work in this thesis has demonstrated that the OmpA protein, specifically 
OmpA2, is directly involved in the interaction with host oral epithelial cells and in biofilm 
formation, specifically demonstrating the direct role of the extracellular surface loops in 
this interaction. This work also hypothesises a role for the OmpH protein in chaperoning 
outer membrane proteins, with the identification of potential clients, such as OmpA and 
the gingipains. Finally, this work has developed an improved mutagenesis technique for the 
creation of P. gingivalis mutants based on a modified natural competence method.  
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1.1 Overview of Periodontal Disease 
Periodontal disease is a group of inflammatory infections initiated by oral pathogens which 
exist as complex populations in biofilms on the tooth structure and cause tissue 
destruction, loss of alveolar bone and eventually can lead to loss of teeth. The World Health 
Organisation (WHO) classes periodontal disease as a “global burden” and incidence is ever 
increasing. The treatment of periodontal disease is thought to be at a great cost to health 
care systems worldwide, with over £1.6 billion per annum spent by the NHS (Marsh, 2003) 
and estimated $14 billion in the U.S. (Brown et al., 2002).   
The incidence for periodontal disease is difficult to accurately analyse as a significant 
proportion of sufferers avoid professional treatment until a problem arises, as shown in the 
2009 Adult Dental Health Survey (http://www.hscic.gov.uk/pubs/dentalsurveyfullreport09). 
On a global scale, it has been reported that gingivitis affects up to 90% of the entire world’s 
population (Pihlstrom et al., 2005), with periodontal disease affecting up to 15% of the 
adult population worldwide (Petersen and Ogawa, 2012), meaning dental caries and 
chronic periodontitis occupy the top two spots on the list for Global Burden of Disease in 
terms of sheer population numbers (Borgnakke et al., 2013), demonstrating that 
periodontal disease is a major health issue.  
Periodontitis is a complicated multifactorial disease; however it is agreed by the majority 
that the cause is due to a build-up of dental plaque which is made up of oral pathogens, 
extracellular matrix proteins from bacterial and salivary origins (Marsh, 2006), coupled with 
the host immune response to these bacteria. A specific subset of bacteria known as the 
“red complex” is highly associated with periodontitis with raised numbers in sub-gingival 
plaque (Socransky et al., 1998; Griffen et al., 2011). This red complex is made up of 
Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola, a group that 
possess many virulence factors that are thought to contribute to the disease, such as the 
lipopolysaccharide (LPS) layer, capsule, fimbriae, glycosidases, sialidases and surface 
proteins and which are capable of causing periodontal symptoms in animal models (Sharma 
et al., 2001; Singh et al., 2011). In addition, several oral bacteria such as P. gingivalis have 
been shown to invade human cells as part of the disease process (Lamont et al., 1995). 
Notably, bacteria from the red complex have been shown to reside within the buccal 
epithelial cells of the oral cavity (Rudney et al., 2001; Rudney et al., 2005; Rudney and 
Chen, 2006) and can persist even after treatment, such as root planing, antibiotic and anti-
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microbial rinses (Johnson et al., 2008), which may lead to a rapid repopulation of disease-
related bacteria and the progression into aggressive periodontitis.  
The understanding of the molecular mechanisms behind host cell interaction is therefore 
critical in the prevention of periodontal disease, and the aim of this project will be to 
further understand the molecular mechanisms that the oral pathogen P. gingivalis used in 
the adherence to and invasion of oral epithelial cells.   
1.2 Periodontitis: The Clinical Setting 
The periodontium is made up the major components as seen in Figure 1.1. These structures 
are inflamed or destroyed during periodontal disease, resulting in loss of periodontal 
attachment, dissolving of the alveolar bone and eventual loss of teeth if left untreated. 
 
Figure 1.1 Schematic demonstrating the healthy and diseased periodontium. The left 
shows the healthy gingiva, whereas the right shows the inflamed gums and loss of bone 
typical of periodontitis. Tooth image obtained from Dr Graham Stafford and used with 
permission.  
  
It is thought that there are 6 major steps in the progression of periodontal diseases, as 
shown in Figure 1.2. The severity of periodontal disease can range from reversible and mild 
(category 1) to an irreversible chronic destruction of the supportive tissues, formation of 
the periodontal pocket and loss of teeth (category 2 onwards). Category one is what is 
commonly known as gingivitis, the acute inflammation of gingival tissues and is present in a 
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large proportion of the population, up to 90% (Pihlstrom et al., 2005). Gingivitis usually 
presents with mild bleeding from the gums during tooth brushing. If left untreated, 
gingivitis can progress into chronic periodontitis, which initially appears as mostly 
asymptomatic except for inflammation, but progresses further to be diagnosed by a loss of 
bone structure and tooth loss, known as aggressive periodontitis.  The diagnosis of chronic 
periodontitis clinically is usually through visual checking and radiographic methods such as 
X-rays to detect any underlying alveolar bone loss (Kim et al., 2008). Visual methods include 
the probing of periodontal pocket depth, which in a healthy individual are between 1-3 mm 
in depth, but increase as bone and connective tissue are lost. Visual examinations also 
include the observation of supragingival plaque, gingival bleeding and exudate recording 
(Loesche and Grossman, 2001). Chronic and aggressive periodontitis are classed as 
irreversible, visualised by the junctional epithelium migrating away from the tooth surface, 
creating a periodontal pocket as shown in Figure 1.1. Necrotising periodontitis and abscess 
formation (category 5 and 6) clinically present with large necrotic regions of the gingival 
tissues coupled to severe pain and include a weakening of the immune system, such as a 
defective lymphocyte reaction and a reduction in immunoglobulin expression (Bermejo-
Fenoll and Sánchez-Pérez, 2004). 
 
Figure 1.2 The six major stages of periodontal disease progression. Adapted from 
(Soskolne and Klinger, 2001)  
 
1. Gingival 
Diseases 
2. Chronic 
Periodontitis 
3. Aggressive 
Periodontitis 
4. Periodontitis 
Associated With 
Systemic Diseases 
5. Necrotising 
Periodontitis 
(NUG/NUP) 
6. Abscess 
Formation in the 
Periodontium 
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As periodontitis is classed as a multifactorial and complex disease, the initial gingivitis steps 
do not always progress into a chronic disease.  Salvi (1997) described a “critical path model” 
which details the major steps in progression of periodontal disease. This progression can be 
seen in Figure 1.3, and details not only the microbial components but also the host 
components, which make critical contributions to allow the progression from gingivitis to 
chronic periodontitis (Salvi et al., 1997). Initial steps include the progression into gingivitis 
and then the host-produced response brings the disease under control. Progression 
through the cycle leads to periodontitis, but it is not always the outcome. This model 
demonstrates only the essential elements for the progression, not inclusive of the risk 
factors which are discussed later. 
 
Figure 1.3 The critical pathway model. Steps 1-8 represent the major steps in progression 
of disease, including both the bacterial aetiology and the components of the host response. 
Adapted from (Salvi et al., 1997).  
 
Periodontal diseases can be treated in a number of ways. Because gingivitis and 
periodontitis begin with the build-up of dental plaque, the first method of prevention or 
treatment is the removal of this plaque biofilm. This can be removed with tooth brushing, 
flossing (Sambunjak et al., 2011; Poklepovic et al., 2013) or the use of mouthwash which 
contains some antimicrobial agents, such as chlorohexidine and salifluor (Eley, 1999). 
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Previous studies have shown after all oral hygiene procedures stop, the biofilm build up 
begins within 24 h and results in gingivitis within as little as 10 days, and when followed by 
thorough tooth cleaning, the gingiva return to health within 7 days (Theilade et al., 1966), 
demonstrating the clear importance of biofilm control in the prevention and treatment of 
gingivitis. Non-surgical techniques may also be employed professionally to remove biofilms 
from periodontal pockets, including scaling and root planing, which if coupled to better oral 
hygiene at home, can reverse gingivitis effects and improve periodontal attachment. With 
aggressive periodontitis, treatment may involve the need for the prescription of systemic 
antibiotics, such as azithromycin which also contributes as an anti-inflammatory (Hirsch et 
al., 2012) alongside the usual non-surgical subgingival debridement (Pihlstrom et al., 2005).  
1.3 Links to Other Diseases 
1.3.1 Diabetes 
The association between periodontal diseases and diabetes has been a long standing 
discussion and of all the links to systemic diseases, provides the most consistent evidence. 
There appears to be a bidirectional association between diabetic patients and prevalence of 
periodontitis (Grossi and Genco, 1998; Taylor, 2001). It is thought that poorly controlled 
diabetes can increase the risk of periodontal diseases, especially due to the healing of 
wounds being adversely affected by diabetes (Emrich et al., 1991).  In the periodontium, 
the fibroblast cells act as the reparative cells when tissue destruction occurs. These cells are 
incapable of functioning properly in high-glucose environments (Moore et al., 1999), such 
as those found in poorly-controlled diabetic patients. Coupled to this, the collagen 
produced in the healing process by fibroblasts is broken down by matrix 
metalloproteinases, the levels of which are increased in in diabetic patients (Sbordone et 
al., 1998), thus exacerbating the disease and propelling the evidence between the 
association.  
Studies of the literature by Taylor et al., have shown significant associations between the 
severity of periodontal disease and the diabetes, and concluded not only that there appears 
to be a greater prevalence of the symptoms of periodontal disease in diabetic patients, but 
also that the progression of the periodontal disease symptoms are a lot more aggressive in 
these patients also (Taylor, 2001; Taylor and Borgnakke, 2008; Preshaw et al., 2012). A 
cohort study by Soskolne and Klinger (2001) demonstrated that 12.5% of patients that had 
periodontitis also had diabetes, or that 17.3% patients with diabetes also presented with 
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periodontitis. In comparison, diabetic non-periodontitis patients (6.3%) and non-diabetic, 
periodontitis patients (9%), suggesting that periodontitis is more prevalent amongst 
patients with diabetes (Soskolne and Klinger, 2001). More recently, the idea that the 
periodontal pathogen can adversely affect glycaemic control in diabetes has been studied 
and evidence shown that nonsurgical treatment of periodontal disease can improve the 
blood glucose levels (Telgi et al., 2013). However the link between diabetes and periodontal 
disease still remains under question as a large study of all the recent literature by 
Borgnakke et al (2013) demonstrated that there is limited current evidence to suggest that 
periodontal disease has an adversely affect or promote diabetes (Borgnakke et al., 2013). 
The link between diabetes and periodontal disease may just rely on the synergistic 
influences the two have on each other, both exacerbating the effects of the other on the 
immunoinflammatory response whereby inflammation is a central feature of both 
periodontal disease and diabetes, and therefore appear to be interlinked. This is supported 
by the evidence from the bacterial load or species being relatively unchanged between 
diabetic and non-diabetic patients with periodontitis (Emrich et al., 1991). 
1.3.2 Heart Disease 
An association between periodontal disease and coronary heart disease has been 
speculated since the 1960’s (Mackenzie et al., 1963), where a study examined the links 
between diabetes, arteriosclerotic, non-diabetic patients and a group suffering from 
neither condition. The arteriosclerotic individuals were the only group to demonstrate 
more alveolar bone loss than the control group, suggesting a link between the two. This 
study also coincidentally showed no association between diabetes and periodontal disease 
(Beck et al., 1996).  Periodontal pathogens have also been implicated in cardiovascular 
disease with studies showing an association with myocardial infarction (Marcus and Hajjar, 
1993), with some studies even showing poor periodontal health preceding a cardiovascular 
event , although various follow up studies have shown no such association (Howell et al., 
2001); (Hujoel et al., 2000). This inconsistency between studies has left a shadow of doubt 
over the true association between cardiovascular disease and periodontitis. More recent 
studies have implicated the periodontium as the source of the bacteria and inflammatory 
mediators which are then disseminated into the blood stream, leading to cardiovascular 
events (Li et al., 2000), and the inflammatory burden of periodontitis appears significant in 
atherosclerosis (Schenkein and Loos, 2013), however the direct role in stimulating the 
inflammatory response in the vessel wall is still unclear. Some studies have even gone as far 
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as to detect the DNA of T. forsythia and P. gingivalis in atherosclerotic plaques using 
microarrays (Kozarov, et al., 2006; Gaetti-Jardim, et al., 2009), and simple PCRs using 
primers against P. gingivalis, A. actinomycetemcomitans and T. forsythia detected high 
levels of these pathogens in atheromatous plaque in patients that had periodontal disease, 
whereas P. intermedia was found in all plaque samples but not in atheromatous samples  
(Rath et al., 2014). 
 It is thought that oral pathogens are capable of entering the bloodstream, causing 
inflammation and increasing plaque build-up which subsequently leads to a contribution in 
the dilation of the arteries (Bartold and Narayanan, 2006). The cariogenic bacteria, 
Streptococcus mutans, has been identified in heart valve tissues and atheromatous plaque 
at a higher frequency than any other species (Nakano et al., 2006), and when coupled with 
P. gingivalis, the two species have been shown to accelerate atherogenic plaque formation 
in a mouse model (Kuramitsu et al., 2001), whilst follow up studies have shown a 
polymicrobial infection of oral bacteria are capable of accelerating the plaque formation 
(Chukkapalli et al., 2015). There is evidence demonstrating the ability of P. gingivalis to 
invade cardiovascular endothelial cells (Deshpande et al., 1998; Kozarov et al., 2005), and 
cultivable P. gingivalis has been isolated from atheromatous tissue (Rafferty et al., 2011). 
These various studies demonstrate there are severe implications on the systemic health of 
a patient with periodontitis. More recently, as P. gingivalis is often found associated with 
atherosclerotic plaque and atheromatous tissue, a study investigated the causal link 
between P. gingivalis and plaque development (Velsko et al., 2014). Velsko et al 
demonstrated that in an ApoE-knock out mouse (used as a model as it develops extensive 
atherosclerotic lesions), long term periodontal disease allowed a constant exposure of 
periodontal bacteria systemically, increasing the interactions of P. gingivalis with 
endothelial cells and the arterial wall, responding with an increase in inflammatory cells 
and leading to the formation of atherosclerotic plaque (Velsko et al., 2014). This study so 
far has been the most convincing link between periodontal disease and heart disease. It has 
been relatively well established that there is a direct link between periodontal disease and 
heart disease (Pizzo et al., 2010) but conversely, the American Heart Association has 
recently noted that neither the treatment of periodontal disease has been proven to treat 
cardiovascular disease, nor that periodontal disease has been proven to cause 
atherosclerotic disease (Lockhart et al., 2012; Hayashi et al., 2015), demonstrating that it 
may just be a correlation of shared risk factors (obesity, aging, tobacco use etc.) that 
indicates a causality between the two diseases (Genco and Borgnakke, 2013). 
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1.3.3 Pre-Term Birth 
Several cohort studies have also attempted to understand the links between poor maternal 
periodontal health and the association with low birth weight and pre-term birth. The role of 
bacterial infections influencing premature births is well understood, such as bacterial 
vaginosis (BV) causing chorioamnionitis (Reviewed by Romero et al., 2004). BV, like 
periodontal disease, is caused by an imbalance of the bacteria which leads to an over 
population of disease-causing bacteria (Gilbert et al., 2013). The putative link between pre-
term birth and periodontal disease is thought to be due to inflammatory mediators 
entering the blood stream and triggering an inflammatory cascade in the uterine lining, or 
the bacteria themselves entering the systemic circulation causing a repeat exposure in the 
same tissues (Gibbs, 2001). To further support this hypothesis, various animal studies have 
shown than injection of mice with periodontal pathogens can lead to preterm or still births 
(Han et al., 2004), and various oral microorganisms have been detected in the amniotic 
fluid, such as F. nucleatum and Capnocytophaga sputigena (Bearfield et al., 2002).  The use 
of 16S sequencing rather than culture-dependant methods has indicated a far greater 
microbial diversity in amniotic fluid than previously expected. A study by Wang et al 
demonstrated the presence of F. nucleatum, Bergeyella lachnospiraceae, S. sanguinegens 
and S. mitis amongst other non-periodontal species, in the amniotic fluid and cord blood, 
which leads to the heightened inflammatory state found within many preterm newborns, 
and hypothesised F. nucleatum especially, is as important at E. coli in causing early-onset 
neonatal sepsis (Wang et al., 2013). Wang et al hypothesised that as F. nucleatum has 
previously been shown to invade epithelial and endothelial cells (Han et al., 2000; Han et 
al., 2004) and is capable of colonising the placenta (Han et al., 2004; Liu et al., 2007) which 
leads to a high level of inflammation and foetal loss, that the presence of other oral species 
in the amniotic fluid is due to a co-migration with F. nucleatum from the oral cavity (Wang 
et al., 2013).  
1.3.4 HIV/AIDS 
HIV/AIDS has a difficult connection with periodontal disease to dissect as the geographical 
location of high prevalence of HIV/AIDS is usually coupled to areas of little access to oral 
health care, such as in Sub-Saharan Africa (Petersen and Ogawa, 2012). The prevalence of 
patients being HIV positive and suffering from chronic periodontitis is relatively low 
compared to other pathogenic associations with HIV positive patients, although these 
patients often suffer from distinct types of necrotising ulcerating periodontitis (Robinson, 
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1992). Studies have shown that when periodontitis presents in this way, it is a strong 
indication of a CD4+ cell count being under 200 cells / µl (Glick et al., 1994), as observed in 
HIV positive patients. This has links to the geographical influence on a disease, as the is a 
higher prevalence of people who are HIV+ in sub-Saharan Africa, who also have a higher 
number of cases of necrotising periodontitis (Arendorf et al., 1998) as the access to highly 
active antiretroviral therapy (HAART) used for managing HIV, is limited (Pihlstrom et al., 
2005). 
1.3.5 Periodontal Disease and Arthritis 
Periodontal disease and rheumatoid arthritis are two very common chronic inflammatory 
diseases affecting the human population, and despite differing etiological mechanisms that 
initiate the two, evidence for an association between these diseases is appearing, with 
periodontal disease being two-fold more prevalent in patients with rheumatoid arthritis 
than the general population (Koziel et al., 2014). Rheumatoid arthritis is generally accepted 
as being caused by an autoimmune response to an accumulation of citrullinated proteins. 
Citrullinated proteins are produced under normal physiological conditions but susceptible 
genetically individuals generate antibodies against these citrullinated proteins (Klareskog et 
al., 2008; Wegner et al., 2010), causing this autoimmune response. Citrullination of proteins 
is a necessary post translational modification in a variety of physiological processes, from 
the proteins involved in brain development to the chromatin remodelling to regulate gene 
expression (György et al., 2006; Wang et al., 2009). Protein citrullination also occurs in 
inflammatory conditions, for example, hypercitrullination of histones in the production of 
neutrophil extracellular traps (NETs) which are necessary in the host innate immune 
response (Wang et al., 2009). The citrullination of these proteins is carried out by peptidyl-
arginine deaminases (PADs), and recently P. gingivalis has been shown to express a 
homolog of this enzyme, which is found to be colocalised in the outer membrane with the 
arginine specific gingipains (Rgps) (Quirke et al., 2014). The gingipains cleave the 
mammalian proteins to expose C-terminal arginines which are rapidly citrullinated by the P. 
gingivalis PAD (PPAD), which has been hypothesised to set in motion a chain of events that 
leads to a significant build-up of citrullinated proteins and therefore causes an intolerance 
and leads to the development of rheumatoid arthritis (Dissick et al., 2010). Recent Mass 
Spectrometry data has revealed that PPAD not only citrullinates other proteins, but itself is 
citrullinated and acts as a potent antigen to further increase the intolerance in the host 
(Quirke et al., 2014). The PAD enzyme of P. gingivalis is therefore being investigated as a 
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potential target to develop a novel treatment for both periodontal disease as well as 
rheumatoid arthritis.  
1.3.6 Periodontal Disease and Cancer 
Both F. nucleatum and P. gingivalis are well characterised to establish chronic infections 
with immune disruptive properties, and similarly, the modulation of the tumour 
microenvironment and the development of tumours has been attributed to chronic and 
dysregulated inflammation (Whitmore and Lamont, 2014), suggesting a potential link. A 
study by McCoy at al has demonstrated a strong positive correlation between cytokines 
and F. nucleatum in colorectal cancer (McCoy et al., 2013), and is thought to be responsible 
for producing a strongly proinflammatory response in colorectal cancer cases in mice by the 
recruitment of tumour-infiltrating immune cells (Kostic et al., 2013) which leads to the 
progression of cancer. More direct evidence for the involvement of F. nucleatum and 
cancer progression has been demonstrated recently, where the adhesin FadA activates the 
β-catenin signalling pathway by binding to the E-cadherin receptor, which leads to an 
increase in the transcription of oncogenes, pro-inflammatory cytokines and stimulated cell 
proliferation (Rubinstein et al., 2013), however at present there is no clear link to oral 
cancer.  
As P. gingivalis is responsible to producing both pro- and anti-inflammatory responses, it is 
harder to tease out a link between P. gingivalis and cancer, however it is widely observed 
that P. gingivalis causes a severely disruptive effect on the host immune response, which 
may lead to the progression of cancer (Whitmore and Lamont, 2014). The link between P. 
gingivalis and oral cancer is more observational, as P. gingivalis is highly antiapoptotic 
through suppression of apoptotic pathways such as Jak1/Akt/Stat3 pathway (Mao et al., 
2007), whilst causing accelerated progression through the cell cycle by reducing the level of 
p53 tumour suppressor (Kuboniwa et al., 2008), and therefore increases the 
dysfunctionality of cell death pathways, which by definition is what causes cancer. The 
fimbrial protein subunit, FimA, is thought to induce this cell cycle progression, as it has 
been noted that a fimA-deficient mutant is not capable of elevating cell cycle progression 
(Kuboniwa et al., 2008). 
The implications of the involvement of oral bacteria in cancer still remain unknown, but in 
future could potentially lead to the appearance of the bacteria in cancer cases as prognosis 
indicators or an improvement in oral hygiene could lead to the limitations of cancer 
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progression and spreading if the link with oral bacterial proves to be more convincing in 
future studies. 
1.4 Factors Affecting Periodontitis 
1.4.1 Periodontitis and Ageing 
Originally, periodontal disease was thought of as an inevitability of ageing, but more 
recently the molecular factors behind this association have been examined. Several studies 
have shown that in older populations who still retain their teeth, periodontal diseases are 
one of the most prevalent chronic conditions and is often coupled to an increase in severity 
with age (Beck et al., 1990; Hugoson et al., 1992; Locker and Leake, 1993), with a particular 
study showing the rate of bone loss was significantly higher in 70-year-old individuals 
compared to 25-year-olds, demonstrating an increased severity (Papapanou and 
Wennström, 1989). This is a potential reflection of the individual’s cumulative oral history, 
whereby the severity of the disease reflects the length of time the periodontal tissues have 
been exposed to plaque (Löe et al., 1986). At a biological level, the tissues are subject to 
progressive and irreversible deterioration with age, especially in the gingival recession, and 
this change to structure and function may affect the host response to pathogens in the oral 
cavity, and ultimately influence the rate of periodontal destruction (Razak et al., 2014). 
Again, this demonstrates that periodontal disease is not only due to the presence of certain 
microorganisms, but is a complicated balance of host response and microbial interactions.  
The age composition of the human population has changed drastically in the later decades 
of the 20th century, with a huge increase in the number of people living to older ages (Razak 
et al., 2014). With the connections of increased age to heightened risk of periodontal 
disease, and the aged population ever increasing, it is imperative to increase our 
understanding of periodontal disease to reduce this burden on our healthcare systems 
1.4.2 Influence of Host-Genetics 
Strong links with certain genetic disorders have been identified that result in severe 
periodontal manifestations. For example, rare autosomal recessive disorders such as Haim-
Munk and Papillon-Lefèvre syndromes are associated with the onset of periodontitis at 
childhood, with the loss of both deciduous and adult teeth (Hart et al., 2000). Several 
studies involving twins indicate that around 50% of the population variance in periodontitis 
is affected by genetic factors (Michalowicz et al., 1991; Corey et al., 1993), however despite 
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several genetic polymorphisms being identified to contribute to periodontal disease 
(Greenstein et al., 2002; Kinane and Hart, 2003), currently there is not enough evidence to 
provide an effective genetic test to assess the risk of developing periodontal disease or to 
determine the response to periodontal treatment.  
1.4.3 Modifiable Risk Factors 
It is widely accepted that periodontal disease is due mainly to the pathogenic microflora 
found in the dental subgingival biofilm. However, several “modifiable” causes have also 
been identified which effect disease progression, for example, the use of tobacco, 
individuals suffering from high levels of stress, and those with poor diets. It has been shown 
that the development of periodontitis is much more likely in smokers than non-smokers, 
including the use of smokeless tobacco products (Bergström, 2004). A study by Preber and 
Bergstrom (1990) showed that even periodontal treatment, such as surgical intervention, is 
much less effective in smokers, which highlights the detrimental effects of smoking on 
periodontitis (Preber and Bergström, 1990). In contrast, a significant but very small 
association can be found between development of periodontitis and alcohol consumption 
(Tezal et al, 2004). Nutrition has historically been associated with periodontal disease, 
especially a lack of Vitamin C. A deficiency in Vitamin C intake is well known for leading to 
scurvy, but this also leads to a decrease in the maintenance of collagen, which leads to loss 
of supporting structures and an increase in inflammation, leading to tooth loss (Pihlstrom et 
al., 2005).  
Associations between trauma and stress and periodontal disease have been observed 
where previously it was thought to be most likely due to a lack of motivation (Genco et al., 
2002; Bakri et al., 2013), however more recently it is being increasingly understood with a 
growing body of evidence. Several groups have demonstrated a potential link between the 
psychological status of a patient and alterations in their immune activity, known as 
“Psychoneuroimmunology”, which connects the psychological and physiological sides of a 
disease (Ader et al 1995). Stress and anxiety have been shown by a number of studies to 
influence the onset of periodontal disease, by altering the periodontal environment such as 
the temperature and gingival circulation, and also by suppressing the host immune 
response (Peruzzo et al., 2007; Pöllänen et al., 2013), leading to an exacerbation of the 
disease, although why this occurs is still unclear. Studies have theorised this phenomenon 
could be due to an increase in pro-inflammatory cytokines by the hypothalamic-pituitary-
adrenal axis, whereas immunosuppressive effects may occur from adrenaline, cortisol and 
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noradrenaline released by the sympathetic nervous system, and interestingly, cortisol has 
been suggested to promote the growth of P. gingivalis, the keystone pathogen of 
periodontal disease (Akcalı et al., 2014). The lack of motivation when stressed or anxious 
coupled to physical immune responses pose an interesting challenge and added 
complication in the treatment of periodontal disease.  
1.4.4 The Role of Innate Immunity at the Host-Pathogen Interface 
The innate immune system is a critical subsection of the overall immune system of the host 
which comprises of complex mechanisms that recognise non-specific pathogen associated 
molecular patterns (PAMPs), which are molecular motifs found conserved across the class 
of microbes and are necessary for bacterial survival, and allow a rapid response to the 
impending infection (Medzhitov, 2007). The major functions of the host innate immune 
system include 1) the recruitment of neutrophils and macrophages to the site of infection 
through the production of cytokines (which include the interleukins); 2) the activation of 
the complement cascade to initiate the identification of the invading pathogens, 
recruitment of phagocytes and initiate direct killing of the pathogen, and 3) to activate the 
adaptive immune system to allow a more heightened response to the infection (Roitt et al., 
2011). It is comprised mainly of mechanical (the epithelial cell barrier), cellular (epithelial 
cells, macrophages, dendritic cells, etc.) and chemical elements (pattern recognition 
receptors, cytokines, chemokines, etc.) (Basset et al., 2003).  
The gingival epithelium first provides a physical barrier against infection, with tight 
junctions between cells to prevent entry by pathogens (Sammartino et al., 2010), although 
as discussed later, many bacteria overcome this by invasion of the cells. Part of the innate 
response is the fact the oral epithelium is also coated with saliva and mucins which 
physically prevent adherence by the pathogens, whilst also containing antimicrobial 
peptides like defensins and cathelicidins, which kill the invading pathogens (Roitt et al., 
2011). The epithelial cells also contain pattern recognition receptors (PRRs) which recognise 
PAMPs, such as LPS or flagella. The best characterised family of PRRs are the Toll-like 
receptors (TLRs), which are transmembrane receptors capable of recognising several 
bacterial products, such as TLR-4 recognises LPS, whereas TLR-9 recognises bacterial DNA 
(Medzhitov, 2007). These TLRs are known to elicit an inflammatory response, by activating 
macrophages and dendritic cells resident in the tissues to produce pro-inflammatory 
cytokines such as tumour necrosis factor (TNF), and interleukins (IL), such as IL-1β and IL-6, 
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which increase the vasodilation of the local blood vessels, whilst recruiting neutrophils to 
trigger other sections of the immune response (Basset et al., 2003). 
The complement system is also crucial in the innate immune response. It consists of ~20 
soluble interacting proteins that circulate in the blood, and are inactive until triggered by an 
infection. These complement proteins are also PRRs that can be activated by PAMPs, which 
leads to the activation of the early complement components from either of the three 
complement pathways (classical, lectin and alternative) which all activate the C3 
complement protein (Medzhitov, 2007; Roitt et al., 2011), a pivotal component as previous 
studies have shown individuals the contain a deficiency of C3 are repeatedly subject to 
bacterial infections (Pickering et al., 2000; Botto et al., 2009). The activation of each 
complement protein sequentially activates the next protein, causing a cascade, liberating a 
membrane binding large fragment which binds to the surface of the pathogen and leads to 
the phagocytosis of the pathogen (Cekici et al., 2014).  This liberation also releases a small 
biologically active fragment that can lead to the promotion of the inflammatory response 
through the recruitment of phagocytes and lymphocytes (Hajishengallis, 2015).  
The action of many of these components of the innate immune response is to induce a pro-
inflammatory response, which is a protective response against microbial invasion on a local 
scale (Tracey, 2002). The response is usually short-lived as it can be damaging for the 
tissues involved, and a long-term inflammatory response becomes a chronic inflammatory 
disease (Lawrence and Gilroy, 2007). The periodontal pathogens hijack this pro-
inflammatory response to promote inflammation to cause periodontitis, which by 
definition, is a chronic inflammatory disease (Hajishengallis, 2015). 
1.4.5 Genetic Considerations in Periodontal Disease 
Various studies have shown a genetic component to the risk factor associated with 
periodontitis. Direct evidence for the genetic contribution to the heritable susceptibility of 
periodontitis is unclear, however rapid progression of chronic gingivitis to destructive 
periodontitis affects around 10-15% of the population, consistent with a high-risk group for 
an inheritance of susceptibility (Johnson et al., 1988). Reports in the literature indicate a 
familial aggregation of periodontal disease, however due to lack of standard classifications 
and inconsistent methods of clinical examination it is difficult to determine a familial link 
(Hassell and Harris, 1995). 
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One theory that appears to have credence in the severity of periodontal disease linked to 
genetic factors is the particular genotype of the IL-1 proinflammatory cytokine. The IL-1 
cytokine is a key regulator of the response by the host to the microbial infection, and it has 
been reported that variations in the gene cluster of IL-1 could be influential on the severity 
of periodontitis (Gore et al., 1998), and one of the alleles is associated with a four-fold 
increase in the production of IL-1 (Pociot et al., 1992). High levels of IL-1 are detected in 
gingival crevicular fluid from patients with severe inflammation and tissue destruction 
(Feldner et al., 1994; Ebersole et al., 2000). Patient cohort studies by McDevitt et al 
demonstrated that the IL-1 positive genotypes showed a strong correlation with severe 
adult periodontitis, at higher levels than IL-1 negative patients who were smokers (Mcdevitt 
et al., 2000), indicating the genotype of IL-1 is a significant risk factor of severe adult 
periodontitis. These studies are interesting as they provide a potential biomarker for the 
development of severe periodontal disease, and therefore can be used to apply appropriate 
treatment before the disease becomes chronic.  
1.5 Aetiology of Periodontitis 
As previously mentioned, the cause of periodontal disease is thought to be mainly down to 
the presence of bacteria in a biofilm known as subgingival plaque. The presence of harmful 
oral pathogens in periodontal plaque is not necessarily enough to cause disease, as for 
example, P. gingivalis is found in the periodontium of healthy patients (Ximenez-Fyvie et 
al., 2000). It is the disruption of the balance between health and disease due to an 
ecological pressure, such as one species of disease-causing bacteria out-competing a 
bacterial species associated with health, coupled with the introduction of environmental 
changes, such as a sugar-rich diet (Marsh, 2006). There are several hypotheses developed 
to understand the role of plaque bacteria and the causation of disease, but two major ideas 
are the most recognised. These being the specific plaque hypothesis developed by Loesche 
in the 1970’s which theorises that out of a large collection of bacteria involved in the 
resident microflora, only a select few species are involved in causing the disease (Loesche, 
1976), which explains why there are many patients whose oral cavities contain considerable 
levels of plaque deposits, but only a minority of these patients suffer from severe 
destructive periodontitis (Hasan and Palmer, 2014). This hypothesis leads to the idea that 
targeting only those bacteria can produce preventative treatments for periodontal disease. 
However, to date there has only been identification of “keystone” pathogens (Hajishengallis 
et al., 2012) and the idea of a dysbiotic population as opposed to a single species 
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responsible for the disease. The theory of microbial dysbiosis indicates a “shift” in the 
membership of the local microbiota of the mouth, where a decrease in the number of 
beneficial bacteria occurs coupled to an increase in pathogens, especially those found in 
the keystone population (Nath and Raveendran, 2013), leading to the deterioration of the 
oral health of the host until periodontal disease occurs. The other major idea is the non-
specific plaque hypothesis developed by Theilade over a decade later from Loesche. This 
theorises that it is the overall action of the entire plaque microflora which produces the 
disease (Theilade, 1986). This theory implies that no one specific bacterium has the ability 
to cause disease; rather it is due to the bacterial accumulation irrespective of the bacterial 
composition. Both hypotheses, although seemingly opposing, complement each other well 
as plaque is a polymicrobial infection where only a limited number of species can be 
dominant. In response to these hypotheses, Marsh developed another theory known as the 
“ecological plaque hypothesis” that describes the key elements in both. It theorises that 
plaque-mediated diseases are due to an enrichment of oral pathogens, causing an 
imbalance in the resident microflora (Marsh, 2006). This theory proposes a shift from 
predominantly Gram-positive aerobic bacteria to the more disease-associated Gram-
negative anaerobic bacteria. Thus, the production of a mainly alkaline environment suitable 
for asaccharolytic bacteria due to the production of novel nutrients that allows the 
enrichment of these anaerobic Gram-negative bacteria such as P. gingivalis (Zilm et al., 
2007). These theories all demonstrate the complex relationship between bacteria and the 
host which results in periodontal disease.  
1.6 Microbiology of Periodontitis 
Periodontitis is thought to be one of the major polymicrobial infections in the human body 
(Saito et al., 2009). A polymicrobial disease consists of a number of complex interactions 
between multiple causative agents acting in a synergistic manner to elicit a range of host 
responses. The oral microbiome is thought to harbour over six billion bacteria, making up 
over 700 bacterial species (Kuramitsu et al., 2007), as well as other microorganisms such as 
protozoa, mycoplasma and fungi, and possibly even viruses (Pennisi, 2005). Despite this 
complex community, only relatively few bacteria, around 10-20 species, are thought to 
participate significantly in the disease process (Socransky et al., 1998). The primary 
contributing factors to periodontitis can be split into two groups; an immunological factor 
and a microbial factor. The immunological contributor is the host’s destructive 
inflammatory response to the infection, which will be discussed later in reference to P. 
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gingivalis specifically, whereas microbial factors of disease is the shift in the content of the 
oral microbiota from a health-associated population to a disease-associated one (Berezow 
and Darveau, 2012), causing a dysbiosis of the oral microbial population (Hajishengallis, 
2014). The shift in oral microbiota involves various complex reactions between several 
different species but originally comes due to a build-up in the number of bacteria as a 
whole in what is known as subgingival plaque.   
1.6.1 Subgingival Plaque and Biofilm Formation 
Biofilms are clinically relevant as over 65-80% of human bacterial infections involve biofilms 
(Rasamiravaka et al., 2015), the understanding of the interactions is important to be able to 
eradicate the issue. Biofilms form on a variety of surfaces, from living tissue such as heart 
valves, to medical devices such as prosthetic devices and implants, often causing rejection 
(Prieto-langarica, 2013). It is thought that bacteria growing within a biofilm express 
differing phenotypes to their planktonic counterparts, exhibiting a greater tolerance to 
environmental conditions such as pH and oxygen levels, encouraging growth (Hojo et al., 
2009).  
The first steps in biofilm formation depends on the bacterium, for example the 
opportunistic pathogen Pseudomonas aeruginosa uses flagella to swim along surfaces to 
find potential sites, and then type IV pili are employed to pull themselves towards other 
early colonisers to begin to form microcolonies (O’Toole and Kolter, 1998; Barken et al., 
2008). Other bacteria rely mainly on cell division to form the sheer numbers needed for 
biofilm formation (Chicurel, 2000). Once established, various genes are expressed to begin 
producing the components of the surrounding biofilm matrix, whereas others are activated 
to adapt the bacterial phenotype to the biofilm community environment. Studies have 
shown that up to 38% of the genes are altered in E. coli (Prigent-Combaret et al., 1999), 
whereas P. aeruginosa appears to be much more modest at ~200 of the 5750 genes being 
altered (Chicurel, 2000). These genetic changes are thought to be coordinated by quorum 
sensing, whereby small diffusible signalling molecules are constantly secreted by the 
bacteria, and only when the population becomes large enough the critical threshold is 
reached and changes within the bacterial gene expression occur leading to behavioural 
changes. This has been extensively studied in the biofilm of P. aeruginosa which uses two 
main quorum sensing systems (las and rhl) which coupled to two-component regulatory 
systems (Rasamiravaka et al., 2015), interact with the formation and production of the 
biofilm matrix, known as the extracellular polysaccharides (EPS). The EPS constitutes 
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around 85% of the mature biofilm biomass (Flemming et al., 2007), and is comprised of 
biomolecules, extracellular DNA (eDNA), cellular components, exopolysaccharides and 
polypeptides, which form a scaffolding architecture to the biofilm by forming a highly 
hydrated polar structure (Sutherland, 2001; Branda et al., 2005), providing both protection 
and nutrition for the bacterial component.  
Biofilms are of great interest to medical research due to the ability of the bacteria to 
become less susceptible to antimicrobial agents and can show an enhancement of 
pathogenicity, known as pathogenic synergism (Steenbergen et al., 1984). For example, one 
study demonstrated that F. nucleatum will support the growth of P. gingivalis and P. 
nigrescens in an oxygenated and CO2-depleted environment by providing a capnophilic 
environment (Bradshaw et al., 1998). The most significant gain to a bacterium in a biofilm is 
that of greater tolerance to antimicrobial agents, with certain studies (Sedlacek and Walker, 
2007) showing the inhibitory concentration for growth of bacteria in a biofilm was 
increased 250 times compared to the same culture grown planktonically. Primarily, it is 
thought that the EPS prevents the diffusion of antimicrobial agents, so the drugs cannot 
physically reach the bacteria. Secondly, if the drugs can diffuse in to the EPS, the bacteria 
are shown to grow markedly slower in a biofilm, and therefore the biofilm formation causes 
a decrease in sensitivity to these drugs. The third major mechanism is thought to be that if 
the drugs can enter the EPS and effect targets not to do with growth, the sheer number of 
species involved in a biofilm will make it more likely that at least one species will possess a 
drug-inactivating enzyme, which allows any neighbouring species that do not produce the 
enzyme to benefit from a drug-free area (Hojo et al., 2009). A more recently observed 
mechanism of survival through antibiotic application is the presence of “persister” cells, 
which are dormant, non-dividing cells making up less than 1% of the biofilm population. 
These are present in late-stage biofilms and their tolerance to antibiotics isn’t thought to be 
due to a genetic modification but merely a phenotypic state in which they do not divide in 
the presence of antibiotics. Once these bacteria resume growth, they return to a normal 
antibiotic susceptible phenotype (Lebeaux et al., 2014; Conlon et al., 2015). As the name 
suggests, these bacteria persist through antibiotic treatments and can then resume normal 
growth when there is no longer a presence of antibiotics, reforming the biofilm. These 
persister cells play a major role in the resistance of chronic infections to antibiotics.  
Of the 700 bacterial species found in the oral microbiome, approximately 400 species are 
found in the subgingival plaque (Al-Jehani, 2014). Dental plaque has been defined as a 
community of microorganisms that form as a biofilm on the surface of the tooth (Marsh, 
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2006). Dental plaque is a dynamic and very complex structure, with initial colonisers of the 
sub- and supra-gingival surfaces being predominantly commensals which are Gram-
positive, including Streptococcus species such as Streptococcus gordonii as well as 
Actinomyces species (Park et al., 2005). The biofilm that forms in the oral cavity can be seen 
as a schematic in Figure 1.4 and begins with the formation of a pellicle, a thin glycoprotein 
rich film, which attaches to the tooth surface.  
 
Figure 1.4 Oral biofilm formation. A) represents the formation of the pellicle, derived from 
salivary glycoproteins attached to the tooth surface. B) Shows the initial adhesion of the 
early bacterial colonizers, which bind to the glycoproteins. C) Shows the maturation, and 
the change from a reversible to irreversible form of bacterial adherence. D) Demonstrates 
the dispersal of bacteria from the biofilm surface and spread so as to colonise a new site. 
 
The oral biofilm is unique in its requirement of a host-derived protein surface to attach to 
(Huang et al., 2011). Once the pellicle has been formed, planktonic bacteria can recognise 
binding sites, such as α-amylase, and bind (reversibly) to the pellicle. The initial binding of 
the bacteria is mainly due to a physical attachment, usually via protein appendages such as 
fimbriae and adhesins, therefore the bacteria can detach easily (Filoche et al., 2010). It isn’t 
until the biofilm matures that the attachment becomes more permanent. Once the 
foundation of bacterial cells are laid down, the bacteria are able to grow and synthesise 
outer membrane components to allow adherence of bacteria that are incapable of binding 
to the pellicle directly (Hasan and Palmer, 2014). Later colonising bacteria recognise binding 
sites on the early pioneering bacteria, such as cell surface receptors or polysaccharides, 
which leads to bacterial aggregation and a maturation of the biofilm. Mature biofilms 
contain water channels and porous layers to allow essential nutrients to enter the biofilm, 
however oxygen gradients begin to form as the superficial bacterial layers rapidly utilise the 
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oxygen, leading to more anaerobic conditions developing within the biofilm (Hasan and 
Palmer, 2014). Bacteria are capable of leaving the biofilm via sloughing, erosion or seeding 
when the bacteria are dispersed due to the sheer force of the salvia movement, which is a 
passive host defence to remove biofilms, or the bacteria can actively be dispersed when 
limiting factors arise, such as a lack of nutrients (Huang et al., 2011).  
Despite a study by Kolenbrander in the early 1990’s showing that over 90% of oral bacteria 
are capable of co-aggregating in paired tests, very specific cell-to-cell interactions need to 
take place for this to occur in biofilms, for example S. mutans is capable of aggregating with 
F. nucleatum, but P. gingivalis cannot (Bradshaw et al., 1998). The mechanism behind 
bacterial aggregation is recognition of polysaccharides between bacteria. One bacterium 
has a specific recognition site to a specific adhesion molecule on another bacterium, 
leading to a timeline of events in biofilm formation depending on the presence of certain 
bacteria (Hojo et al., 2009). Early pioneering colonisers consist mainly of Streptococci, which 
contribute up to 80% of the bacteria found in dental plaque. Other early colonisers include 
Actinomyces complexes which are thought to attach via its Type I fimbriae, and using its 
Type II fimbriae to allow inter-bacterial binding (Rosan and Lamont, 2000).  
Early colonising bacteria may help facilitate the attachment of P. gingivalis through 
providing attachment sites or changing conditions to be more favourable for the 
attachment, such as the anaerobic facultative bacteria, S. gordonii which it thought to 
encourage colonisation through reduction of oxygen tension to levels that would allow 
growth of an obligate anaerobe such as P. gingivalis (Gaffen and Hajishengallis, 2009).  The 
presence of S. gordonii is also thought to be the major binding point for P. gingivalis via the 
interaction of the long and short fimbriae of both species (Lamont et al., 2002). The long 
fimbriae of P. gingivalis have been shown to bind to the surface protein, glyceraldehyde-3-
phosphate dehydrogenase of S. gordonii, and rapidly then progressing to a biofilm (Cook, 
1998). This bridging of early and late colonising species of the oral cavity in biofilm 
formations is also observed between F. nucleatum and T. forsythia, whereby the former (an 
early coloniser) synergises with the latter during biofilm formation and pathogenesis 
(Sharma et al., 2005). Coinfections with these two species induces a much more potent 
infection than either alone, inducing a severe pro-inflammatory response for monocytes 
and macrophages, and a greater increase in bone loss compared to the single species 
infections of a murine model (Settem et al., 2012). The interactions between these 
pathogens during biofilm formation and infection of the host are especially important in the 
pathogenesis and severity of periodontal disease.  
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1.6.2 Microbial Complexes Involved in Periodontitis 
Understanding the complex relationship and their interactions between different bacterial 
species is important to understand how to control the infection. It is believed that there is 
no one species that causes the tissue changes and periodontal destruction that is 
associated with disease, but instead a mixture of species and complexes is likely required 
for the progression of disease (Marsh, 2006). The defining study of microbial complexes in 
subgingival plaque was performed by Socransky and his group in 1998. Using both cluster 
analysis and community ordination techniques on over 13,000 samples, the work set out to 
understand the relationship between closely related species within a community of 
bacteria in subgingival plaque and to then relate that to other communities in periodontal 
disease as a whole (Socransky et al., 1998). Socransky highlighted several bacteria observed 
in association with either the healthy state in the mouth or with periodontal disease, 
grouping them into various complexes.  Figure 1.5 details these complexes. The green, blue 
yellow and purple complexes are associated with a “disease-free” state, including mainly 
Gram positive bacteria such as Streptococcus species. The other two complexes are highly 
associated with a periodontal disease state, detailing an increased pocket depth and 
bleeding on probing. The orange complex contains P. intermedia, Peptostreptococcus and 
Fusobacterium nucleatum. The latter of which is accredited with bridging the gap between 
early colonisers such as Streptococcus gordonii and red complex members in biofilm 
formation (Socransky et al., 1998). It is thought that these species act as bridging species 
due to their expression of specific cell surface structures for binding both early colonisers 
and red complex bacteria, and also the ability to utilise and release nutrients from the 
dental plaque biofilm, encouraging growth of other bacteria (Socransky et al., 1998).  
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Figure 1.5 The major complexes of bacteria found in the periodontal cavity. Complexes 
yellow, blue, green and purple are associated with oral health, whereas the orange and red 
complexes are associated with periodontal diseases. Subgingival plaque complexes adapted 
from (Socransky et al., 1998). 
 
The study identified that members of the red complex of bacteria are rarely observed in the 
absence of members of the orange complex. It was surmised that the orange species 
preceded the colonisation of the red complex members. Socransky demonstrated the 
relationship between bacterial complexes and the clinical parameters of the disease via 
studies of pocket depth on the gingival tissue. A strong correlation between the presence of 
orange complex members and greater pocket depth was observed, and a further increasing 
pocket depth when red complex bacteria were present. This study exemplified the idea that 
periodontal disease was a polymicrobial infection whereby no one bacterial species is the 
causative agent, with data showing pocket depth and bleeding on probing increasing with 
an increasing number of pathogens of a diverse range of species. It did however 
demonstrate that most of the disease-causing bacteria are Gram-negative anaerobes 
(Socransky et al., 1998). More recently, a study has confirmed these complexes through 16S 
pyrosequencing technology, which involves the extraction of DNA and circumvents the 
need for culturing the bacteria whilst allowing the collection of thousands of sequences per 
sample collected, giving high level of information on the composition of the oral community 
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at the species level. This study confirms the presence of the Gram negatives dominating the 
disease-related microbiome, however it showed the additional species to the disease-
related microbiome, specifically with the novel addition of a Gram-positive Spirochetes, 
Filifactor alocis which is appears to be at least as common as P. gingivalis and T. denticola 
and strongly associated with disease (Griffen et al., 2011), and still remains relatively under 
investigated to date.  
 A noted relationship within the red complex is that of P. gingivalis and T. forsythia where 
both are detected in higher numbers and more frequently in deeper periodontal pockets. P. 
gingivalis is never detected without T. forsythia, whilst P. gingivalis was always present in 
the sites with the deepest mean pocket depth (Socransky et al., 1998) which has led to the 
“keystone pathogen hypothesis” which is defined as “the species whose effects on their 
communities are disproportionately large relative to their abundance” (Hajishengallis et al., 
2012). If the keystone pathogen of a disease can be identified, the structure of the 
microbial community can be further understood and therefore the mechanisms that 
maintain the healthy relationship with the host, or indeed, the mechanisms that cause 
dysbiosis can also be investigated. P. gingivalis is considered to be the keystone pathogen 
of periodontal disease due to its ability to instigate inflammation despite being present at 
relatively low numbers, at the same time causing a significant alteration to the community 
organisation and the number or oral commensals (Curtis et al., 2011). A recent mouse 
model supports the keystone qualities of P. gingivalis as periodontitis was induced at very 
low colonization levels (0.01%), coupled to significant alterations to the organization of the 
oral microbiota (Hajishengallis et al., 2011). Because P. gingivalis is considered the keystone 
pathogen, this facilitates the possibility of novel treatments for polymicrobial diseases that 
target the limited number of species that cause the dysbiosis, stabilising the homeostatic 
balance and leaving the “health-associated” bacteria unharmed (Hajishengallis et al., 2012).  
1.6.2.1 The Red Complex 
The red complex bacteria are considered to be the major contributors to the progression of 
periodontal disease, with an increase in numbers and prevalence in these members are 
coupled to an increase in the clinical parameters of periodontitis (Steenbergen et al., 1984). 
A study by Rôças et al., (2001) detailed this consortium of bacteria as being heavily 
associated with endodontic infection , with clinical isolates from root canals, identifying the 
presence of at least one member of the complex in 33 out of 50 cases, with the detection of 
T. denticola, T. forsythia and P. gingivalis at 44%, 30% and 26% respectively in the number 
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of cases (Rôças, et al, 2001).  These bacteria are thought to be the major contributors to the 
later stages of periodontal disease as they are found deep inside the periodontal pocket 
(Suzuki et al., 2013). The appearance of these bacterial in many cases of periodontal 
disease suggests the presence of virulence factors which contribute to disease progression, 
including lipopolysaccharide, the capsule, secreted proteins for tissue destruction or 
fimbriae for attachment (Hajishengallis and Lamont, 2012).  
1.6.3 Treponema denticola 
The periodontal pathogen, T. denticola is a Gram-negative aerotolerant anaerobic 
spirochete (Syed et al., 1993) that is a member of the red complex responsible for 
furthering the progression of periodontal disease. T. denticola is one of at least ten species 
of the Treponema genus found in the oral cavity (Visser and Ellen, 2011) and displays a wide 
variety of virulence factors that allow host tissue penetration, immune evasion and 
ultimately survival and replication within the oral environment.  
The colonisation of the oral cavity by T. denticola has been well studied, and the bacterium 
is capable of forming a multispecies biofilm via adherence to other bacteria as well as 
various host proteins. T. denticola is capable of co-aggregating with various periodontal 
pathogens, such as P. gingivalis, F. nucleatum and T. forsythia through various surface 
proteins to form subgingival plaque (Hashimoto et al., 2003; Ikegami et al., 2004; Rosen et 
al., 2008). More recently, it has been shown that the haemagglutinins of these bacteria are 
essential in this interaction, such as the Hgp44 domain of the P. gingivalis gingipains and 
haemagglutinin A (Ito et al., 2010). 
The adherence and colonisation of the host is crucial in the virulence of this pathogen, T. 
denticola has been demonstrated to interact with various extracellular matrix (ECM) 
proteins, such as collagen, fibronectin and laminin (Haapasalo et al., 1991) to initiate the 
process of cell adherence and tissue penetration. T. denticola is also able to adhere to 
epithelial cells (Cells et al., 1819) as well as endothelial cells (Peters et al., 1999). This 
adherence is facilitated by the outer membrane proteins such as the major outer sheath 
protein (Msp) and the oligopeptide transporter unit (OppA). The Msp proteins are classic β-
barrel outer membrane proteins with surface-exposed loops, and demonstrate a plethora 
of roles in pathogenesis, from the adherence to ECM molecules and co-aggregation with 
other pathogens as mentioned above, as well immune activation and evasion, to the 
formation of pores in cell membranes of epithelial cells (Egli et al., 1993; Mathers et al., 
1996), which may contribute to nutrient acquisition via cell lysis or delivery of toxins into 
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the host cell (Mathers et al., 1996). The innate immune response is induced by T. denticola 
Msp proteins, such as MspA and MspTL, which initiate the production of pro-inflammatory 
cytokines IL-6, IL-8, TNF-α and IL-1β by macrophages and epithelial cells (Lee et al., 2009; 
Gaibani et al., 2010), which lead to the destruction of host tissues through an inflammatory 
response.  
One of the other major virulence factors of T. denticola is the protease, dentilisin. This 
protease complex, made up of three lipoproteins encoded by prcB-prcA-prtP gene locus 
(Fenno, 2012), displays a wide range of cytopathic effects on the host tissue, namely due to 
this proteolytic activity. In particular, this protease complex induces the permeability of 
intercellular junctions and the shrinkage of cells, which vastly increases the penetration 
ability of this bacterium (Chi et al., 2003), contributing to the pathogenesis of the chronic 
infection.  
Synergistic infections with this bacterium and other members of the red complex have 
demonstrated a significantly enhanced virulence and rapid progression of periodontal 
disease (Nath and Raveendran, 2013), and therefore it is important to have awareness of 
more than a single pathogen in the study of molecular determinant of periodontal disease.  
1.6.4 Tannerella forsythia 
Studies of the Gram-negative anaerobe, T. forsythia were relatively slow to come about due 
to its difficulty to culture in vitro and mechanisms for genetic manipulation were 
unavailable until around 2001 (Honma et al., 2001). T. forsythia has an essential 
requirement of the sugar N-acetylmuramic acid (NAM), which is a component of the cell 
wall; however this bacterium cannot synthesise NAM alone, so T. forsythia is often found 
growing synergistically with the other members of the red complex (Sharma, 2010). This 
synergy also is thought to contribute to an enhancement of the virulence of T. forsythia, as 
abscess formation in rabbits and alveolar bone loss in rats was greatly enhanced when 
coinfected with F. nucleatum or P. gingivalis (Takemoto et al., 1997; Kesavalu et al., 2007).   
T. forsythia is found associated with various form of periodontal disease, from early 
gingivitis to aggressive periodontitis (Tanner and Izard, 2006), and numerous studies have 
found T. forsythia to be implicated in the clinical attachment loss of the periodontal support 
structures in aggressive periodontal disease (Dzink et al., 1988; Listgarten et al., 1993). To 
date, only a relatively low number of putative virulence factors have been identified in T. 
forsythia, largely due to difficultly in genetic manipulation. T. forsythia possesses a surface-
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layer (S-layer) composed of at least two glycoproteins, encoded by tfsA and tsfB (Lee et al., 
2006). This S-layer provides a protective layer, whilst trapping metabolites from the 
environment and contributes to epithelial cell adherence and invasion (Sabet et al., 2003; 
Sakakibara et al., 2007). T. forsythia also encodes several homologs of a protein known as 
BspA, which has been shown to bind to the extracellular matrix components (Sharma et al., 
1998) as well as the other red complex pathogen, T. denticola (Hirt et al., 2002), indicating 
important interaction roles in the virulence of this pathogen. BspA also induces the release 
of various pro-inflammatory cytokines, such as IL-1β, IL-8 and TNF-α, contributing to the to 
the inflammatory destruction of periodontal disease (Bryzek et al., 2014). Sialidases, such 
as NanH, are also a critical virulence factor as they allow the cleavage of the terminal sialic 
acid residues from sialoglycoconjuates which are ubiquitously present in the oral cavity, in 
mucin and on epithelial cells for example (Roy et al., 2011). The sialic acid residues can be 
then used as a nutrient source, or to coat ligands on the cell surface for immune evasion 
and mediate cell-to-cell interactions (Honma et al., 2011). The bacterial sialidases 
themselves are involved in the induction of chemokines from epithelial cells (Kuroiwa et al., 
2009), revealing of cryptitopes for cell adhesion and invasion (Honma et al., 2011), 
degradation of host glycoproteins for nutrients (Bradshaw et al., 1994) and promoting the 
formation of biofilm (Soong et al., 2006). 
The combination of these virulence factors coupled to the synergistic growth of this 
bacterium with other members of the red complex make T. forsythia a formidable 
pathogen in periodontal disease.  
1.6.5 Porphyromonas gingivalis 
The bacterium P. gingivalis is a black-pigmented, Gram-negative obligate anaerobe 
belonging to the Bacteroidetes genus. P. gingivalis belongs to the red complex of bacteria, 
and is recognised as a major aetiological agent of chronic and severe cases of adult 
periodontal disease (Lamont & Jenkinson, 1998), and in fact, P. gingivalis was found in 
85.75% of subgingival plaque samples obtained from patients suffering from chronic 
periodontitis (Lenz et al., 2016). It grows on horse-blood supplemented agar, changing 
colour from beige to black after 4 – 5 days of growth (Holt et al., 1999) due to the essential 
acquisition of hemin from host cells. The acquirement of hemin is also coupled to 
pathogenesis as the host tissue is damaged due to haemolytic activity, releasing the hemin 
to support bacterial growth (Bramanti and Holt, 1991). The haemolytic activity of P. 
gingivalis is one of many virulence factors which contribute to the progression of 
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periodontal disease. Working either on its own or in an agonistic manner with other 
members of the orange and red complex, P. gingivalis can attach and invade host cells and 
apply a variety of virulence factors to cause disease, such as the lipopolysaccharide (LPS), 
capsule polysaccharide (CPS), gingipains, fimbriae and outer membrane proteins. More 
recently, strains of P. gingivalis have been classed as either non-invasive or invasive 
regarding their ability to form abscesses in murine models, and further demonstration has 
shown the invasive strains contain more pathogenic activities than their non-invasive 
counterparts, which will be discussed further in the next few sections (Dorn et al., 2000; 
Baek et al., 2015). 
1.6.6 Virulence Factors of P. gingivalis 
The virulence factors of P. gingivalis allow the bacteria to not only attach to cells and 
acquire nutrients for growth, but also to invade cells to multiply and evade the host 
immune system and cause tissue destruction leading to the progression of disease in a 
hostile host environment. The following section will deal with various structural and 
secreted virulence factors, and in particular how they relate to attachment and invasion of 
host cells, and the avoidance and subversion of the host immune system. 
1.6.6.1 Capsular Polysaccharide  
For a bacterium to colonise the oral cavity, it must be capable of adhering to oral structures 
such as teeth or mucosal surfaces, or to other bacteria to be able to resist the removal by 
the force of the saliva flow (Yoshimura et al., 2009). Not all strains of P. gingivalis contain a 
capsule, and the chemical composition varies between different strains, producing at least 
six serotypes of capsule antigens (K1-K6) (Laine et al., 1997). The capsule of P. gingivalis has 
been shown to influence the ability of P. gingivalis to adhere to epithelial cells found in the 
periodontal pocket (Dierickx et al., 2003), whilst other studies have demonstrated the 
adherence and aggregation with the “bridging” pathogen, F. nucleatum from the orange 
complex, is capsular dependant (Rosen and Sela, 2006).  
Capsulation of bacteria was originally seen to only protect bacteria from the host immune 
system by reducing the ability of immune effectors to reach the bacteria, however more 
recently, the capsule is seen to induce an immune response and promoting virulence. This 
leads to a long-term survival and a long-term, low level of inflammation leading to a chronic 
infection. Two complementary studies showed encapsulated strains of P. gingivalis trigger 
different immune responses from the host in comparison to mutant strains absent in 
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capsules (Glaros, et al., 2009; Vernal et al., 2009).  However, these studies used mutants 
with differing genotypic backgrounds to the capsule-possessing strains so the data couldn’t 
ultimately confirm the role of the capsule. A recent study from Brunner et al., (2010) 
demonstrated that the presence of a capsule can cover the short fimbriae, hiding them 
from the host immune system, and suppressing a pro-inflammatory response. The 
capsulated strain also was shown to down-regulate the cytokine response, another pro-
inflammatory response, in addition to an increased induction of various interleukins (IL-6, 
IL-8) in the absence of a capsule (Brunner et al., 2010). This study was supported by Singh 
et al., (2011) who show an increase in the level of cytokine suppressors, inhibiting an 
inflammatory response which keeps the bacteria hidden from the immune system for 
longer, in comparison to the non-capsulated strain (Singh et al., 2011).  In addition to this 
survival method, the capsule has been shown to also reduce the effects of defensins, the 
bactericidal small antimicrobial peptides (Igboin, 2011), leading to increased survival and 
prolonged infection. 
1.6.6.2 Lipopolysaccharide 
The LPS of Gram-negative bacteria is the major outer membrane component, which 
provides structural integrity, protection from chemical attack and causes a strong immune 
response from the host due to its endotoxin properties (Caroff and Karibian, 2003). The 
pure LPS of P. gingivalis reduces the expression of E-selectin, a cell adhesion molecule 
expressed on the surface of endothelial cells, which reduces the ability of neutrophils to 
attach to endothelial cells, and thereby decreasing migration to the site of infection 
(Darveau et al., 1995). The LPS of P. gingivalis has also been shown to play a vital role in 
facilitating inflammation by inducing cells to secrete pro-inflammatory cytokines, such as IL-
1β and TNF-α, causing tissue destruction (Kadono et al., 1999), whilst disrupting the bone 
remodelling process (Kato et al., 2014). The LPS has been shown to bind TLRs, activating 
intracellular inflammatory signalling pathways of the host cell, such as the c-Jun N-terminal 
kinase (c-JNK) pathway and upregulating cytokine gene expression (Okahashi et al., 2004). 
The LPS of P. gingivalis has also been shown to cause “chemokine paralysis” whereby it 
contributes to the prevention of gingival epithelial cells to secrete IL-8 which would usually 
activate neutrophils and basophils (Darveau et al., 1998). This results in an absence of an 
effective innate response allowing a sharp increase in bacterial load in the gingival area, 
consistently seen in the aetiology of periodontal disease.  
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The LPS is made up of three components, the core oligosaccharide, the O-antigen and the 
Lipid A molecules (the endotoxin portion of LPS) (Ogawa and Yagi, 2010). P. gingivalis is 
capable of expressing a heterogeneous mixture of structures of the latter which interact 
with TLRs of the innate immune system. Different lipid A structures interact with TLRs in 
very different ways, from triggering TLR2, to antagonising TLR4 activation, which is the 
reverse of most Gram-negative bacteria (Darveau et al., 2004). The Lipid A produced by P. 
gingivalis can be a mixture of two glycan repeating units, O-antigen tetrasaccharide 
repeating units or anionic (A-antigen) polysaccharide repeating units (Rangarajan et al., 
2008), and the structure relies upon the influence of microenvironmental hemin 
concentrations, which itself is reliant upon inflammation (Gaffen and Hajishengallis, 2009). 
This differentially regulated structure production indicates an ability to manipulate the host 
innate immune response and eventually suppress the TLR-mediated immunity. Recent 
studies have shown the differences in the LPS profile contributes to a resistance to 
polymyxin B (Díaz et al., 2015), however the role of the different structures and 
components of LPS is still poorly understood.  
1.6.6.3 Attachment and Invasion 
Host cell invasion by an infecting bacterium is hugely advantageous in a number of ways. 
An intracellular location provides protection from the host immune system, facilitate 
replication in a nutrient-rich environment, whilst also affording cell-to-cell spreading of the 
bacteria or allow tissue destruction. The mechanism of invasion, in general terms, begins 
with the attachment of bacteria to the cell membrane thereby inducing a collection of 
biochemical and structural changes, resulting in the entry of the host cell (Beachy, 1981). In 
many cases after attachment, the subsequent signalling cascade in the host cell causes 
protein phosphorylation, ion fluxes and protein synthesis leading to cytoskeleton 
rearrangement, facilitating entry of the bacterium (Bliska et al., 1993).  
A well-studied mechanism of invasion through actin rearrangement is by the pathogenic 
Salmonella strains. These bacteria are not only highly adherent to the host cell but have 
particularly efficient invasive machinery through secretion of effectors by the Type Three 
Secretion System (TTSS) into the host cell (Pizarro-Cerdá and Cossart, 2006). The bacteria 
are especially effective in invasion as they use both “trigger” and “zipper” mechanisms of 
invasion, the former involving the injection of effectors triggers a large-scale cytoskeleton 
rearrangement from the inside of the host and formation of membrane ruffles, allowing 
internalisation of the bacterium. Specifically, the SpiC protein of the TTSS drives actin 
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polymerisation and bundling of the actin filaments, whilst SopE activates GTPases for actin 
polymerisation and the formation of the membrane ruffles (Agbor and McCormick, 2011; 
Ribet and Cossart, 2015). The latter “zipper” mechanism causes only minor cytoskeletal 
rearrangements relying on specific contact to a host cell receptor, and has only been 
recently recognised for certain strains of Salmonella (Rosselin et al., 2010). 
Rather than using a host cell receptor for invasion, the Enteropathogenic E. coli (EPEC) 
generates its own receptor for adhesion by injecting the translocated intimin receptor (Tir) 
into the host via the TTSS, which inserts itself into the host cell membrane for the bacterial 
adhesins to interact with (Kenny et al., 1997) 
There is a huge diversity amongst bacteria in the adherence and invasion for colonisation of 
the host. The identification of host cell receptors used by pathogenic invading bacteria is a 
valuable tool in the combating of disease, as it can be used to design therapeutic agents to 
interrupt the host-pathogen interaction and prevent the disease occurring.  
1.6.6.4 Adherence and Invasion of P. gingivalis  
The invasive capabilities of P. gingivalis were first demonstrated by Lamont and his group in 
the early 1990’s, where primary cultures of gingival epithelial cells were subject to P. 
gingivalis through an antibiotic protection assay which counts the number of bacteria that 
can invade a host cell, and the total number of bacteria that associate with the host cells to 
determine attachment and invasive capabilities (Lamont et al., 1992). Further work has 
shown invasion of a multi-layered pocket epithelium (Papapanou, et al., 1994) and even 
invasion of aortic and heart endothelium (Deshpande et al., 1998). It has been proposed 
that one of the major factors contributing to the pathogenesis of P. gingivalis is in its ability 
to invade host cells, and facilitating the invasion of other Gram-negative species to further 
the progression of periodontitis (Hajishengallis et al., 2012).  
Various molecular mechanisms of invasion by P. gingivalis have been well characterised and 
will be discussed below. Invasion is a very complex process there appears to be no one 
definitive method of invasion. Whilst some mechanisms are deemed “major” there are 
multiple routes available to the bacteria to use in a complementative manner. 
 1.6.6.4.1 Fimbriae  
There is a great deal of evidence indicating the involvement of P. gingivalis fimbriae for 
attachment and invasion purposes and a large number of studies have been carried out 
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since its first identification by Yoshimura et al. in 1984. Fimbriae are non-flagellar protein 
filaments which project out from the bacterial cell surface (see Fig 1.6). Yoshimura purified 
and characterised a 43 kDa protein subunit, fimbrillin, using SDS-PAGE techniques, and 
detailed the morphological and immunological features (Yoshimura et al., 1984). This 
protein subunit was later discovered to be encoded by the fimA gene and was identified as 
the major type of fimbriae that P. gingivalis possesses. The minor type known as Mfa1 is 
comprised of a 74 kDa protein but is less well characterised due to its shortened length 
making it more difficult to purify (Hasegawa et al., 2009).  
 
 
Figure 1.6 Electron microscopy of P. gingivalis indicating the presence of Fimbriae. Red 
arrows indicate the fimbrial structures. Images taken from this study. 
 
Recently, it was demonstrated that the fimbriae of P. gingivalis may be involved in 
adherence to the cell through their specific binding to fucose moieties, which indicates a 
potential fucose-specific interaction with the fimbriae of P. gingivalis with the host cell for 
adherence (Sojar and Smith, 2012). Whereas the major fimbriae have been shown to be 
involved in adhesion to epithelial cells and the subsequent downstream signalling events 
involved in invasion in many studies, and indeed the mutation of the fimA gene causes a 
great reduction in the invasive capability (Weinberg et al., 1997; Njoroge et al., 1997). 
Fimbrial-deficient strains of P. gingivalis have been shown to display poor invasive 
capabilities, poor binding to tooth surfaces and salivary components, and cannot produce 
periodontitis in rats, suggesting their clear role in invasion and the disease process (Malek 
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et al., 1994). Yilmaz et al. demonstrated a direct physical association between fimbriae and 
β1 integrins, and using anti-ß1 antibodies to inhibit binding, elucidated the target of 
epithelial cells as the α5β1 integrins (Yilmaz, 2003). Integrin activation is thought to be 
linked to phosphorylation of paxicillin, a focal adhesion protein, and focal adhesion kinase 
(FAK), which activate signalling molecules, leading to the assembly of focal adhesion 
complexes (Yamada and Geiger, 1997). The construction of these complexes is thought to 
contribute to the generation of forces which regulate cytoskeleton dynamics through 
affecting actin and microtubule activity (Yilmaz, 2003). A fimA mutant created in this study 
showed only a 10-fold decrease in internalisation by epithelial cells, so therefore showing 
that fimbriae are not the only method for invasion. Indeed, not all variants of invasive P. 
gingivalis contain the fimA gene (Andrian et al., 2006).  The FimA protein is noted to not 
only be involved with the interaction of human epithelial cells, but also to other bacterial 
species during colonisation of the subgingival surfaces. Studies have shown that FimA is 
capable of interacting with the prokaryotic protein, glyceraldehyde-3-phosphate 
dehydrogenase on many Streptococcus species (Maeda et al., 2004). The subsequent build-
up of P. gingivalis into a mixed-species biofilm is thought to be due to an additional 
interaction of Ssp proteins on the surface of Streptococcus species with the minor fimbriae, 
Mfa1 (Park et al., 2005). Mfa1 has also been shown to facilitate autoaggregation of P. 
gingivalis, thereby permitting the bacteria to accumulate to prevent elimination from the 
subgingival regions due to shearing forces or salivary flow allowing efficient infection (Lin et 
al., 2006). The minor fimbriae are also attributed to the stimulation of IL-1α, IL-1β, IL-6 and 
TNF-α, by macrophages, and is thought to be the causative agent of alveolar bone in 
murine models (Amano et al., 2004). 
1.6.6.4.2 Gingipains 
Gingipains are cell-surface anchored proteolytic enzymes that are used by the bacterium in 
a multitude of ways, including the cleavage of receptors found on the host-cell surface, 
inactivation of components of the complement system such as cytokines, to obtain 
nutrients and also to stimulate certain protease-activated expression by host-cell receptors 
(Andrian et al., 2006). As well as cell-associated, gingipains can also be secreted or 
membrane bound on vesicles, called “blebs” (Grenier et al., 1989) and can be up to 85% of 
the extracellular proteolytic activity displayed by P. gingivalis at the site of infection (de 
Diego et al., 2014). These targets and functions of gingipains activity contribute to the 
maintenance of the chronic inflammatory state at the infection site, which can lead to cell 
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lysis and the expelling of nutrients from host cells. Coupled to this, gingipains can activate 
plasma kallikrein (human serine proteases), degrade fibrinogen and increase the levels of 
thrombin, all to increase the vascular permeability and increase bleeding to increase the 
availability of heme, a requirement for P. gingivalis growth (de Diego et al., 2013). Stafford 
et al., (2013) demonstrated how secreted gingipains also manipulate the host cell 
responses by the degradation of the mammalian target of rapamycin (mTOR). This study 
created mutants in the gingipains genes, including a triple ragABkgp mutant which couldn’t 
invade cells, and showed that secreted gingipains, especially the Lys gingipain, degrades the 
mTOR which may contribute to the change in certain cellular process such as proliferation, 
cell survival and autophagy which are all observed during a P. gingivalis infection (Stafford 
et al., 2013). The gingipains have also been shown to be important in the growth of T. 
forsythia and A. actinomycetemcomitans in multi-species biofilms (Bao et al., 2014; 
Haraguchi et al., 2014) 
There are two types of gingipains, the arginine-specific gingipains, of which there are two, 
encoded by the rgpA and rgpB genes, and the lysine-specific gingipains, encoded by the kgp 
gene (Travis et al., 1997). All three genes are conserved amongst both laboratory strains 
and clinical isolates, demonstrating the essentiality of gingipains for bacterial survival and 
proliferation. The arg-specific gingipains cleave the Arg-X dipeptide bond, and the lys-
specific gingipains cleaves the carboxy-terminal (COOH) side of the lysine residue. RgpA and 
Kgp have been shown to contain a heamagglutinin-adhesin domain which has also been 
implicated in the coaggregation of P. gingivalis with other oral pathogens involved in 
periodontal disease, such as T. denticola and S. gordonii (Guo et al., 2010). Gingipains are 
also required in the processing of other virulence factors, such as FimA, which is secreted in 
a precursor form onto the cell surface and needs the proteolysis from Rgps to be able to 
assemble into the filamentous form (Shoji et al., 2004).   
Gingipain proteolytic activity is thought to be modulated by a number of mechanisms. The 
putative outer membrane protein, VimA is thought to influence the proteolytic activity of 
the gingipains via post-translational modification of the protein with an uncharacterised 
glycan group. For example, a ∆vimA mutant shows significant reductions in haemolytic and 
proteolytic activities, resulting in a non-black pigmented phenotype, despite no alterations 
in the gingipain expression levels but does display altered reaction with a glycan specific 
antibody (Abaibou et al., 2001; Vanterpool et al., 2006). Gingipain maturation is also 
thought to be modulated by the Por secretion system (PorSS), which is thought to be 
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involved in translocation of proteins across the outer membrane (Sato et al., 2010) and 
anchoring of the gingipains to the surface (Chen et al., 2011). The PorSS gene locus is 
encoded by several por genes, which make up a unique secretion system that bears no 
homology to the type I-VIII secretion systems seen in many bacteria. P. gingivalis is known 
to produce upwards of 30 putative CTD motif-containing proteins (Veith et al., 2013; 
Taguchi et al., 2016), including the gingipains which are recognized by the porT gene 
product in the periplasm to be secreted (Sato et al., 2010). Whilst in the periplasm, the 
gingipains are processed into the final form by the cleavage of the prodomains (Glew et al., 
2012), and glycosylated. The Sov protein then is involved in the translocation of the 
processed gingipain across the outer membrane (Saiki and Konishi, 2012), before PorU 
cleaves the CTD from the protein (Glew et al., 2012) and conjugation to the A-LPS occurs of 
membrane-anchored gingipains. This process can be seen diagrammatically in Figure 1.7. 
Mutations in the porR gene of the PorSS gene locus showed production of Rgp and Kgp, but 
they were not retained on the bacterial cell surface (Shoji et al., 2002), indicating a role in 
anchoring the gingipains to the A-LPS, and a deletion in the terminal 2 residues of the CTD 
results in the proteins being trapped in the periplasmic space (Chen et al., 2011), detailing 
their critical need in the targeting of these proteins to the PorSS system.  
  
Figure 1.7 Summary of the secretion of the gingipains via PorSS. After secretion across the 
inner membrane via the Sec system (1), the Sec-signal is removed with the prodomains via 
PorT (2-3), whose location within the periplasm is still under investigation. This is followed 
by translocation across the outer membrane via the Sov protein (4), with further processing 
of the protein occurring to remove the CTD (5) via the action of PorU. The gingipains are 
then attached to the A-LPS via the PorV protein for membrane anchoring. Diagram created 
by Kathryn Naylor and Chatchawal Phansopa for a review (Douglas et al., 2014), and used 
with permission.  
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Gingipains have been positively implicated in the attachment (Chen and Duncan, 2004) and 
negatively in the invasion (Suwannakul et al., 2010) of host cells, i.e. the presence of 
gingipains increases the ability of attachment to epithelial cells, yet the deletion of 
gingipains by Suwannakul showed an increase in invasion (Suwannakul et al., 2010). These 
demonstrate the ubiquitous nature of the gingipains and their involvement in many 
virulence processes of pathogenicity of P. gingivalis.  
1.6.6.4.3 Haemagglutinins  
The haemagglutinins are a large class of virulence factors of P. gingivalis with a variety of 
roles in the infection process, but with a particular importance in the acquisition of iron. As 
P. gingivalis lacks siderophore scavenging systems, the Hag proteins are involved in the 
acquisition of heme for growth from erythrocytes (Lépine et al., 1996). Haemagglutinins are 
expressed on the cell surface of the bacteria, either in association with filamentous 
structures (fimbrial adhesins) or associated with nonfimbrial components (nonfimbrial 
adhesins) (Han et al., 1996) 
P. gingivalis possesses at least 8 haemagglutinins (Lamont and Jenkinson, 2000), however 
only a few of them have been well characterised in a role for host-cell interaction. The 
gingipains RgpA and Kgp both contain haemagglutinin domains (Hgp44, -15, -17 and -27) 
(Potempa et al., 2003), where Hgp44 is also known as HagA and has been demonstrated to 
be important in the coaggregation of P. gingivalis with T. denticola as previously discussed 
(Ito et al., 2010). Song et al (2005) demonstrated that HagB facilitates adherence to 
endothelial cells, but it alone is not sufficient for the internalisation of the bacterium (Song, 
Bélanger, Whitlock, Kozarov, Progulske-fox, et al., 2005), suggesting other molecules are 
responsible for the invasive step. More recently, HagB and also HagC have been implicated 
in mediating the bacterium’s adherence to oral epithelial cells, with an additional 
implication of the HagB involvement in invasion of the host cell (Connolly et al., 2015). 
1.6.6.4.4 Sialidases 
P. gingivalis like many pathogenic bacteria, synthesise sialidase enzymes which utilize and 
cleave host sugars known as sialic acids for use as nutrients or as “camouflage” from the 
immune system, by decorating their own surface exposed molecules such as the LPS with 
the host-derived sialic acid (Li et al., 2012). Sialidases are regarded as virulence factors in 
many bacteria, such as Vibrio cholerae, which uses sialidases to increase the activity of the 
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exotoxin (Galen et al., 1992), whilst P. aeruginosa uses the sialidase enzymes to enhance 
the binding to the host cell (Cacalano et al., 1992). P. gingivalis is also thought to use 
sialidases, neuraminidases in particular, for a multitude of virulence processes. A study by 
Aruni et al., (2011) analysed the activities of several sialidases of P. gingivalis and 
hypothesised the use of neuraminidases PG0778 and/or PG1724 to hydrolyse the mucin on 
the epithelial cells, which exposes the terminal sialic acids for PG0352 to cleave and 
enhance the adherence to host cells. When the gene sequences for these neuraminidases 
are deleted, the adhesion and invasion of P. gingivalis is greatly affected. These mutants 
also showed no change in gene expression of the gingipains, but their activities were 
reduced by up to 90%, suggesting a role for sialidases in the post translational regulation of 
gingipains (Aruni et al., 2011). An extensive study by Li et al., (2011) demonstrated the 
importance of PG0352 in biofilm formation (reduced 2.5-fold in the mutant), and in 
capsular production, as an intact capsule was not observed using cryo-ET (Li et al., 2012).  
1.6.7 Effects on the Immune System: The Oral Context  
The periodontal breakdown occurring in periodontal disease relies on very complex 
interactions between the bacterial components and the host defence mechanisms, which 
influence the balance between host protection and bacterial aggression, and ultimately can 
lead to chronic disease (Hajishengallis et al., 2012). For P. gingivalis to be a successful 
pathogen it relies on more than just the capacity for virulence factors to secure a niche and 
persist within it, the bacterium must also evade or subvert the host immune system to be 
able to establish a chronic infection. Initially an infecting pathogen will encounter the 
innate immune system, which is thought to be preferentially targeted by many microbes 
(Rosenberger and Finlay, 2003); however by subverting the innate host mechanisms, this 
may also undermine the adaptive immune response, debilitating the overall host response 
mechanisms (Medzhitov, 2007).   
At the start of infection, the bacteria are subject to detection and killing by the host 
immune system. As part of the innate immune system, neutrophils migrate to the site of 
infection via chemotaxis signalling, and indeed, the huge accumulation of neutrophils in the 
junctional epithelium, the gingival epithelial tissue and the periodontal pocket is a classic 
hallmark of chronic periodontitis (Murray and Patters, 1980). Gingival epithelial cells 
produce interleukin 8 (IL-8) to attract neutrophils and to activate them for intra- and extra-
cellular killing. However, P. gingivalis is capable of causing “local chemokine paralysis” 
whereby they inhibit the production of IL-8 via several mechanisms to suppress the influx of 
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neutrophils to the crevicular niche. The serine phosphatase protein, SerB, inhibits synthesis 
of IL-8 by epithelial cells, thereby delaying the recruitment of neutrophils and allowing 
further time for the bacterium to colonise the host (Hajishengallis, 2012). The gingipains of 
P. gingivalis have also been shown to degrade the IL-8 cytokine using soluble and vesicle-
associated gingipains, mainly Arg-specific gingipains. In the study by Mikolajczyk-Pawlinska 
(1998), the degradation of IL-8 appears to be in a concentration dependant manner, where 
the concentration of vesicle-associated gingipains is high in close proximity to the dental 
plaque biofilm on the tooth pellicle, providing a safe niche from neutrophil killing 
(Mikolajczyk-Pawlinska et al., 1998). Soluble gingipains have the ability to diffuse away 
further and reach the gingival epithelial tissues to prevent release of IL-8, providing extra 
protection. P. gingivalis is also implicated in stimulating T helper cells, such as Th17, which 
causes the production of IL-17. This cytokine is thought to be involved in the destruction of 
alveolar bone that is often observed in severe cases of periodontitis (Gaffen and 
Hajishengallis, 2009). 
Once reaching the host cells unharmed by neutrophils, P. gingivalis is known to invade 
epithelial cells, providing protection from the humoral immune system (i.e. recognition by 
antibodies). However, once inside the host cell, the bacteria are not completely protected 
as cell-mediated killing, such as the targeting of P. gingivalis-infected epithelial cells by 
cytotoxic T cells, macrophages and natural killer cells, which will encourage destruction of 
the host cell. These host-mediated killing cells are activated by IL-12 produced by 
macrophages. P. gingivalis can again inhibit this interleukin by the use of fimbriae to 
interact with the complement receptor-3 (CR-3), activating a kinase to selectively inhibit the 
production of IL-12.  
If the infecting bacteria manages to subvert all other attacks from the host immune system, 
the cell has a last resort to prevent replication and spreading of the infection, to cause 
apoptotic cell death (Yilmaz, 2008). P. gingivalis can prevent the apoptosis process of host 
cells by the secretion of an ATP-hydrolysing enzyme, inhibiting ATP-induced apoptosis. 
Apoptosis may also be inhibited by the down-regulation of Bax expression, an apoptotic 
molecule, or the up-regulation of Bcl-2 expression, an anti-apoptotic molecule (Nakhjiri et 
al., 2001). However, in certain circumstances, P. gingivalis may use the apoptosis event as a 
“safe exit” from the cell, to allow spreading of the infection (Gaffen and Hajishengallis, 
2009).  
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1.6.8 Intracellular Spreading of P. gingivalis  
The invasion of P. gingivalis is completed in around 15 minutes and once inside the cell, P. 
gingivalis is thought to localise at the perinuclear region where it has been observed to 
persist for up to 8 days without causing cell death (Belton et al., 1999). Recently, a study by 
Yilmaz et al., showed that P. gingivalis is capable of using the same actin-dependant 
mechanism used to invade the cell initially, to allow cell-to-cell spread. The results of the 
study demonstrated intercellular spreading utilises cytochalasin D for polymerisation of 
actin filaments to form projections for P. gingivalis to be transmitted to adjacent cells 
(Yilmaz et al., 2002). This is been further supported by a study demonstrating the presence 
of P. gingivalis in the connective tissue between adjoining cells (Katz et al., 2000). 
The internal environment of a mammalian cell is vastly different for the P. gingivalis to 
enter compared to the extracellular space. There will be many environmental pressures the 
bacteria needs to adapt to via genetic and protein regulation. Hosogi & Duncan 
demonstrated using transcriptional profiling that during attachment to HeLa cells, there 
was an up-regulation in genes encoding heat-shock proteins and oxidative stress response 
genes, indicating an exposure to oxidative stress upon attachment to host cells (Hosogi and 
Duncan, 2005). A protein profiling study using whole-cell proteomic analysis was carried out 
between internal and external P. gingivalis showed interesting results. Virulence factors 
such as FimA, RgpAB and Kgp all show a decrease in expression when P. gingivalis is 
internalized (Xia et al., 2007). It is evident that from this study, virulence factors that help 
the bacteria gain entry into the host cell soon become superfluous and are down regulated 
to prevent an excessive expenditure of energy.  
A recent study from The University of Sheffield has shown a “signature” set of genes that 
are shown to be differentially regulated in the invading populations of P. gingivalis. Using a 
modified standard antibiotic protection assay, Suwannakul et al., initially identified a sub-
population of bacteria that were more adapted at invading host epithelial cells, before 
identifying the genes that appear to be involved (Suwannakul et al., 2010). This involved 
exposing oral keratinocytes to two strains of P. gingivalis (NCTC 11834 and W50), isolating 
the invading bacteria and immediately allowed them to invade a fresh monolayer of 
keratinocytes as shown in Figure 1.8. The invaded bacteria form the second round were 
isolated and analysed through viable plating and microarrays. Bacteria found in the 
supernatant of the first round of invasion (non-invaded bacteria) were shown to be less 
invasive in the second round of invasion, compared to the bacteria isolated from inside the 
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host cell in the first round, indicating that different subpopulations exist within an entire 
population of P. gingivalis, including invasive and non-invasive subpopulations (Suwannakul 
et al., 2010). 
 
Figure 1.8 Schematic of the invasive population of P. gingivalis. A natural P. gingivalis 
population is thought to contain subpopulations of invasive and non-invasive bacteria. 
Invasive subpopulations invade host cells (round 1), and after culturing on blood agar 
plates, are capable of re-invading host cells before being isolated and cultured for a second 
round (round 2). Invasive populations retain their invasive capabilities when subcultured on 
blood agar for 12-18 generations before mixed invasive populations redeveloped. Figure 
adapted from (Suwannakul et al., 2010). 
The microarray experiments were carried out to assess global gene expression changes 
between the invasive and non-invasive subtypes, which identified 139 and 136 genes 
differentially regulated (>3.5 fold) in P. gingivalis ATCC 33277 (wild-type) and W50 (non-
fimbriated strain) respectively. Because it was shown that a lower gingipain activity 
correlated with a higher invasive capability, the group tested the gene expression in two 
sets of microarray experiments; high versus low proteinase activity and invasive versus non-
invasive sub-populations. This identified 19 genes which are differentially regulated in all 
four datasets, which can be seen in Table 1.1. Of note, it is interesting to see the down-
regulation of cell-associated rgpB, which explains the reduced gingipain activity in the 
invasive subtype of the population. It is a necessity for the gingipain proteins to be down 
regulated as a potential overexpression intracellularly could result in excessive damage to 
the inside of the host cell. Also to note, the putative periplasmic chaperone protein, OmpH, 
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was upregulated in all four datasets. This protein is a periplasmic chaperone protein that 
assists in the assembly of many of the outer membrane proteins, some of which are 
thought to be involved in invasion, such as the OmpA protein. Various stress-related genes 
were upregulated in their expression, such as oxyR and sodB, which may be needed in 
response to the change to an intracellular environment, such as the exposure to reactive 
oxygen species. A common occurrence amongst the upregulated genes also included the 
heme-acquisition genes such as feoB-1 and hmuR, suggesting that the intracellular 
environment may be hemin-limiting. Analysing the effects these genes have on invasion 
when a mutant is created with the gene deleted may hold further information on how the 
P. gingivalis bacteria is so adept at invading, and may yield potential pathways to target for 
disruption in an anti-microbial therapy. 
Table 1.1 Regulated genes in the signature gene set 
Gene No. Name Location Function Reg.
A
 SD
B
 
PG0063 PG0063 OM putative outer membrane efflux pump 6.30 2.9 
PG0104 topB CY DNA topoisomerase III 3.64 0.2 
PG0193 ompH PP cationic outer membrane protein OmpH 4.16 0.5 
PG0205 prfC CY peptide chain release factor 3 4.33 0.7 
PG0270 oxyR CY redox-sensitive transcriptional activator 
OxyR 6.61 1.4 
PG0328 hutI CY imidazolonepropionase 7.58 4.7 
PG1043 feoB-1 CY ferrous iron transport protein B 4.81 1.9 
PG1058 PG1058 OM putative Outer membrane protein 4.65 1.9 
PG1106 murF CY murein sacculus synthesis 9.86 8.1 
PG1481 TraG CY conjugative transposon protein TraG 4.14 0.5 
PG1545 sodB CY superoxide dismutase, Fe-Mn 8.01 0.6 
PG1552 hmuR OM TonB-dependent receptor HmuR 5.78 3.5 
PG1560 rfbB CY dTDP-glucose 4,6-dehydratase 10.29 6.6 
PG1638 trx PP thioredoxin family protein 7.92 4.6 
PG1807 atpK IM v-type ATPase, subunit K 10.09 4.1 
PG2190 ftsE IM cell-division ATP-binding protein 6.70 0.8 
PG0506 rgpB EC arginine-specific cysteine proteinase -3.57 0.1 
PG0910 PG0910 CY FHA domain protein -4.10 0.5 
PG1824 eno CY enolase -3.49 0.2 
Abbreviations: RegA, Regulation; SD, Standard Deviation; OM, outer membrane; CY, 
cytoplasmic; PP, periplasmic; IM, inner membrane; EC, extracellular. 
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1.6.9 The Gram-negative Outer Membrane  
The cell envelope of Gram-negative proteins consists of two membranes, the inner and the 
outer membrane, which display differing compositions. These membranes are separated by 
the periplasmic space, containing a peptidoglycan layer. The outer membrane is an 
asymmetric bilayer, made up of an inner phospholipid layer and a lipopolysaccharide layer 
(LPS) layer and usually several major proteins, known as outer membrane proteins (OMPs). 
The outer membrane provides a protective barrier against environment stresses, such as 
biophysical, chemical and biological attacks (Nikaido, 2003), whilst also allowing the 
selective uptake of nutrients essential for growth and the secretion of toxins, effectors and 
metabolic waste products (Masi and Pagès, 2013). A schematic of the cell envelope can be 
seen Figure 1.9. The outer membrane proteins also often serve as antigen-recognition sites 
to the host immune system, as studies have shown outer membrane proteins are capable 
of inducing pro-inflammatory cytokines (IL-1β and IL-6) from T-helper cells activated with 
proteins found in the outer membrane of P. gingivalis (Gonzales et al., 2014). 
 
Figure 1.9 Schematic of the typical cell membrane of a Gram-negative cell.  
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Outer membrane proteins are usually classed as either outer membrane lipoproteins, 
which are anchored via an N-terminal lipid tail, or classed as integral outer membrane 
proteins, which contain membrane spanning regions, often β-barrels (Bos and Tommassen, 
2004). Almost all of these types of proteins show an even number of β-sheets running in an 
antiparallel fashion (Fairman et al., 2011), which is evolutionally conserved due the high 
stability they provide in the membrane. The outer membrane proteins are an integral part 
of the bacterium, with as much as 3% of the overall Gram-negative genome encoding them 
(Wimley, 2003), and therefore it is expected they demonstrate a wide variety of roles, 
ranging from virulence, transporters and channels for nutrient uptake, enzymatic roles such 
as proteases, etc. (Rollauer et al., 2015) Due to the exposed location on the extracellular 
face of the bacterium, outer membrane proteins are often found associated with 
pathogenesis, such as the porin OprF in Pseudomonas aeruginosa, which is responsible for 
the virulence of the bacterium, with knock-out mutants causing significantly less necrosis in 
eukaryotic models and a reduction in the toxins secreted (Fito-Boncompte et al., 2011). The 
OprF protein has been shown to be involved in adherence to epithelial cells (Azghani et al., 
2002; Fito-Boncompte et al., 2011) and in the formation of a biofilm (Hassett et al., 2002).  
The outer membrane and its protein components are involved in a plethora of roles within 
pathogenesis, including the interaction with the host cell and the host defence mechanisms 
so it is important to understand the composition. 
1.6.10 Outer Membrane of P. gingivalis 
Analysis of the outer membrane proteins of P. gingivalis has been limited due to the 
hydrophobic nature of these proteins. One of the earliest studies of the outer membrane 
proteins was performed by Yoshimura et al (1989) which identified a 75 kDa protein 
involved in the activation of B-cells to produce IL-1 in murine macrophages (Yoshimura et 
al., 1989; Watanabe et al., 1992). This was followed by the identification of a 40 kDa 
protein by Saito et al (1997), which was shown to be involved in the aggregation of P. 
gingivalis with A. viscous, an early coloniser of tooth structures, and it therefore important 
in the ability of P. gingivalis to form a biofilm (Saito et al., 1997; Maeba et al., 2005). This 
protein since has been isolated and shown to provide protection against alveolar bone loss 
in animal models when used as a vaccine (Zhang et al., 2009; Liu et al., 2010), and proved 
especially effective when introduced nasally in conjunction with the cholera toxin (Cai et al., 
2013) demonstrating the importance of the understanding of the outer membrane of P. 
gingivalis against fighting periodontal disease.  
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A defining study by Murakami et al (2002) identified seven major outer membrane 
proteins, Pgm 1 – 7.  Pgm 1 was identified using the then recently obtained genomic 
sequence of P. gingivalis as RagA. RagA (alongside RagB) is a TonB-linked receptor complex, 
with extensive homology to susC of Bacteroides thetaiotaomicron which is known to be 
involved in the uptake of maltose (Murakami et al., 2002). Further studies have shown the 
deletion of the RagAB proteins result in a bacterium severely reduced in virulence, 
suggesting the need for the Rag proteins for the transport of large degradation products of 
proteins across the cell membrane as part of the virulence of P. gingivalis (Nagano et al., 
2007). The RagB protein has been associated with the invasion of epithelial cells (Nagano et 
al., 2007; Dolgilevich et al., 2011) and is involved in the induction of pro-inflammatory 
mediators (Hutcherson et al., 2015), but one of its major functions inferred from the 
structural determination is that of a sugar transporter across the P. gingivalis membrane 
(Goulas et al., 2015). Pgm 3 and 5 are noted to be the Lys- and Arg-gingipain proteins 
respectively, and are important in virulence as described previously. Pgm 6 / 7 were 
identified as the immunoreactive antigens PG32 and 33 respectively, also known as Omp40 
and Omp41 (Veith et al., 2001), or OmpA1 and OmpA2, and discussed further in a later 
section.  
1.6.11 The OmpA Protein in Gram-negative Bacteria  
The OmpA family of proteins are surface-exposed, temperature-affected porin proteins 
that are expressed in relatively high numbers in the outer membrane of all Gram-negative 
bacteria (Beher et al., 1980). The structure is characterised by a C-terminal domain which 
forms a globular shape that associates with the peptidoglycan layer, and an N-terminal 
domain that forms an eight-stranded, ß-barrel structure embedded in the outer membrane 
with exposed extracellular loops (Wang, 2002), as shown in Figure 1.10.  
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Figure 1.10 The predicted structure of E. coli OmpA. The structure is predicted to form a β-
barrel structure in the outer membrane with a peptidoglycan-associated globular domain. 
Dotted line represents the expected chain between the two domains as each structure was 
submitted separately into Uniprot, and therefore doesn’t model as one entity.  
 
The overall structural homology remains largely conserved between species; however 
significant variations are observed in the extracellular loops (Pautsch and Schulz, 1998), 
implying a species-specific role dependant on the environmental niche. It has been shown 
that the external environment can influence the expression of OmpA-like proteins, such as 
nitrogen shortage or anaerobic culturing which increases the expression, or antimicrobial 
peptide exposure and challenging with acid causes the decrease in expression (Smith et al., 
2007), and later a study by Zhang et al (2011) showed that a phenol exposure causes 
upregulation of OmpA, suggesting a role for OmpA in stress resistance (Zhang et al., 2011). 
The OmpA surface protein found in Klebsiella pneumoniae interacts with TLR2, which leads 
to activation of dendritic cells and natural killer cells (Chalifour et al., 2004). In addition, 
OmpA is shown to be upregulated in biofilm formation in E. coli, as well as OmpA 
expression being closely linked to fimbrial expression, as shown by Teng et al., (2006) 
where a ΔompA mutant showed suppressed expression of the type I fimbriae (Teng et al., 
2006).  All of these examples found show an increasingly evident role in pathogenesis. 
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OmpA of E. coli is a relatively inefficient porin, compared to the classical OmpF and OmpC, 
and is thought to be involved in host cell attachment and invasion in certain strains as 
shown by Shin et al., (2005), who applied purified samples of E. coli K1 OmpA to brain 
microvascular endothelial cells and demonstrated adherence (Shin et al., 2005). Meningitis-
causing strains of E. coli demonstrate the association between OmpA and invasion by the 
creation of an ompA-deficient strain which was 25-50 times less invasive than comparable 
parent strains (Meier et al., 1996), or indeed the same reduction was achieved when 
incubating with an anti-OmpA antibody. Aside from E. coli, the OmpA protein has been 
found to be important in many Gram-negative bacteria, with a role attributing to the 
interaction with the host cell. The OmpA protein found in Neisseria gonorrhoeae has been 
shown to be involved in adhesion and invasion to human endometrial cells and cervical 
carcinoma cells, with a decrease in bacterial association by 3.5-fold in an ∆ompA mutant 
(Serino et al., 2007). This work by Serino et al., also showed the involvement of OmpA in 
phagocytosis by macrophages and subsequent survival within the cell (Serino et al., 2007). 
The OmpA found in Coxiella burnetii, the known pathogen for causing Q fever, has been 
shown to be involved in the interaction with the host, and more specifically the 
extracellular loops of the OmpA protein show specificity to increasing the ability of the 
bacterium to invade lung epithelial cells (Martinez et al., 2014).  
The OmpA protein isn’t only important in the interaction with human cells, as elegant work 
by Weiss et al., (2008) has shown that the OmpA of Sodalis glossinidius, a symbiotic 
bacterium, is important in the interaction with its host, the tsetse fly (Glossina morsitans). 
This work involved the introduction of recombinant OmpA from E. coli K12 to Sodalis, 
resulting in the transformation of the symbiotic bacterium into displaying a pathogenic 
phenotype (Weiss et al., 2008).  This work also demonstrated a comparison of alignments 
of the two OmpA proteins, resulting in significant insertions in one of the extracellular loops 
of the Sodalis OmpA, not found in the pathogenic-form of OmpA, indicating the specific role 
for OmpA in the bacterium’s pathogenic phenotype. 
1.6.12 OmpA in P. gingivalis  
The study by Murakami et al., (2002) mentioned previously, identified a trimeric structure 
of the OmpA proteins of P. gingivalis, which is typical of porins, and showed extensive 
structural homology with the OmpA porin of E. coli along the entire length (Murakami et 
al., 2002). The OmpA-like protein of P. gingivalis (from here on known simply as OmpA), is 
predicted to show a similar structure to those seen in other OmpA-like porins, as 
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demonstrated by Nagano, et al (2005). The ompA operon can be seen in Figure 1.11, and is 
made up of two genes (pgm6/7 or ompA1/A2). Protein analysis by SDS-PAGE demonstrated 
a single band at ~40kDa and at ~120kDa when prepared with and without 2-
mercaptoethanol respectively, suggesting the formation of a heterotrimer in native 
conditions. Immunoreactive studies demonstrated a greater concentration of Pgm6 
produced compared to Pgm7, suggesting a 2:1 ratio in the heterotrimer.  Deletion of the 
entire structure by Nagano et al., produced mutants that had higher membrane 
permeability suggesting a structural role for OmpA, with a role for the anchoring of the 
protein to the peptidoglycan layer. This study also demonstrated a role for OmpA in the 
survival of P. gingivalis in the inflamed periodontal pockets during infection. An inability of 
ΔompA1A2 to grow in the presence of 0.2 M NaCl suggests a reduced survival rate in an 
environment with high osmotic pressure, such as that found in an infection (Nagano et al., 
2005). In the microarray analysis of the hyperinvasive subpopulations of P. gingivalis by 
Suwannakul, the OmpA protein was upregulated 4-fold in three of the four datasets, but as 
it wasn’t upregulated in all four, it did not make the table of signature genes (Table 1.1); 
however it indicates a highly likely role in the adherence and invasion of the host cell.  
 
Figure 1.11 The ompA operon of P. gingivalis. 
 
Studies describing the importance of P. gingivalis adherence and invasion of the host have 
been detailed by multiple investigators (Njoroge et al., 1997; Chen et al., 2001), with some 
studies demonstrating the intracellular location in buccal cells in vivo (Rudney et al., 2005; 
Rudney and Chen, 2006). However, few studies have detailed the role of OmpA in these 
interactions. More recently, a study by Murakami et al (2014) has indicated the potential 
glycosylation of the OmpA1 protein subunit through identification of glycoprotein-
attachment sites in mass spectrometry.  This study also showed purified OmpA1A2 protein 
bound to extracellular matrix (ECM) proteins, such as fibronectin and laminin, whereas 
purified OmpA2 bound significantly less, indicating a potential role for the predicted 
glycosylation of the OmpA1 subunit in the adherence to the host cell (Murakami et al., 
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2014). However, purified OmpA1 protein was not examined for its role in binding ECM 
molecules, and therefore the reduction in binding may be due to the loss of the 
heterotrimer.  
In the context of TNF-α –stimulated endothelial cells, an increase in adherence of wild-type 
P. gingivalis was observed that was not seen in a ∆ompA1A2 mutant (Komatsu et al., 2012). 
This study also purified OmpA and demonstrated an inhibition of P. gingivalis binding 
endothelial cells in the presence of the recombinant protein, in concentrations as low as 
0.25 ng ml-1.  
Currently, there is no evidence demonstrating the importance of OmpA in the interaction of 
oral epithelial cells, the cell type P. gingivalis is most likely to contact during the infection 
process.  
1.6.13 The OmpH Protein 
As demonstrated in the schematic of the cell envelope of Gram-negative bacteria (Fig. 1.9), 
once proteins bound for the outer membrane have been translocated across the inner 
membrane, they must be transported across the periplasm to be assembled and inserted in 
to the outer membrane. Chaperone proteins exist to transport these outer membrane 
proteins through their intermediate periplasmic stage, to prevent inappropriate folding and 
aggregation in the periplasm and guide them to the outer membrane. In E. coli, three major 
chaperone proteins are thought to exist, SurA, the protease, DegP, which also displays 
chaperone-like properties (Spiess et al., 1999), and the Seventeen Kilodalton Protein (Skp, 
or OmpH). Individually, these proteins are not essential but merely result in a reduction of 
proteins in the outer membrane; however double mutants display often lethal phenotypes 
suggesting two parallel chaperone pathways are at work (Chen and Henning, 1996). It is 
thought the SurA-dependant pathway is the major chaperone pathway, and an alternative 
Skp- and DegP-dependant pathway is present as a minor route (Rizzitello et al., 2001; Sklar 
et al., 2007). SurA has been shown to have specificity for chaperoning the LptD, whereas 
the major role for DegP is to prevent the toxic accumulation of aggregated and misfolded 
proteins in the periplasm (Bos et al., 2007; Walther et al., 2009). P. gingivalis encodes 
proteins homologous to these systems and further chaperone-related proteins, which is 
discussed later in the bioinformatics analysis in Chapter 5.3.1. 
The Skp/OmpH protein of E. coli is thought to form a homotrimer, composed of a β-barrel 
central domain with three α-helical extensions forming a pronged structure around an 
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internal cavity (Korndörfer et al., 2004), which has been described as “jellyfish-like” (Walton 
and Sousa, 2004), with the outer membrane protein to be chaperoned binding in this cavity 
(Walton et al., 2009). The Skp/OmpH chaperone is required for the efficient release of 
unfolded proteins that emerge from the Sec system on the inner membrane (Chen and 
Henning, 1996; Harms et al., 2001), and was thought to be required in the correct folding of 
several outer membrane proteins before delivering them to the Bam complex on the outer 
membrane (De Cock et al., 1999). However, more recently, the Skp/OmpH chaperone has 
been noted more as a holdase, preventing aggregation, rather than having an active role in 
folding of the outer membrane proteins (Walton and Sousa, 2004; Walton et al., 2009), 
especially as in vitro experimental evidence demonstrates a prevention of aggregation of 
protein but no effect was observed on the folding rates of the proteins (Entzminger et al., 
2012). The substrates of the Skp/OmpH chaperone appear to be of a broad spectrum, with 
a bias towards proteins of an acidic nature (Jarchow et al., 2008), and vary from outer 
membrane proteins such as OmpA, OmpC, OmpF and LamB (Chen and Henning, 1996) to 
periplasmic proteins such as MalE and OppA (Jarchow et al., 2008), demonstrating a broad 
substrate spectrum. Multiple studies have shown evidence for the OmpA protein being a 
client of this chaperone system (De Cock et al., 1999; Bulieris et al., 2003; Patel et al., 2009), 
from being identified as a binding partner in Skp-related pull down assays (Jarchow et al., 
2008), to the Skp/OmpH chaperone binding OmpA in solution (Qu et al., 2007) and 
completely preventing the aggregation of OmpA in solution when the denaturing buffer is 
removed (Walton et al., 2009). 
Homologs of the Skp/OmpH protein have been described in various Gram-negative 
bacteria, suggesting a high level of importance to the protein. The ompH gene has been 
identified in many species of the Enterobacterial family, including E. coli as mentioned 
above, Salmonella typhimurium (Koski et al., 1989) and Yersinia enterocolitica (Hirvas et al., 
1991) which all display remarkable homology within their OmpH proteins (up to 91% and 
65% amino acid sequence homology respectively to E. coli)  (Hirvas et al., 1990), suggesting 
most species within this family will contain highly homologous versions of this protein. In all 
cases, the OmpH protein shows a similar chaperone-type role, often coupled to an 
interaction with LPS and the two genes (skp and lipid synthesis genes) are usually found 
coupled in a cistron or operon, and is also observed outside of this family, for example in  
Pasteurella multocida (Delemarche et al., 1995), however this is not the case in 
P. gingivalis.  
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1.6.14 OmpH in P. gingivalis  
Very few studies have been performed on the OmpH protein of P. gingivalis. The OmpH 
protein is encoded by two genes, PGN0300 and PGN0301, also known as PG0192/3 and 
ompH1 and ompH2, however, currently there is no evidence if these genes encode a 
trimeric structure similar to the E. coli OmpH protein.  Both genes have been shown to be 
upregulated in a multispecies community of P. gingivalis, F. nucleatum and S. gordonii 
(Kuboniwa et al., 2009), indicating a potential involvement in delivering proteins to the 
outer membrane involved in multispecies interaction. These two genes were also 
upregulated in the signature gene set of genes differentially regulated in the hyperinvasive 
subset of the P. gingivalis population, described by Suwannakul et al (2010), indicating the 
OmpH protein may be involved in the chaperoning of proteins involved in interaction with 
the host cell (Suwannakul et al., 2010). These two studies demonstrate the potentially 
broad spectrum of proteins that act as clients to the OmpH protein, involved in interacting 
with both host for infection and other bacteria for biofilm formation. As both of these 
processes are involved in the virulence of P. gingivalis, further investigation into the OmpH 
protein and its clients could reveal crucial information on the proteins involved in these 
processes and provide new antimicrobial therapeutic targets. Very recently, a study by 
Taguchi et al (2016) described the OmpH chaperone protein as being encoded by an operon 
containing PGN0299 (which encodes Omp85, or BamA), and the two ompH1 and ompH2 
genes. The study created an ompH1 mutant, detailing its location to be associated with the 
outer membrane due an N-terminal α-helix, whereas a knockout of ompH2 couldn’t be 
created and thus was determined to be an essential gene (Taguchi et al., 2016), which is 
contradictory to all previous studies of the OmpH protein mentioned above. This study 
investigated the role of OmpH on gingipain production, showing with a loss of OmpH, the 
level of gingipain activity was severely reduced and a higher level of unprocessed gingipains 
were present. As the gingipain proteins contain a CTD for PorSS secretion (discussed in 
earlier in 1.6.6.4.2), the group connected the OmpH protein to potentially being the 
chaperone of the PorSS system. This was supported by MALDI-TOF analysis of the 
supernatant, which contained two other CTD-containing proteins, suggesting a potential 
role for OmpH in the PorSS secretion system (Taguchi et al., 2016). This paper will be 
discussed in further detail in Chapter 5.4. 
As the OmpH protein has been shown to be involved in the chaperoning of OmpA in E. coli 
(Chen and Henning, 1996; De Cock et al., 1999; Jarchow et al., 2008; Walton et al., 2009), it 
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potentially shows a similar role in the P. gingivalis chaperone system. Coupled to the 
upregulation of OmpH in the hyperinvasive subset of the P. gingivalis population 
(Suwannakul et al., 2010), and the postulated role for OmpA in the interaction with host, 
this protein may be an essential protein contributing to the virulence abilities of P. 
gingivalis and would therefore be an interesting target of study in this project.  
 
1.7 Aims   
An extensive review of the literature and the lab data on the signature gene set determined 
a gap in the research surrounding the interaction with the host oral epithelial cells via the P. 
gingivalis OmpA protein. This protein is indicated as important for host cell adherence and 
invasion largely due to the mutagenesis studies of Komatsu et al (2012) showing a 
reduction in invasion of endothelial cells with the loss of OmpA, coupled to data presented 
by Suwannakul et al (2010), demonstrating a four-fold increase in ompA expression in a 
hyperinvasive subset of the P. gingivalis population. This data also revealed the 
upregulation of ompH expression in the hyperinvasive subset, indicative of an importance 
of the clients of this chaperone being important in host cell interaction. Therefore, the 
specific research questions addressed in this thesis will be to determine the role of OmpA in 
adherence and invasion of the host, both through deletion of the genes and overexpression 
of the protein, as discussed below, whilst performing a preliminary characterisation of the 
OmpH protein of P. gingivalis through the creation of an ∆ompH1H2 mutant.  
 
1.7.1 Specific Aims of the Project 
 To create individual ompA1 and ompA2 P. gingivalis  mutants  
 To assess and compare the adhesion and invasion of an appropriate cell line 
between ompA mutant strains, and determine a role, if any, for the individual 
subunits of OmpA 
 To assess and compare general phenotypic attributes of P. gingivalis and the ompA 
mutant strains, including several virulence factors and biofilm formation 
 To express and purify the OmpA subunits, and assess their interaction with the host 
cell 
 To model and analyse the OmpA protein bioinformatically, and determine 
structural aspects of the protein 
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 To utilize this structural information to determine host-cell interaction of the OmpA 
protein, and analyse through interaction studies and fluorescent labelling 
 To perform general phenotypic characterization of the OmpH protein chaperone of 
P. gingivalis through deletion of the ompH operon 
 To determine any potential substrates of the OmpH chaperone 
 To develop and optimize a mutagenesis technique for P. gingivalis  
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Chapter 2 
Materials and Methods 
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2.1 Manufacturers and Suppliers 
All reagents used in this study were of analytical grade and were obtained from the 
following manufacturers and suppliers (Table 2.1). Reagents were purchased from Sigma-
Aldrich or ThermoFisher Scientific unless otherwise stated.  
Table 2.1 Main manufacturers and suppliers  
Supplier Location  
Agar Scientific Essex UK 
BDH Laboratory Suppliers Poole UK 
Bioline London UK 
BioRad Laboratories Hertfordshire UK 
BMG Labtech Aylesbury UK 
Corning Fisher Scientific Distributor, Loughborough UK 
Don Whitely Scientific Shipley, West Yorkshire UK 
FlowGen Biosciences (SLS 
Life Sciences) 
Hassle, East Riding of Yorkshire UK 
GE Healthcare Life Science 
(Amersham Biosciences) 
Buckinghamshire UK 
Gibco (Thermo Fisher 
Scientific) 
Leicestershire UK 
iNtRON Biotechnology Kyungki-Do Korea 
Invitrogen Paisley UK 
LabM Bury UK 
Life Technologies (Thermo 
Fisher Scientific) 
Leicestershire UK 
New England Biolabs (NEB) Hitchin, Hertfordshire UK 
Novagen (Merck Millipore)  Darmstadt Germany 
NunC Fisher Scientific Distributor, Loughborough UK 
Oxoid Hampshire UK 
Progen Scientific London UK 
Promega Southampton UK 
QIAGEN West Sussex UK 
Sigma-Aldrich Poole UK 
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Syngene Cambridge UK 
ThermoFisher Scientific Leicestershire UK 
Xograph Gloucestershire UK 
 
2.2 Main Buffers and Reagents 
2.2.1 Phosphate Buffered Saline 
Phosphate buffered saline (PBS) was made by adding 8.18 g Sodium Chloride (NaCl), 0.2 g 
Potassium Chloride (KCl) (BDH Laboratory Suppliers), 1.41 g Sodium Phosphate Dibasic 
Anhydrous (Na2HPO4) and 0.244 g Potassium Dihydrous Orthophosphate (KH2PO4) (BDH 
Laboratory Suppliers). The pH was adjusted to 7.3 and the total was made up to 1000 ml 
with H2O. 
2.2.2 Crystal Violet Stain 
The stain is a 0.1 % Crystal Violet stain made up of 20 ml Solution A (5 g crystal violet (BDH 
Laboratory supplies) in 95 ml Ethanol) and 80 ml Solution B (1% Aqueous Ammonium 
oxalate in H2O).  
2.2.3 Protein Purification Elution Buffer 
Protein elution of His-tagged proteins was performed using increasing concentrations of 
imidazole in an elution buffer. The elution buffer comprised of 120 mM NaCl, 150 mM PBS 
and imidazole in varying concentrations (20 mM, 150 mM and 200 mM). 
Glutathione-S-transferase (GST)-tagged proteins were eluted from glutathione resin using 
reduced glutathione (GSH) elution buffer. The elution buffer was made up of 20 mM GSH, 
120 mM NaCl in a 50 mM Tris solution. The GSH was then aliquoted into 1 ml fractions and 
stored at -20°C.  
2.3 Bacterial Strains, Plasmids and Primers Used In This Study 
Table 2.2 shows the strains of P. gingivalis used in this study. Strains were either obtained 
from Dr. Graham Stafford or generated in this study.  
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Table 2.2 P. gingivalis strains 
P. gingivalis strain Relevant Characteristic(s) Source 
ATCC 33277 Wild-type, type strain ATCC 
∆ompA1 ompA1 (PGN0729) deletion mutant of ATCC 33277 
(ery
R
) 
This study 
∆ompA2 ompA2 (PGN0728) deletion mutant of ATCC 33277 
(ery
R
) 
This study 
∆ompA1A2 ompA1 (PGN0729) and ompA2 (PGN0728) deletion 
mutant of ATCC 33277 (ery
R
) 
Dr. Graham 
Stafford 
∆ompA2 + pT-COW-
A2 
∆ompA2 complemented mutant with ompA operon 
promoter and ompA2 gene (from ATCC 33277) on 
pT-COW plasmid (Tc
R
)  
This study 
∆ompH1H2 ompH1 (PGN0300) and ompH2 (PGN0301) deletion 
mutant of ATCC 33277 (ery
R
) 
This study 
Ery
R
 – erythromycin resistance; Tc
R 
– Tetracycline resistance 
The strains of E. coli used throughout this study can be seen below in Table 2.3.  
Table 2.3 E. coli strains 
Strain Genotype Supplier 
E. coli C41 (DE3) F- ompT hsdSB (rB
- mB
-) gal dcm (DE3). 
Derived from BL21 (DE3) as described in  
(Miroux and Walker, 1996).  
Strain collection 
E. coli C41 Rosetta F- ompT hsdSB(rB
- mB
-) gal dcm (DE3) 
pRARE (CamR) 
Strain collection 
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E. coli BL21 (DE3)  F–ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Strain collection 
E. coli BL21 Rosetta F–ompT gal dcm hsdSB (rB
– mB
–) λ (DE3) 
pRARE (CamR) 
Strain collection 
E. coli BL21 Star F-ompT hsdSB (rB
-,mB
 -) galdcmrne131 
(DE3) 
Strain collection 
E. coli DH5α E. coli fhuA2 lac(del)U169 phoA glnV44 
Φ80' lacZ(del)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
New England 
Biolabs (NEB) 
Plasmids used and created in this study can be seen below in Table 2.4 
Table 2.4 Plasmids 
Plasmid Insert Antibiotic 
Resistance 
Supplier 
pGEX-4-T-3 Empty vector for GST-tagged 
protein overexpression 
Ampicillin GE Healthcare 
pGEX-ompA1 ompA1 for GST-tagged protein 
overexpression, inserted 
between BamHI and EcoRI 
restriction sites. 
Ampicillin This study 
pGEX-ompA2 ompA2 for GST-tagged protein 
overexpression, inserted 
between BamHI and EcoRI 
restriction sites. 
Ampicillin This study 
pJET (Clone Jet) Blunt end cloning storage vector Ampicillin Thermo Fisher 
Scientific 
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pJET-
ompA2::em 
Storage vector containing Insert 
of P. gingivalis ompA2 gene 
interrupted with erythromycin 
gene for ompA2 knock out, 
flanked with 1000 bp upstream 
and downstream of native 
ompA2. Inserted between HincII 
restriction sites. 
Ampicillin This study 
pET-15b Empty vector for His-tagged 
protein overexpression 
Ampicillin Novagen 
pET-ompA1 ompA1 for His-tagged protein 
overexpression, inserted 
between BamHI and NdeI 
restriction sites. 
Ampicillin Dr Graham Stafford 
pET-ompA2 ompA2 for His-tagged protein 
overexpression, inserted 
between BamHI and NdeI 
restriction sites. 
Ampicillin Dr Graham Stafford 
pET-ompA1b 
(pJET-OmpA121-
245) 
ompA1 (β-barrel only) for His-
tagged protein overexpression, 
inserted between BamHI and 
NdeI restriction sites. 
Ampicillin This study 
pET-ompA2b 
(pJET-OmpA222-
236) 
ompA2 (β-barrel only) for His-
tagged protein overexpression, 
inserted between BamHI and 
NdeI restriction sites. 
Ampicillin This study 
pT-COW Modified Bacteroides-Prevotella 
shuttle vector 
Tetracycline (Gardner et al., 
1996) 
pT-COW + A2 Shuttle vector as above, 
containing P. gingivalis omp 
Tetracycline This study 
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operon promoter joined to 
ompA2 gene for mutant 
complementation inserted 
between BamHI and SalI 
restriction enzyme sites. 
The primers used in this study can be seen below in Tables 2.5-2.13. 
Table 2.5 Primers for ompA1 gene knock out 
Primer Sequence 
ompA1-f1 for TGGAAGTTAGCATCGCCAAC 
ompA1-f1 rev CGGGCAATTTCTTTTTTGTCATGCCTATTCGCTACACAAATG 
ompA1-f2 for GTCCCTGAAAAATTTCATCCTTCGTATTATTAGCACTTGCGGG 
ompA1-f2 rev GATCAAGGTAGTAGGTTAC 
ompA1-em for CATTTGTGTAGCGAATAGGCATGACAAAAAAGAAATTGCCCG 
ompA1-em rev CCCGCAAGTGCTAATAATACGAAGGATGAAATTTTTCAGGGAC 
 
Table 2.6 Primers for ompA2 gene knock out 
Primer Sequence 
ompA2-f1 for ATAGGTTCTCTTTCTGTCGG 
ompA2-f1 rev CGGGCAATTTCTTTTTTGTCATCTGTATGTCATTTTATATTATCC 
ompA2-f2 for CTCGTCATGAGACAGCCTCAGCCGAAGGATGAAATTTTTCAGGGAC 
ompA2-f2 rev TTCACTTTGTCTTTCAGATCCTCT 
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ompA2-em for GGATAATATAAAATGACATACAGATGACAAAAAAGAAATTGCCCG 
ompA2-em rev GTCCCTGAAAAATTTCATCCTTCGGCTGAGGCTGTCTCATGACGAG 
 
Table 2.7 Primers for ompA2 gene complementation 
Primer Sequence 
ompA promoter for CAGGGATCCCCGGAGAATCTTCTTTGCAGC 
ompA promoter rev – 
ompA2 for tail 
GCTAATAATAAAGATTTAGCTTTCATAGTTTTACTTTTCTAAGTGTATTT 
ompA2 for – ompA 
promoter tail 
AAATACACTTAGAAAAGTAAAACTATGAAAGCTAAATCTTTATTATTAGC 
ompA2 rev CAGGTCGACTTATTCCGCTGCAGTCATTACTAC 
 
Table 2.8 Primers for ompH1H2 gene knock out confirmation 
Primer Sequence 
ompH1H2 for ATGCGGATCCCAAGAAGCTACTACACAGAACAAAGC 
ompH1H2 rev TACGGAATTCTTATTCCGCTGCAGTCATTACTAC 
Flank for CCGGCGACCTCTATACTCAGGC 
eryR for ATGACAAAAAAGAATTGCCCG 
eryR  rev GTCCCTGAAAAATTTCATCCTTCG 
Flank 2 rev GTCATCGACAAAGAGCCGG 
Table 2.9 Primers for GST-tagged OmpA1 protein overexpression 
Primer Sequence 
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OmpA1 for ATCGGGATTCCAGGAGAATACTGTACCGGCAACGGG 
OmpA1 rev ATCGGAATTCTTACTTGGAGCGAACGATTACAACACG 
 
Table 2.10 Primers for GST-tagged OmpA2 protein overexpression 
Primer Sequence 
OmpA2 for ATATATCATATGCAGAACAAAGCAGGGATGC 
OmpA2 rev GGATACCTGATACGAAACATTCCTAGGTATATA 
 
Table 2.11 Primers for His-tagged OmpA1 barrel only protein overexpression 
Primer Sequence 
OmpA1b for ATCGGGATTCCAGGAGAATACTGTACCGGCAACGGG 
OmpA1b rev ATCGGAATTCTTACTTGGAGCGAACGATTACAACACG 
 
Table 2.12 Primers for His-tagged OmpA2 barrel only protein overexpression 
Primer Sequence 
OmpA2b for ATATATCATATGCAGAACAAAGCAGGGATGC 
OmpA2b rev ATATATGGATCCTTACAAAGCATAGTCCATAGG 
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Table 2.13 Plasmid primers for template insertion confirmation 
Plasmid Primer Sequence 
pET15b T7 promoter (for) TAATACGACTCACTATAGGG 
T7 Terminator (rev) GCTAGTTATTGCTCAGCGG 
pGEX-4T3 pGEX 3’ (for) CCGGGAGCTGCATGTGTCAGAGG 
M13 pUC (rev) TCACACAGGAAACAGCTATGAC 
pJET/1.2 pJET (for) CGACTCACTATAGGGAGAGCGGC 
pJET (rev) AAGAACATCGATTTTCCATGGCAG 
pT-COW E. coli TetC (for) TCAGGCACCGTGTATGAAATCTAAC 
E. coli TetC (rev) CCGGCTTCCATTCAGGTCGAGG 
 
2.4 Bacterial Cell Culture 
2.4.1 Antibiotics 
Antibiotics were used to prevent contaminating infections and for selecting for an 
introduced mutation and are listed in the Table below at their appropriate concentrations 
for use. 
Table 2.14 Antibiotics used in this study 
Antibiotic Concentration 
Ampicillin Sodium Salt 100 µg/ml 
Gentamycin 50 µg/ml 
Erythromycin 10 µg/ml 
Tetracycline 3 µg/ml 
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2.4.2 Bacterial Culture 
The cultures for E. coli were grown either in day (starter) or overnight cultures. A single 
colony of E. coli was inoculated into a 5 ml Luria Broth (LB) and grown aerobically at 37°C 
with agitation (250 r.p.m) for the required amount of time. For strains harbouring plasmids 
encoding genes for protein overexpression, LB was supplemented with antibiotics (100 
µg/ml ampicillin sodium salt) for selection.  
P. gingivalis was cultured on fastidious anaerobic agar (Lab M Limited) supplemented with 
7.5% horse blood (Oxoid) for 72 hours in an anaerobic incubation cabinet (Don Whitley 
Scientific miniMAC Anaerobic Workstation) at 37⁰C and containing 10% CO2, 10% H2 and 
80% N2. A liquid culture of P. gingivalis was grown under the same anaerobic conditions, 
except liquid cultures were cultured for 16 hours and in Brain Heart Infusion (BHI) broth 
containing 0.5% yeast extract and supplemented with 250 µg/ml cysteine, 1 mg/ml vitamin 
K and 1 mg/ml hemin. Antibiotics were included in the media where appropriate, including 
gentamycin and erythromycin. Antibiotics were filter sterilised and added to media once 
autoclaved for sterilisation (20 minutes at 121⁰C high pressure steam).  
2.4.3 Long Term Storage of Bacteria 
Bacterial cultures were stored at -80°C or in liquid nitrogen for long term purposes. A 5 ml 
culture of the bacterial strain was grown for 16 h under the specified conditions in 2.4.2 
before harvesting through centrifugation (4,500 x g, 5 min) and resuspension in  1 ml of 
fresh growth media and 0.5 ml 50 % glycerol and immediately stored.  
2.5 Epithelial Cell Lines and Growth 
2.5.1 Epithelial Cell Line 
The oral epithelial cell line, OK-F6, was originally obtained from James G. Rheinwald 
(Harvard Institute of Medicine, Boston, MA) (Mark a Dickson et al., 2000), and for this study 
was obtained from freezer stocks at passage 3-5 from The Department of Oral Pathology, 
School of Clinical Dentistry, The University of Sheffield. The OK-F6 cell line was stored in 1 
ml aliquots of 1 x 106 cells in liquid nitrogen. 
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2.5.2 Epithelial Cell Culture 
All mammalian cell culture was undertaken in a Class II microbiology safety cabinet that had 
been sterilised using 70% industrial methylated spirits (IMS). Any items introduced to the 
cabinet throughout the cell seeding process were also thoroughly cleaned using 70% IMS. 
Any media and trypsin solutions were pre-heated to 37°C before use.  
2.5.3 Growth Media 
Defined keratinocyte serum-free media (DKSFM) (Gibco) was used for both weekly 
maintenance of cells and for the antibiotic protection assays and fluorescence studies. The 
500 ml bottles of DKSFM were supplemented with the 1 ml aliquot of defined keratinocyte 
SFM growth supplement and stored at 4°C. Neutralising media (used in passaging OK-F6 
cells) consisted of Dulbecco’s Modified Eagle Media (DMEM) supplemented with 10 % 
Foetal Bovine Serum (FBS) and also stored at 4°C.  
2.5.4 Defrosting Mammalian Cells 
Cell aliquots were retrieved from liquid nitrogen and placed into a 37°C water bath to 
defrost and immediately resuspended in 2 ml DKSFM and centrifuged for 5 minutes at 1250 
x g (room temperature). After centrifugation, the supernatant was decanted and the pellet 
gently resuspended in 8 ml DKSFM before being transferred to a T75 cm2 cell culture flask 
(Nunc) and incubated at 37°C, 5% CO2 with humidity. 
2.5.6 Cell Passaging 
The OK-F6 cells were grown until confluency levels reached 70 – 80% and then passaged. 
The DKSFM media was discarded and the cell monolayer washed twice with 8 ml sterile 
Dulbecco’s PBS. To detach the cells from the flask, 2 ml trypsin-EDTA buffer 1X was applied 
to the cells and incubated at 37°C, 5% CO2 with humidity for 10 minutes. Cell detachment 
from the flask was confirmed using light microscopy under x20 magnification. After 
complete cell detachment, 4 ml of neutralising media was added to neutralise the 
enzymatic activity of the trypsin. The cell suspension was centrifuged at 1250 x g. for 5 
minutes at (room temperature) before the supernatant was discarded and the cell pellet 
resuspended in 2 ml DKSFM. The cell density was calculated using a Neubauer Improved 
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haemocytometer whereby 10 µl Trypan Blue stain 0.4% (Life Technologies) was added to 10 
µl of the cell suspension and applied to the haemocytometer and four quadrants of 16 
squares were counted for viable cells. The total cell density was calculated using the 
following equation: 
Cells / ml = 2(n / 4) x 10000 
Cells were then either seeded into a new T75 cm2 flask at 2 x 107 cells / ml or into a  
microtitre plate (MTP) at the desired cell density. Due to unpredictable genetic changes 
during cell replication, when cells reached passage 20 they were discarded and a new 
aliquot of cells retrieved.  
2.6 Molecular Biology Methods 
2.6.1 Bacterial Chromosomal DNA Isolation 
Genomic DNA isolation was carried out using the Wizard® Genomic DNA Purification Kit 
(Promega) as described by the manufacturer’s instructions. Plasmid DNA was isolated using 
a QIAGEN miniprep kit as according to the manufacturer’s instructions. 
2.6.2 DNA Analysis 
2.6.2.1 Tris-Acetate-EDTA Buffer 
Tris-acetate-EDTA (TAE) buffer was used to make agarose gels for DNA analysis, and as a 
running buffer in the gel tank. A 50X stock solution was made and diluted to a 1X buffer 
when used. The 50X TAE buffer was made by adding 57.1 ml of glacial acetic acid, 242 g 
Tris(hydroxymethyl)aminomethane (Tris Base), 100 ml of 0.5 M ethlenediaminetetraacetic 
acid (EDTA) (pH 8), and made up to 1000 ml by adding 842.9 ml dH2O and adjusted to pH 8. 
2.6.2.2 Agarose Gel Analysis 
Any DNA analysis was carried out using a 1% agarose gel. Agarose powder was added to a 
1X TAE buffer to make a 1 % solution. 0.5 µl of ethidium bromide was added and the gel 
poured into the prepared mould. Gels were run at 90-120 v until the desired level of DNA 
separation had occurred.  
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2.6.2.3 Polymerase Chain Reaction 
The polymerase chain reaction (PCR) was used to amplify specific sequences of DNA or to 
perform overlap PCRs for specific gene knock outs for the creation of mutants. The PCR 
reaction consists of a denaturing step to separate DNA strands, an annealing step for 
primers to anneal to the DNA and an extension step for the nucleotides to be added to 
create the complementary strand, which is catalysed by a DNA polymerase enzyme. These 
steps are repeated for several cycles to amplify the DNA.  
Table 2.15 Reagents and their volumes for PCRs needed for cloning and expression 
Reagent Volume (µl) 
dH2O 31.8 
DMSO 1 
dNTPs (40 mM) 0.2 
5 x Buffer 10 
PhusionTM Polymerase Enzyme 1 
DNA 1 
Primer 1 (10 µM) 2.5 
Primer 2 (10 µM) 2.5 
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Table 2.16 Reagents and their volumes for PCRs needed for routine screening 
Reagent Volume (µl) 
dH2O 4 
GreenTaq 2X Master Mix 10 
DNA 1 
Primer 1 (10 µM) 2.5 
Primer 2 (10 µM) 2.5 
The components of the PCR reaction carried out can be seen in Table 2.15 and Table 2.16. 
DNA concentrations ranged between 50–250 ng (genomic) and 10-50 ng (plasmid). Two 
different enzymes were used depending on the reaction. PhusionTM (New England Biolabs) 
was used to amplify sequences needed for cloning and expression, whereas GreenTaqTM 
(Thermo Scientific) was used for routine screening, such as confirmation of successful 
transformation. The reaction conditions for both of these enzymes can be seen in Table 
2.17. 
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Table 2.17 Reaction conditions for PCR with different polymerase enzymes 
 Polymerase Enzyme 
 PhusionTM GreenTaqTM 
PCR Step Temperature 
(°C) 
Time 
(mins:secs) 
Temperature 
(°C) 
Time (mins:secs) 
Initial 
Denaturation 
98 0:30 95 3:00 
Denaturation 98 0:10 95 0:30 
Annealing 55-65 0:30 50-55 0:30 
Extension 72 0:30 / kb 72 1:00 / kb 
Final Extension 72 5:00 72 5:00 
Hold 4 ∞ 4 ∞ 
PCR samples were then analysed using 1% agarose gel electrophoresis as described in 
Materials and Methods 2.6.2.2 DNA samples in the gel were detected using UV radiation 
and images taken were using a G:Box (Syngene).   
2.6.2.4 Overlap PCR for ompA1 and A2 Gene Knockout Cassette Amplification 
Overlap PCR was carried out under the same conditions as those reactions described in 
Table 2.17, using the primers described in Table 2.5 and 2.6.  
2.6.2.5 DNA Extraction from Agarose Gel 
DNA samples were extracted from the agarose gel using a Gel Extraction Kit (QIAGEN) as 
described in the manufacturer’s instructions. DNA samples could also be purified from the 
PCR mixture using the Bioline ISOLATE PCR and Gel kit.  
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2.6.2.6 Restriction Enzyme Digest & Ligation 
After the PCR product was analysed and purified, the product and plasmid were both 
digested using restriction enzymes. Table 2.18 denotes the various components and their 
quantities for a 30 µl reaction. The reaction was carried out at 37°C for 2 hours. After two 
hours of digestion using the restriction enzymes, 1 µl of calf intestinal alkaline phosphatase 
(CIP) (Promega) or Antarctic phosphatase (New England Biolabs) was added to the reaction 
containing the plasmid vector, and incubated at 37°C for one further hour. The enzymatic 
activity of the restriction enzymes was halted by heat inactivation or removed by using a 
PCR clean up kit (Bioline). The digested plasmid vector and PCR product were ligated 
together in a 20 µl reaction seen in Table 2.19. The reaction mixture was incubated at room 
temperature for 16 – 20 h. The plasmid containing the ligated insert was stored at -20°C. 
Table 2.18 Reagents and volume required for a restriction enzyme digest 
Reagent Volume (µl) 
DNA 15 
10X Buffer 3 
Restriction Enzyme 1 1 
Restriction Enzyme 2 1 
dH2O 10 
For digestion of the ompA1 or ompA2 gene for protein overexpression, BamHI and EcoRI 
were used as the enzymes, and the buffer was buffer 4, all supplied from New England 
Biolabs. 
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Table 2.19 Reagents and volumes needed for a ligation reaction 
Reagent Volume (µl) 
10X Buffer  2 
T4 Ligase 1 
Vector (plasmid) 3 
Insert 14 
T4 Ligase was purchased from New England Biolabs.  
For OmpA1 or OmpA2 (insert) ligation for overexpression with a GST-tag, the vector was 
the pGEX-4T3 plasmid, or pET-15b for His-tag expression, from Table 2.4 
Alternatively, PCR products or DNA strings purchased from GeneArt® (Life Technologies) 
were cloned into the pJET plasmid using the CloneJET PCR Cloning Kit (Thermo Scientific) 
according the manufacturer’s instructions.  
2.6.3 Preparation of E. coli for Electroporation and Cloning 
The appropriate expression strain of E. coli was grown from a single colony in 10 ml of LB 
broth until OD600 reached 0.6. The culture was pelleted by centrifugation at 11200 x g. for 
15 minutes at 4°C. The pellet was resuspended in 1 ml of sterile ice-cold 10% glycerol and 
transferred to a 1 ml Eppendorf before centrifugation for 1 minute at 11200 x g. The pellet 
was washed three times in 1 ml sterile ice-cold 10% glycerol. On the final centrifugation, 
the pellet was resuspended in 100 µl sterile ice-cold 10% glycerol. Then, 1 µl of the ligated 
plasmid with insert of interest was added to the E. coli suspension and the mixture 
incubated on ice for 5 minutes. The suspension was transferred to a 1 mm path length 
electroporation cuvette (Flowgen Biosciences). The cells were then electroporated using a 
BIO-RAD MicroPulserTM series 411BR (BioRad Laboratories), with the parameters set 
according to Table 2.20. The electroporated E. coli was then incubated on ice for a further 5 
minutes before being added to 1 ml LB broth and incubated at 37°C for 1 h. The cells were 
then centrifuged at max speed for 1 minute and resuspended in 100 µl LB broth before 
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being spread onto LB agar with the appropriate antibiotics for selection. The cells were 
incubated for 16 h at 37°C to allow for colony growth.  
Table 2.20 Parameters for electroporation 
Potential Difference 2.5 kV 
Resistance 200 Ω 
Capacitance 25 µF 
This provides a time constant between 2.9 – 4.3 milliseconds.  
Alternatively, E. coli was transformed using DH5α competent cells (New England Biolabs) 
and heat-shock. Heat shock transformation was carried out according to the 
manufacturer’s instructions. Cells were spread onto LB agar with the appropriate antibiotics 
for selection.  
2.6.4 Preparation of P. gingivalis for Electroporation and Cloning 
A 5 ml liquid culture of P. gingivalis ATCC 33277 was set up as described in Materials and 
Methods section 2.4.2 and grown for 16 h, whereby the OD600nm was observed between 1.0- 
1.2. A 20 ml day culture was set up using 1:10 dilution from the overnight culture into fresh 
liquid broth and grown statically for 6 h at 37°C under anaerobic conditions.  
The next steps were carried out in less than 40 minutes to minimise the amount of aerobic 
exposure for the P. gingivalis cells. The cell suspension was removed from anaerobic 
conditions and centrifuged for 10 minutes at 10000 x g at 4°C. The supernatant was 
discarded and the pellet was resuspended in 10 ml ice-cold 10% glycerol supplemented 
with 1 mM Magnesium Chloride (MgCl2). The cells were then pelleted by centrifugation at 
10000 x g for 10 minutes (4°C), the supernatant discarded and the pellet resuspended in 
200 µl ice-cold sterile 10% glycerol. The cell suspension was then added to a 2 mm path 
length cuvette (Flowgen Biosciences) with 5 µl DNA and incubated on ice for 5 minutes. 
Electroporation was carried out as in Table 2.20 and the contents were added to 500 µl 
liquid broth before being spread on a blood agar plate supplemented with gentamycin and 
grown at 37°C under anaerobic conditions. After 24 h growth, the cells were removed from 
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the plate and suspended in 1 ml fresh liquid broth and centrifuged for 1 minute at 
11200 x g. The cells were resuspended in 100 µl fresh liquid broth and spread onto blood 
agar plates supplemented with gentamycin and erythromycin as previously described. The 
plates were incubated at 37°C under anaerobic conditions and left undisturbed for 2 weeks 
before recovery of successful colonies. 
2.6.5 P. gingivalis Transformation Using Natural Competency 
Multiple variations in methods for transformation via natural competency were used to 
assess transformation efficiency. Wild-type P. gingivalis for transformation was harvested 
from either a blood agar plate grown for 72 hours (plate-to-plate or plate-to-liquid 
methods), or from a liquid culture (liquid-to-liquid or liquid-to-plate methods), prepared as 
previously described in Materials and Methods 2.4.2. In all cases DNA concentration was at 
least 200 ng/µl.  
2.6.5.1 Plate-based P. gingivalis Transformation 
For the plate-to-plate method, an inoculum loop of bacteria was removed and resuspended 
in 1 ml BHI broth with supplements described in Materials and Methods 2.4.2, to create 
OD600 ~1.0-1.2. Then, the bacterial suspension was centrifuged at 11200 x g for 1 min, 
resuspended in 100 µl, and 5 µl DNA (≥200 ng/µl) was added to the cell suspension. This 
was then incubated at room temperature for 15 minutes before plating on blood agar 
plates supplemented with gentamicin and incubated anaerobically for 24 h. After 24 h, cells 
were harvested and plated onto erythromycin-containing blood agar plates.  
For the plate-to-liquid method, an inoculum loop of bacteria was removed and 
resuspended in 1 ml BHI broth with supplements described in Materials and Methods 2.4.2, 
to create OD600 ~1.0-1.2. Then DNA (5 µl at ≥200 ng/µl) was added to the P. gingivalis cell 
suspension and incubated anaerobically for 24 hours without agitation. After 24 hours, the 
1ml cell suspension was centrifuged at 11200 x g. for 1 minute before plating onto 
erythromycin-containing blood agar plates.  
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2.6.5.2 Liquid-based P. gingivalis Transformation 
For the liquid-to-liquid method, a 5 ml liquid culture of P. gingivalis ATCC 33277 was set up 
as described in Materials and Methods section 2.4.2 and grown for 16 h. Then, 1 ml from 
the overnight culture in to a fresh 9 ml liquid broth and grown for 6 h until OD600 reached 
between 1.0-1.2. Then, 1 ml of the cell suspension was centrifuged at 11200 x g. for 1 
minute and the supernatant discarded. The pellet was resuspended in 1 ml of fresh liquid 
broth with supplements, and 5 µl DNA (≥200 ng/µl) was added, before the cell suspension 
was incubated under anaerobic conditions for 24 hours. The cells were then centrifuged 
(11200 x g, 1 min) before plating onto erythromycin-containing blood agar plates.  
For the liquid-to-plate method, a 5 ml liquid culture of P. gingivalis ATCC 33277 was set up 
as described in Materials and Methods 2.4.2 and grown for 16 h. Then, 1 ml from the 
overnight culture in to a fresh 9 ml liquid broth and grown for 6 h until OD600 reached 
between 1.0-1.2. Then, 1 ml of the cell suspension was centrifuged at 11200 x g. for 1 
minute and the supernatant discarded. The pellet was resuspended in 100 µl of fresh liquid 
broth with supplements, and 5 µl DNA (≥200 ng/µl) was added, before the cell suspension 
was incubated at room temperature for 15 min before being plated on blood agar plates 
supplemented with gentamycin and incubated under anaerobic conditions for 24 hours. 
The cells were then harvested from the plate and centrifuged (11200 x g, 1 min) before 
plating onto erythromycin-containing blood agar plates.  
All erythromycin-containing plates with potential transformants were incubated at 37°C 
under anaerobic conditions and left undisturbed for 2 weeks before recovery of successful 
colonies.  
2.6.6 Complementation of ∆ompA2  
A complementation construct for the ompA2 gene was created by overlap extension PCR 
fusing the ompA2 gene to the 300 base pair upstream region of the ompA1 gene which 
contains the ompA operon promoter region, using primers found in Table 2.7. Primers 
contained restriction enzyme sites of BamHI and SalI for cloning into pT-COW plasmid 
(Gardner et al., 1996), and transformed into E. coli and plated onto LB plus ampicillin plates. 
Positive colonies were grown by selecting for colonies that would grow on ampicillin 
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containing plates, but not on tetracycline containing plates, due to the ompA2 insert 
interrupting the E. coli tetR gene, and confirmed by sequencing. Plasmids positive for the 
promoter and insert (pT-COW-ompA2) were transformed into P. gingivalis ∆ompA2 
mutants, alongside an empty pT-COW vector via natural competency as described in 2.6.5. 
An empty pT-COW vector was also transformed into wild-type ATCC 33277 P. gingivalis as a 
positive control. All P. gingivalis colonies were selected for positive inclusion of the plasmid 
by selection on tetracycline containing BA plates.  
2.7 Protein Methods 
2.7.1 Protein Purification 
2.7.1.1 Overexpression of Protein & Cell Free Extract Preparation 
A single colony of transformed E. coli c41 cells containing the plasmid positive for the insert 
for OmpA1 or OmpA2 protein overexpression was used to inoculate 5 ml LB broth and 
grown at 37°C with agitation for 16 h. The 5 ml culture was then used to inoculate a 500 ml 
LB broth in a 2 L flask. The 500 ml culture was grown at 37°C with agitation until the OD600nm 
reached 0.6. The flask of E. coli was induced with 0.1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) (Calbiochem) and grown for another 4 hours with agitation at 
37°C, or cooled to 20°C and grown for 16 h. The cells were then pelleted by centrifugation 
at 6000 x g. for 25 minutes at 4°C. The cell pellet was resuspended in 10 ml sterile PBS with 
1 proteinase inhibitor tablet (cOmplete ULTRA Tablets, EDTA-free EASYpack, Roche) and the 
cells disrupted using a French Pressure Cell (Thermo Electron Corporation) at 1000 psi twice 
before a further centrifugation at 15000 x g. for 30 minutes at 4°C to separate the cell 
lysate from the insoluble material.  
2.7.1.2 His-Tagged Protein Purification Using Affinity Column 
Ni2+-NTA resin (QIAGEN) was prepared by washing a washing a 0.5 ml (50%) slurry 3 times 
in PBS by centrifugation at 1000 x g. for 2 minutes. The final pellet was resuspended in 0.5 
ml PBS and added to the cell lysate before incubation at 4°C with agitation for 1 hour.  
After allowing the protein to bind to resin, it was applied to a 10 ml Polyprep® 
chromatography column (BioRad). For His-tag purification, the Ni2+-NTA-resin containing 
cell lysate was added to the column and the flow through obtained. The column was 
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washed twice with two column volumes of 20 mM imidazole in PBS (pH 7.4) to remove any 
non-specifically bound proteins. The cap was then placed on the column and the resin was 
incubated with 2 ml 150 mM imidazole in PBS for 30 minutes at 4°C with agitation. The cap 
was then removed and the elution fractions were caught in 1 ml fractions by gravity flow. 
Then, 2 ml 200 mM imidazole in PBS was added and the incubation repeated twice more. 
Finally, 4 ml of the 200 mM imidazole in PBS was added and the elution was caught 
immediately in 1 ml fractions.  
2.7.1.3 GST-Tagged Protein Purification Using Affinity Column 
Glutathione resin (QIAGEN) for GST-tag purification was prepared by washing a 0.5 ml 
(50%) slurry 3 times in PBS by centrifugation at 1000 x g for 2 minutes. The final pellet was 
resuspended in 0.5 ml PBS and added to the cell lysate before incubation at 4°C with 
agitation for 1 hour.  
After allowing the protein to bind to resin, it was applied to a 10 ml Polyprep® 
chromatography column (BioRad). For GST-tag purification, the glutathione-resin containing 
cell lysate was added to the column and the flow through obtained. The column was 
washed twice with two column volumes of 50 mM Tris (pH 7.4) to remove any non-
specifically bound proteins. The cap was then placed on the column and the resin was 
incubated with 2 ml GST-elution buffer (see Materials and Methods, 2.2.3) for 30 minutes 
at 4°C with agitation. The cap was then removed and the elution fractions were caught in 1 
ml fractions by gravity flow. Another 2 ml of elution buffer was added and the incubation 
repeated twice more. Finally, 4 ml of the elution buffer was added and the elution was 
caught immediately in 1 ml fractions.  
2.7.2 Purified Protein Analysis 
The fractions were visualised by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) and stained with Coomassie Blue. The samples were then 
dialysed in 200 times volume of 50 mM Tris (GST-tagged protein) or 140 mM PBS (His-
tagged protein) at 4°C for 16 h and the samples kept at -20°C.   
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2.7.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
2.7.3.1 SDS-PAGE buffers  
2.7.3.1.1 SDS-PAGE Upper and Lower Tris 
SDS-PAGE upper Tris buffer was made from 6.06 g Tris Base and 0.4 g Sodium dodecyl 
sulphate (SDS) and made up to 100 ml using dH2O before adjusting the pH to 6.8. 
SDS-PAGE lower Tris buffer was made from 18.17 g Tris Base and 0.4 g Sodium dodecyl 
sulphate (SDS) and made up to 100 ml using dH2O before adjusting the pH to 8.8. 
2.7.3.1.2 SDS-PAGE Running Buffer 
SDS-PAGE running buffer was made by adding 12 g Tris Base, 4 g sodium dodecyl sulphate 
(SDS) and 57.5 g glycine and made up to 1000 ml using dH2O. Before use, 160 ml of the 
solution was diluted in 840 ml H2O 
2.7.3.1.3  2X SDS Loading Buffer 
The loading buffer is added to the protein samples before running them on an SDS-PAGE 
gel. A 50 ml solution was made by adding 40 ml of a 100 mM Tris-HCl solution, 10 ml of 
20 % glycerol, 1 g of SDS and 0.1 g Bromophenol Blue. Just before use, 200 mM DTT was 
added. 
2.7.3.1.4 SDS-PAGE Destain Buffer 
Destain buffer was used to remove the InstantBlue™ stain from the SDS-PAGE gels. This 
buffer was a mixture of 40% methanol, 10% acetic acid and 50% H2O. 
2.7.3.2 SDS-PAGE gel analysis 
Tables 2.21 and 2.22 show the reagents and their quantities needed for a 10% and 12% tris-
glycine SDS-polyacrylamide gel.  
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Table 2.21 Reagents and volumes needed for the resolving gel 
 Volume 
Reagent 10 % Gel 12 % Gel 
dH2O 4.825 ml 4.3 ml 
Lower Tris 2.5 ml  2.5 ml 
Acrylamide 2.475 ml 3 ml 
TEMED 5 µl 5 µl 
APS 350 µl 350 µl 
Upper and Lower Tris compositions can be seen in section 2.7.3.1.1. 
Table 2.22 Reagents and volumes needed for the stacking gel 
Reagent Volume 
dH2O 4.725 ml 
Upper Tris 2.1 ml 
Acrylamide 0.975 ml 
TEMED 17 µl 
APS 100 µl 
Stacking gel reagents and volumes remained the same for all percentage gels.  
The reagents for the resolving gel were added in the order of listing in the Table with the 
ammonium persulphate (APS) (0.25 g in 5 ml dH2O) added last. Immediately after APS 
addition, the solution was mixed and the gel poured into BioRad glass plates to ~1 cm from 
the top of the lower plate. As soon as the resolving gel was poured, 100 µl of isopropanol 
was added on top to remove any air bubbles and to prevent the top of the gel drying out. 
After the resolving gel was set, the isopropanol was removed and washed away with 
distilled water. The stacking gel reagents were added, again with the APS added last, 
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poured on top of the resolving gel and the comb was placed to form separate wells. Once 
set, the gel was positioned into a BioRad protein gel tank (mini PROTEAN Tetra System) and 
the tank filled with SDS running buffer. Protein samples were prepared by addition of SDS-
loading buffer and heated at 100°C for 5 minutes. The comb was removed from the gel and 
the 10 µl of each sample was added to the lanes, with one lane reserved for 5 µl EZ-RunTM 
Pre-stained protein ladder. The gel was run at 220 mA (constant milliamps) until the loading 
dye reached the bottom of the gel. The gel was removed from the glass plates and stained 
using InstantBlue™ (Expedeon) for 2 h at room temperature with agitation.  
2.7.3.3 Silver Staining Of Proteins In Polyacrylamide Gels 
If protein concentration was too low for visualisation by EZ-Blue™, silver staining with silver 
nitrite is used as a highly sensitive method for visualisation of protein bands. The stained 
SDS-PAGE gel is completely destained using destain buffer (section 2.7.3.1.4), and washed 
thoroughly in dH2O before silver staining using Silver Stain Plus Kit (BioRad) according to the 
manufacturer’s instructions. 
2.7.4 Western Blot 
2.7.4.1 Western Blot General Buffers 
2.7.4.1.1 Semi-Dry Transfer Buffer 
Semi-dry transfer buffer was made with 2.9 g Tris Base, 1.45 g glycine, 1.85 ml 10% SDS and 
100 ml methanol. The reagents were mixed and the total made up to 500 ml with H2O.  
2.7.4.1.2 Blocking Buffer 
The blocking buffer was made up of 5% semi-skimmed milk, 3% BSA and 0.1% Tween-20 in 
PBS 
2.7.4.2 Antibodies 
Antibodies used in this study are listed in the Table below including the dilution they were 
used at.  
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Table 2.23 Antibodies used in this study 
Antibody Type Dilution Supplier 
Anti-OmpA Primary, rabbit raised 1:1000 Professor Keiji Nagano (Aichi 
Gaukin University, Nagoya, 
Japan) 
Anti-FimA Primary, rabbit raised 1:1000 Professor Ashu Sharma 
(University at Buffalo, NY, 
USA) 
Anti-rabbit IgG-
HRP conjugated 
Secondary, goat raised 1:3000 Cell Signalling 
All antibodies were dilution to their correct concentrations in 0.1% Tween-20 in PBS. 
 
2.7.4.3 Protein Analysis Using Western Blot 
An SDS-PAGE gel is run as above, but prior to staining with Coomassie Blue, the proteins are 
transferred to a re-enforced nitrocellulose (NC) sheet (GE Healthcare). Six sheets of 
chromatography paper (GE Healthcare) and one sheet of NC paper were cut to 8.5 cm x 6 
cm and soaked alongside the gel in semi-dry transfer buffer for 5 minutes. The gel and 
papers were transferred to a BioRad Trans-Blot Semi Dry Transfer Cell in the following 
order; three sheets of chromatography paper, the NC sheet, the gel and the final three 
sheets of chromatography paper. Transfer was achieved by running at 10 A for 60 minutes, 
or until the protein had fully transferred to the NC sheet (detected by the transfer of the 
coloured EZ-run™ protein ladder). The NC sheet was then transferred to a falcon tube 
containing 50 ml blocking buffer and incubated with agitation for either 2 hours at room 
temperature or 4°C overnight. The blocking solution was then poured off and the NC sheet 
washed three times with PBS supplemented 0.1% Tween-20. The NC sheet was then 
incubated for 1 h with the primary antibody, subject to the protein of interest. The NC was 
washed 3 times with PBS + 0.1% Tween-20 to remove excess antibody, and then the NC 
sheet was incubated with a secondary antibody before being washed 3 times and then 
exposed to the developing solution, Pierce® ECL Western Blotting Substrate (Thermo 
Scientific). Equal volumes of each of the solutions were mixed and added to the NC sheet 
and left for 1 minute. Excess liquid was removed and the NC sheet placed in cling film and 
placed into an X-Ray cassette folder (Kodak). Sheets of CL-Xposure™ X-ray films (Thermo 
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Scientific) were placed in the cassette in contact with the NC sheet for varying lengths of 
time, ranging from 1 second to 5 minutes, and the sheets developed using a Compact X4 X-
ray Film Processor (Xograph).  
2.7.5 Outer Membrane Protein Fraction Preparation 
10 ml cultures of P. gingivalis were grown according to 2.4.2 to an OD600 1.0 and pelleted at 
5000 x g for 10 min at 4°C in a Beckman Coulter™ J-26 XP centrifuge. The supernatant was 
discarded before each pellet was resuspended in 2 ml resuspension buffer (0.01 M HEPES, 
pH 7.4, 2 µl deoxyribonuclease and 2 µl ribonuclease (both Promega)). The cell suspension 
was lysed by passage through a French Pressure Cell (2250 psi using a 800 medium ratio 
piston) before the addition of 2 µl 1 mM MgCl2 and centrifugation at 5000 x g for 5 min 
(4°C). The supernatant was then transferred to a new Eppendorf and centrifuged at 75600 x 
g for 45 min at 4°C. The supernatant, containing the cytoplasmic and periplasmic fraction, 
was then removed and stored, whilst the pellet was resuspended in 500 µl 0.01 M HEPES 
(pH 7.4) containing 2 % Triton X-100 and incubated for 10 min at room temperature, before 
being centrifuged at 75600 x g for 45 min at 4°C. The supernatant containing the inner 
membrane fraction was removed and stored, before the pellet was resuspended in 500 µl 
0.01 M HEPES (pH7.4) and centrifuged at 75600 x g for 45 min at 4°C. The supernatant was 
discarded, and the remaining pellet (the outer membrane fraction) was resuspended in 50 
µl 2 x SDS loading buffer (without DTT) and spun in a microcentrifuge (GenFuge, Progen 
Scientific) for 5 min at 16000 x g before being heated to 95°C and run on a NuPAGE® Bis-
Tris 4-12% gradient gel (Thermo Fisher Scientific) for greater protein resolution.  
2.8 Phenotypic Characterisation Methods 
2.8.1 Antibiotic Protection Assay 
The antibiotic protection assay was carried out in a Class II Safety Cabinet, thoroughly 
cleaned with 70% IMS. All media was pre-warmed to 37°C and sterilised before being 
placed into the cabinet. OK-F6 cells were seeded identically at 2 x 105 cells / ml at 1 ml per 
well into two 24-well MTPs and incubated at 37°C, 5% CO2 with humidity for 24 hours until 
70-80% confluency was reached. After the desired confluency was reached, the media from 
each well was removed and the monolayer of cells was gently washed with PBS. In one 
“sacrificial” well, 500 µl trypsin-EDTA was added and the plate incubated for 10 minutes 
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until the cells detached. Then, 500 µl neutralising media was added and the cells counted as 
previously described. The remaining wells were incubated with 1 ml DKSFM supplemented 
with 2% bovine serum albumin (BSA) for 60 minutes at 37°C 5% CO2 with humidity. During 
this incubation, P. gingivalis strains (wild-type or mutants) were removed from a 72 hour 
blood agar plate and suspended in 1 ml of DKSFM. The bacteria were counted and adjusted 
to match a 1:100 ratio (OK-F6 cells: bacteria) to create a multiplicity of infection (MOI) of 
100. After the 60 minute incubation with BSA-containing DKSFM, the OK-F6 cells were 
washed three times with PBS and incubated with 1 ml of DKSFM containing the bacterial 
suspension and incubated aerobically for 90 minutes at 37°C, 5% CO2 with humidity. 
Alongside the OK-F6 containing wells, 3 wells per bacterial strain were seeded with the 
bacterial suspension to analyse the bacterial cell viability throughout the assay. After 90 
minutes incubation with P. gingivalis, the wells containing OK-F6 cells and bacteria were 
washed three times with PBS. One of the MTPs containing wells with OK-F6 cells and 
bacteria was incubated for a further 60 minutes with 200 µM metronidazole per well to kill 
any extracellular P. gingivalis as to assess the number of invaded bacteria. Both MTPs were 
then washed three times with PBS and 100 µl sterile H2O was added for 1 minute to each 
well with scraping to lyse the OK-F6 cells. The cell lysate with bacterial cells was then 
serially diluted 10-fold down to 10-4 and 3 x 10 µl of each spot was then plated onto blood 
agar plates and grown anaerobically for 5 days. Wells containing only P. gingivalis were 
serially diluted and plated onto blood agar plates in the same way, with the exception of 
the washing, addition of water and scraping. 
2.8.2 Antibiotic Protection Assay in the Presence of Peptides 
Standard antibiotic protection assays were carried out as detailed in 2.8.1, with the 
addition of an additional incubation step following BSA incubation, whereby 50 µg/ml of 
each peptide was added to each well containing epithelial cells followed by the 90 min 
incubation step with bacteria in the presence of peptide (50 µg/ml), before processing as 
previously detailed. Biotinylated peptides were purchased from IscaBiochemicals Ltd. 
(Exeter, UK) or CovalAb (Cambridge, UK).  
2.8.3 Fluorescence Binding Assay of Extracellular Peptide Loops to OK-F6 Monolayers 
Peptides were bound to a final working concentration of 50 µg/ml to yellow-green 
fluorescent FluoSpheres® (NeutrAvidin®-labelled Microspheres, Invitrogen) by the following 
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method. Firstly, the beads were washed three times in 0.01 M HEPES buffer (pH 7.4), with 
centrifugation of 14,000 x g (10 min) and then gently sonicated. Peptides were added and 
allowed to adhere to the FluoSphere® for 16 h at 4°C with gentle agitation. Then, the 
FluoSpheres® were washed in HEPES, before gentle sonication and further 1 h incubation 
with 0.1 % BSA at 4°C. Peptide-bound FluoSpheres® were then washed three times in 
HEPES buffer,  sonicated gently, and either stored at 4°C for up to one month, or used 
immediately in binding to oral epithelial cells. FluoSpheres® were also incubated with 2 % 
BSA as a negative control.  
For peptide binding assessment, OK-F6 cells were grown to 90% confluency in a 96-well 
MTP before being washed twice with PBS, then 2% BSA blocking buffer in DKSFM was 
added and incubated for 1 hour at 37°C, 5% CO2. Cell monolayers were washed thoroughly 
with HEPES buffer before the addition of 100 µl peptide-bound FluoSpheres® at a ratio of 
1:100 (cells: FluoSpheres®) as to mimic the MOI of an invasion assay, and incubated at 37°C 
with 5 % CO2  for 4 h. After incubation, wells were gently washed three times in HEPES 
buffer and fluorescence read using a TECAN Infinite® PRO plate reader, with 488nm / 510nm 
(ex/em) filters.  
Alternatively, OK-F6 cells were seeded onto coverslips in a 24-well MTP and grown to a 
confluency of 70 %, before being washed in PBS and 2 % BSA added as above. Cells were 
washed in HEPES and 350 µl peptide-bound FluoSpheres® at a ratio of 1:100 (cells: 
FluoSpheres®) were added and incubated for 4 hours as previously described. After 
incubation, cells were gently washed in HEPES buffer before being fixed using 4 % 
paraformaldehyde and incubated at room temperature for 15 min. Cells were then washed 
in PBS and cell membranes were stained using Wheat Germ Agglutinin, Texas Red®-X 
Conjugated antibody (Life Technologies) at a 1:1000 dilution, and incubated without light 
for 15 min at 37°C with 5 % CO2 , before being thoroughly washed in PBS and mounted onto 
glass microscope slides using ProLong® Gold Antifade Mounting Medium with DAPI and 
imaged using an Axiovert 200M Microscope (Zeiss) 24 h post-mounting.  
2.8.4 Biofilm Formation Assay 
P. gingivalis strains were seeded at an OD600nm of 0.05 into a 96 well MTP (Corning) and 
grown under anaerobic conditions without shaking. After 72 hours, the total growth was 
measured by reading the absorbance (600 nm) using a FLUOstar (BMG Labtech). The 
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planktonic bacteria were removed and the biofilm layer washed 3 times in PBS. The biofilm 
layer was then stained using 100 µl 0.1% Crystal Violet stain and incubated at room 
temperature for 20 minutes. Excess stain was removed and the stained layer was washed 
until the PBS became clear. Images were taken under 400 X magnification using a Nikon 
Elipse TS100 light microscope and then the Crystal Violet stain was extracted using 200 µl of 
20 % acetic acid. Then, 80 µl of the extracted Crystal Violet was centrifuged (11,000 x g, 1 
min) to remove any precipitate and then transferred from each well to a new 96-well MTP 
and the absorbance read at 575nm.  
2.8.5 Electron Microscopy  
2.8.5.1 Sample Processing for Sectioning 
Liquid cultures of P. gingivalis and mutant strains were grown to OD600 1.0, before 1 ml was 
pelleted and supernatant discarded. The cell pellet was washed twice for 5 min in 
cacodylate buffer (0.1 M Cacodylate buffer, pH7.4), and the supernatant removed. The 
pellet was then fixed in 3% glutaraldehyde for 4 hours at 4°C, before being washed three 
times at 4°C in cacodylate buffer (20 min washes). The pellets were then soaked in osmium 
tetraoxide (OsO4) for 1 hour at room temperature before a series of washes were carried 
out: 
 3 x 2 min dH2O 
 2 x 3 min 70 % ethanol 
 2 x 5 min 95 % ethanol 
 2 x 10 min 100 % ethanol 
The pellet was then “dried” in 100 % dried ethanol (dried over copper sulphate) for 15 min 
before being soaked in propylene oxide for 15 min at room temperature. The pellets were 
then soaked for 16 h in a 50/50 reagent mixture of propylene oxide/Agar 100 resin (see 
Table 2.24 for Agar 100 resin) in sealed containers. After 16 h, the 50/50 mixture was 
replaced with 100% Agar 100 resin for 8 h in open containers, before embedding the pellet 
in fresh Agar 100 resin and left to polymerise in a flat embedding silicon mould (Agar 
Scientific) at 60°C for 24-48 h. Embedded pellets were sectioned at 70-90 mm and placed 
onto formvar-coated grids.  
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Table 2.24 Agar 100 Resin reagents for medium blocks 
Reagent Volume (ml) 
Agar 100 epoxy resin 20 
Hardener DDSA  16 
Hardener MNA 8 
Accelerator BDMA 1.3 
Reagents were thoroughly mixed and air bubbles removed via sonication before 
application.  
 
2.8.5.2 Staining of Electron Microscope Grids 
The grids were stained with assistance from David Thompson (The University of Sheffield)  
by the following procedures and stains as previously discussed by Reynolds (Reynolds, 
1963). In brief, a single drop of uranyl acetate (7% saturated in 50% methanol) was placed 
onto a strip of Parafilm M®, and the grid with sections was floated on top to stain for 20 
mins in the dark.  The grid was then rinsed for 20 s in dH2O before being stained in lead 
citrate (Table 2.25) for 5 min in the same way but in a light environment. Grids were then 
washed well before electron microscopy. 
Table 2.25 Lead citrate buffer 
Reagent Amount 
Lead nitrate 1.33 g 
Sodium citrate 1.76 g 
Distilled H2O 30 ml  
1 M Sodium Hydroxide (NaOH) Make up to 50 ml 
 
2.8.9 Proteinase Activity Assays 
These assays were used to assess the level of gingipain activities of whole cell wild-type P. 
gingivalis and mutant strains, as well as the activity of gingipains secreted by these strains. 
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2.8.9.1 Colorimetric Assays 
Colorimetric Assays were used to measure the gingipain activity of whole cell bacteria. 
Overnight liquid cultures of P. gingivalis and mutant strains were grown as described in 
2.4.2 before being centrifuged at 16000 x g for 10 min. Pellets were washed twice in PBS 
and adjusted to OD600 1.0. In a 96-well MTP, triplicate wells of each strain were set up, 
containing 1 µl 1 M L-cysteine, 100 µl TNCT buffer (detailed in Table 2.26) and 10 µl bacteria 
(for Arg-gingipain activity) or 20 µl bacteria (for Lys-gingipain activity). The reaction was left 
to incubate for 5-10 min at room temperature before 100 µl 0.4 mM substrate (N-α-
Benzoyl-L-arginine p-nitroanilide for Arg-gingipains, or toluenesulfonyl-glycyl-L-prolyl-L-
lysine p-nitroanilide for Lys-gingipains, both diluted in TNCT buffer) and read immediately 
at Abs405nm on a TECAN Infinite® PRO plate reader. The absorbance was measured every 
minute for 30 minutes to determine gingipain activity rate.  
Table 2.26 TNCT buffer 
Reagent Concentration 
Tris-HCl (pH7.5) 50 mM 
NaCl 150 mM 
Calcium Chloride (CaCl2) 5 mM 
Tween-20 0.05% 
dH2O Up to 50 ml 
 
2.8.9.2 Fluorometric Proteinase Assay 
Fluorescence based substrates were used to determine the Arg- and Lys-proteinase activity 
of secreted gingipains, due to the disruption of the coloured culture media on the 
colorimetric substrate. Fluorometric assays were adapted from the protocol outlined by 
Chen (Chen et al., 2001), except samples were generated from liquid cultures. Briefly, 
cultures of P. gingivalis strains were grown as outlined in Materials and Methods 2.4.2, the 
OD600 adjusted to 1.0 and the cells were centrifuged (16000 x g, 5 mins) and the pellets 
discarded. To measure Arg-proteinase activity, a reaction mixture of 100 µl PBS containing 
1 mM L-cysteine, 200 µM αN-benzoyl-L-arginine-7-amido-4-methylcourmarin substrate and 
50 µl supernatant was added in triplicate to a 96-well MTP and incubated at room 
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temperature for 10 minutes before the reaction was terminated by the addition of N-α-
tosyl-L-phenylalanine chloromethyl ketone (TPCK) at 200 µM. Lys-proteinase activity was 
assayed in 100 µl PBS containing 1 mM L-cysteine, 10 µM t-butyloxycarboyl-Val-Leu-Lys-7-
amido-4-methylcourmain substrate and 50 µl supernatant and incubated at 40°C for 10 min 
before the reaction was terminated using 500 µM N-α-p-tosyl-L-lysine chloromethyl ketone 
(TLCK). Both Arg- and Lys-gingipain activities were determined by measuring released 7-
amido-4-methylcourmarin using a TECAN Infinite® PRO plate reader, with excitation and 
emission wavelengths of 365 nm and 460 nm respectively.  
2.8.9.3 Sialidase Assay 
Overnight cultures of P. gingivalis and mutant strains were set up according to Materials 
and Methods 2.4.2. Cultures were centrifuged (1600 x g for 5 min) and the pellets 
resuspended in PBS and adjusted to OD600 1.0 and 0.5, before 5 µl of each OD and strain in 
triplicate were added to a 96-well MTP, with 42.5 µl PBS and 2.5 µl MUNANAC (2’-(4-
Methylumbelliferyl)-α-D-N-acetylneuraminic acid) from stock solution of 2 mM and 
anaerobically incubated for 60 or 120 min at 37°C. The reaction was then terminated by the 
addition of 75 µl 100 mM sodium carbonate buffer (pH 10.5) before reading fluorescence at 
355 nm / 420 nm (ex/em) using a TECAN Infinite® PRO plate reader.  
2.8.9.4 Membrane Permeability Assay 
Thiazole Orange (TO) was used to determine the permeability of wild type and ∆ompH1H2 
membranes. Bacterial strains were grown in a liquid culture as described previously. Cells 
were adjusted to 1 x 106 CFU/ml in 20 mM Sodium Phosphate buffer. A 1 ml aliquot of cells 
was added to a Hellma Analytics Quartz Cuvette and agitated using a magnetic stirrer. 
Excitation and emission (510 nmex / 530 nmem) were read using a Varian Cary Eclipse 
fluorescence spectrophotometer every 100 ms for 10 s, before the addition of 25 µl TO at a 
concentration of 17 µM (final concentration of 420 nM). The rate of uptake of TO was 
measured every 100 ms for 20 s at the same excitation and emission wavelengths as before 
(510 nmex / 530 nmem). The data was analysed through the Varian Cary Eclipse Software and 
the rate was determined using the initial uptake within the first 5 s after TO addition.  
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2.8.9.10 Outer Membrane Vesicle Quantification  
Bacterial cultures were grown according to section 2.4.2 and cells were precleared from the 
culture by differential centrifugation. Bacterial cells were pelleted (8000 x g, 10 min) and 
cell-free supernatants were centrifuged for a further 30 min at 10000 x g to remove any cell 
debris. The supernatant was then passed through a 0.44 µm filter before being diluted 10 –
fold in sterile PBS. The OMVs were then analysed using a qNANO (iZON Science Ltd) with 
the application of Tunable Resistance Pule Sensing (TRPS). Then, 40 µl of the diluted sample 
was applied to the upper fluid cell of an NP100 nanopore stretched to 45.5 mm, whilst a 
voltage (42 V) and positive pressure (2 mbr) was applied to cause unidirectional flow of the 
OMVs through the nanopore. Calibration particles (CPC100B) of a known size (114 nm) and 
concentration (1x1013 particles ml-1) were also applied for comparison to the wild-type and 
ΔompA samples. The size and concentration of OMVs were analysed using the iZON Control 
Suite Software (provided with the instrument) and normalised to the OD600 of the 
corresponding bacterial culture.  
2.9 Statistical Analysis 
Each experiment was carried out with triplicate biological repeats unless otherwise stated. 
Statistical analysis used either students’ t-test, One-way ANOVA or 2way ANOVA once 
normal distribution was determined, and is detailed in the figure legend. 
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Chapter 3 
Role of the ompA Gene Cluster in Host-Cell Interactions and 
Biofilm Formation 
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3.1 Introduction 
Host cell interaction is a crucial aspect of a bacterium’s virulence. In particular, the ability 
for a periodontal pathogen to invade the host cell provides a nutrient-rich environment to 
facilitate replication (Madianos et al., 1996), which can lead to cell-to-cell spread and 
contributes to tissue destruction and disease progression (Tribble and Lamont, 2010). It 
also provides an immune-privileged niche whereby the periodontal pathogen is protected 
from the host immune system as well as protection from external antimicrobial challenges 
(Rudney and Chen, 2006), such as the application of antibiotics or removal by mechanical 
methods such as non-surgical debridement (Duncan et al., 1993; Lamont et al., 1995). 
Invasive bacteria have evolved numerous mechanisms for entry into the host cell, however 
first the bacteria must attach to the host cell and induce a number of biochemical and 
structural changes for host cell penetration, there is an extensive literature in this area that 
is summarised in section 1.6.6.3 of the introduction to this thesis.  
As discussed in Section 1.6.6.3, due to the importance for host adherence and invasion, P. 
gingivalis possesses multiple mechanisms to facilitate this. Two of the major mechanisms 
include the fimbriae and gingipain proteases.  Briefly, initial binding is predominantly 
facilitated by the major fimbriae, composed of major FimA subunits and minor FimC, D and 
E subunits (Nishiyama et al., 2007), which engage host cell integrins (αγβ3 and α5β1) and 
cause bacterial internalisation through cytoskeleton rearrangement (Weinberg et al., 1997; 
Yilmaz et al., 2002). The gingipain proteases are integral for successful adherence to the 
host by modulation of host matrix proteins to reveal hidden host receptors (or 
“cryptitopes”) and increase invasive efficiency (Kontani et al., 1996; Park and Lamont, 
1998).  
Due to their cellular surface location, various membrane proteins have been implicated in 
the interaction with the host. This chapter focusses on the major outer membrane protein, 
OmpA. The OmpA protein has been previously shown to be involved in the interaction with 
host in many different Gram-negative bacterial species. Meningitis-causing E. coli (K1-type 
strain) uses the OmpA protein in host cell interaction (Prasadarao et al., 1996), and the 
recently identified OmpA protein of Neisseria gonorrhoeae has been shown to be involved 
in the binding to epithelial cells (Serino et al., 2007). OmpA has also previously been shown 
to interact with a host glycoprotein to induce actin cytoskeleton rearrangement, facilitating 
the internalisation of E. coli (Prasadarao et al., 2002; Prasadarao et al., 2003). The OmpA 
protein found in P. gingivalis shows a high structural homology to the E. coli protein 
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(Nagano et al., 2005) (see section 3.3.1); and has been shown to be involved in interaction 
with human endothelial cells (Komatsu, et al. 2012), however nothing was known regarding 
its role in epithelial cell interactions, which we hypothesised might have a similar role in 
host-interactions with arguably greater relevance to periodontal disease.   
This chapter uses a knockout mutagenesis approach to characterise the role of the ompA 
genes in host-cell interactions by investigating the process of adherence and invasion of 
host oral epithelial cells mediated by the OmpA proteins of P. gingivalis.  
3.2 Aims 
The major aim of this chapter was to investigate the role for individual OmpA subunits in 
the interaction with the host cells, in this case a disease relevant monolayer model of 
infection, using the oral epithelial cell line, OKF6. This was achieved by performing knockout 
mutagenesis of P. gingivalis using allelic replacement and utilising the newly found natural 
competence based method of P. gingivalis transformation. 
N.B. much of the work in this chapter is included in a paper that has been accepted in 
MicrobiologyOpen (see appendix I) 
3.3 Results 
3.3.1 Basic Bioinformatic Analysis of the ompA Genes. 
The ompA genes of P. gingivalis are predicted to sit in the ompA operon, with the two 
genes, ompA1 (PGN_0729) and ompA2 (PGN_0728), arranged in tandem on the bacterial 
chromosome as shown in Figure 3.1, and predicted to transcribed from a single promoter 5’ 
of ompA1.  
 
Figure 3.1 Schematic representation of the ompA operon in the P. gingivalis 
chromosome. The ompA1 and ompA2 genes are indicated in red, adjacent genes in grey. 
Adapted screenshot from (http://www.oralgen.org/microbe.php?class=oral).  
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The sequence similarities between P. gingivalis ompA coding sequences at the primary 
amino acid level and ompA from E. coli was assessed in silico using online alignment tools, 
originally in BLASTP, and then in programmes such as MultAlin (Corpet, 1988) and Clustal 
Omega (Mcwilliam et al., 2013). Based on BLAST searching for homologous matches of E. 
coli OmpA in the P. gingivalis genome, homology only exists in the C-terminal domain of the 
protein and demonstrated by MultAlin alignments seen in Figure 3.2, as evidenced by high 
levels of similarity and identity in the last 100 amino acids.  
 
Figure 3.2 Protein sequence alignments between E. coli OmpA and P. gingivalis OmpA1 
and OmpA2. Alignments performed with Multalin, showing E. coli OmpA (top sequence) 
compared to P. gingivalis OmpA1 (PGA1, middle sequence) and OmpA2 (PGA2, bottom 
sequence). Residues highlighted in Red indicate presence in all three sequences, whereas 
blue indicates alignment in only two sequences.  
 
The similarity between protein sequences was limited, with only 23 and 24% homology 
observed for OmpA1 and OmpA2 respectively against E. coli OmpA, whereas the sequence 
homology between P. gingivalis OmpA1 and A2 is much higher, at 47% similarity. Structural 
homology is predicted to be much higher, as shown by Nagano et al (2005) and discussed in 
greater detail in Chapter 4.3.5, with all proteins having predicted eight-stranded β-barrel in 
the N-terminal region and a peptidoglycan-associated C-terminal domain.  
3.3.2 Generation of ∆ompA1 and ∆ompA2 Mutants  
Mutants of the single ompA1 and ompA2 genes were generated to understand their 
individual roles in host interaction. A double mutant (∆ompA1A2), whereby the entire 
ompA operon was deleted, was generated in a previous study by Mary Connolly at The 
University of Sheffield whilst part of Dr Stafford’s research group and was provided for this 
research.  Single ∆ompA1 or –A2 mutants were generated through the production of a gene 
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knock out construct through either overlap extension PCR or gene synthesis of similar 
constructs (GeneArt™, Thermo Fisher Scientific). The gene knock out constructs consisted 
of an erythromycin resistance cassette (eryR) flanked on either side by DNA 5’ and 3’ of the 
gene of interest to allow homologous recombination and allelic exchange when introduced 
into the wild type P. gingivalis, thus replacing the gene of interest with an antibiotic 
resistance marker for selection. The technique of overlap extension PCR is detailed in Figure 
3.3, and involves using methods of conventional PCR to assemble three double stranded 
DNA fragments into one large DNA construct. Primers for the single DNA fragments were 
designed with “tails” which complement the starting sequence of the next single fragment. 
Each single fragment is amplified through the first PCR reaction with the “tail” of the next 
fragment, and is then used as the template for the second PCR reaction which assembles 
the fragments into one large construct (Fig. 3.3). 
 
 
Figure 3.3 Overlap Extension PCR and Allelic Exchange for P. gingivalis ompA mutant 
production. (A) Two PCR reactions are carried out, first to amplify the flanking regions and 
the erythromycin cassette with tails complementary to the region they are to be linked to 
                 
PCR 1  
(single 
products 
produced) 
PCR 2  
(triplet 
construct 
produced and 
amplified) 
Transformation 
of P. gingivalis  
B)  
A)  
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then a second PCR is performed to combine the three separate regions and amplify the 
final construct. These constructs are then introduced to the wild-type bacterium as either 
linear fragments or incorporated into a plasmid for allelic exchange and production of the 
knock out mutation (B).  
Genomic DNA from wild-type P. gingivalis ATCC 33277 was extracted using the Promega 
Wizard® Genomic DNA Extraction Kit and using primers detailed in Table2.5 and 2.6., 
flanking regions of ~1000 bp upstream (flank 1) and downstream (flank 2) of the ompA1 or 
–A2 gene were amplified, alongside an erythromycin resistance cassette gene, from 
genomic DNA of P. gingivalis ATCC 33277 from a previous study. A second PCR reaction was 
then performed using these single fragments as the DNA template, and primers ompA1-f1 
for and ompA1-f2 rev (or the ompA2 equivalent) (Table 2.5 and 2.6), to assemble these 
fragments into the gene knock out cassette (Flank 1- eryR – Flank 2). After each PCR, 
products were analysed on a 1% TAE agarose gel, as shown in Figure 3.4, and cleaned up 
using a QIAGEN QIAquick PCR purification kit, or extracted from the gel before purification 
if multiple bands were present, which was often the case for the final 3-way PCR reaction 
products. All PCR reactions were carried out as detailed in Materials and Methods 2.6.2.4 
using Phusion™ as the polymerase enzyme to ensure no errors in the erythromycin 
resistance gene or flanking regions.  
 
Figure 3.4 PCR Amplification of ompA1 and ompA2 flanking regions and eryR cassette for 
gene knock out (A) and combined constructs for transformation (B). Regions were 
amplified using Phusion™ polymerase enzyme in conditions described in Table 2.17. 
Flanking regions appear as the prominent bands at ~1000 bp (except for ompA1 flanking 
region 2), and erythromycin cassette appears at ~800 bp. A second PCR was carried out to 
combine single PCR products (B) into the full knock out construct (~2800 bp). 
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PCR constructs were sequenced using GATC sequencing (GATC-Biotech, Germany), and 
non-erroneous constructs were used in transformation of P. gingivalis. Only the ompA2::em 
construct was produced through the overlap PCR method, as the full flank 1-eryR-flank 2 
construct for ompA1 gene knock out could not be assembled from singlet templates. 
Multiple annealing temperatures, DNA concentrations and extension times were used, as 
well as intermediate PCR reactions to assemble flank 1-eryR and eryR-flank 2 products 
before the final assembly; however no full construct could be created. Instead, the 
construct was generated by constructing the sequence in silico, replacing the ompA1 gene 
with the sequence from the erythromycin cassette at the ompA1 start codon. As with the 
ompA2::em construct, the erythromycin gene was flanked both side with 1000 bp from the 
original ompA1 gene, and synthesised by GeneArt™ (Thermo Fisher Scientific). The 
construct was cloned into pJET1.2/blunt plasmid vector (a blunt-end cloning vector that 
cannot replicate in P. gingivalis) before transformation as circular plasmid DNA and stored 
in E.coli DH5-α.   
Either the circularised plasmid DNA (~200-250 ng/µl) or linear PCR fragment (~200-250 
ng/µl) was then used for transformation into P. gingivalis wild-type. Transformation for 
∆ompA1 and ∆ompA2 was achieved through natural competency (as detailed by Tribble et 
al., (2010)) as well as electrocompetency method, as detailed in Section 2.6.3 and 2.6.4. For 
both techniques, the transformed P. gingivalis were grown on plain BA plates for 24 hours 
to allow for the production of erythromycin resistance, before being transferred to BA 
plates supplemented with erythromycin for selection of successful mutants. After plating 
on erythromycin-containing BA-plates, the mutagenesis experiments were incubated at 
37°C anaerobically for 14-21 days.  Typically erythromycin-resistant colonies appeared after 
9 days and were initially replated by streaking to fresh erythromycin-containing BA-plates 
before individual clones being assessed for correct recombination using PCR. 
Colonies that grew on erythromycin supplemented plates were analysed to check for 
faithful insertion of the antibiotic cassette in place of the gene of interest using PCR, as 
illustrated in Figure 3.5, and in all cases wild-type DNA was used as a control. DNA was 
extracted from erythromycin-resistant colonies and used in PCR reactions using GreenTaq™ 
polymerase enzyme and primers ompA1-f1 for and ompA1-f2 rev (or the ompA2 
equivalent) for whole construct generation (flank 1 - eryR - flank 2) to determine the gene 
had be successfully knocked out (Fig 3.6A, C) and primers ompA1-f1 for and ompA1-em rev 
(or the ompA2 equivalent) for generation of a flank 1 – eryR construct to ensure the 
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erythromycin gene is present (Fig 3.6B, D). Products from these confirmation PCRs were 
also sequenced to ensure the ompA gene had correctly been knocked out from the P. 
gingivalis genome.  
 
Figure 3.5 Schematic demonstrating primer pair locations for knock out mutagenesis PCR 
confirmation. (A) shows primers used to amplify the whole construct of (flank 1 – eryR - 
flank 2) and the expected product sizes, whereas (B) shows the primer placements used to 
amplify the flank 1 - eryR which would only appear if the erythromycin gene has been 
successfully incorporated.  
 
These combinations of PCR reactions were also chosen as they would assess correct 
incorporation into the genome in the case of the plasmid transformation. In some cases, 
single crossovers may occur whereby the genome inherits the erythromycin resistance 
cassette by homologous recombination at one of the homologous regions, alongside the 
retention of the gene, whereas a double crossover of the knock out construct would nullify 
the gene by removal. Whole construct amplification would indicate a single crossover event 
as both the plasmid containing the gene knock out and the wild-type gene would be 
amplified, giving two bands upon agarose analysis.  
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Figure 3.6 Confirmation of ∆ompA1 and ∆ompA2 mutant generation through colony PCR. 
DNA from 13 colonies that appeared on BA plates supplemented with erythromycin (10 
µg/ml) was extracted and colony PCRs were carried out according to Chapter 2.6.2.3 using 
GreenTaq™ polymerase. Successful knockout of ompA1 and ompA2 displayed bands at 
~2800 bp for full gene construct confirmation (A and C for ∆ompA1 and ∆ompA2 
respectively) or ~1800 bp for flank – eryR construct generation (B and D for ∆ompA1 and 
∆ompA2 respectively). Wild-type controls were negative for the presence of the 
erythromycin resistance gene (not shown).  
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Only colonies that were positive for bands on both agarose gels were taken for sequencing 
and if they contained no errors in the sequence, these colonies were stored in -80°C for 
experimental use. It is of note that of all the antibiotic resistant colonies, none tested 
negative for the single recombination event, indicating double crossover events in all 
mutants and a successful knock out of the gene.  
As mentioned above, in the generation of both ∆ompA1 and –A2 mutants, the natural 
competency method and electrocompetence methods were tested, in addition to 
comparison of linear PCR product and circular suicide plasmid DNA.  As shown in Table 3.1 
P. gingivalis transformation via the natural competency method generated more colonies 
compared (5-10-fold) to the traditional method of electrocompetency using identical 
amounts of DNA in the reactions (Table 3.1). 
Table 3.1 Number of ompA mutant colonies generated through different methods of P. 
gingivalis transformation 
 Method of Transformation 
 Electrocompetence Natural Competence 
Mutant Linear  
(colonies µg-1) 
Plasmid 
(colonies µg-1) 
Linear 
(colonies µg-1) 
Plasmid     
(colonies µg-1) 
∆ompA1 1.6 0 14.4 12 
∆ompA2 4.8 3.2 >100 >100 
The number denotes the number of colonies observed on the erythromycin plate in 
relation to the overall concentration of DNA input in the transformation, as the 
concentration of DNA varied between samples (between 200 ng/µl – 250 ng/µl) whilst the 
volume remained the same. Colony number observed for ∆ompA2 was unquantifiable as a 
lawn of bacteria was observed (>100), which was later streaked to single colonies and these 
single colonies were confirmed using PCR for correct incorporation of the PCR construct. 
 
The transformation efficiency for generating the ∆ompA1 mutant was generally lower than 
∆ompA2 and overall fewer colonies were produced when introducing the externally 
generated construct of ∆ompA1::em. This data also demonstrated that the introduction of 
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DNA through natural competency is more effective for generation of mutants than the 
electrocompetency method.  
3.3.2.1 Characterisation of the OM Profile of ompA Mutants 
Aside from PCR confirmation, ∆ompA1, ∆ompA2 and ∆ompA1A2 mutants were confirmed 
by purifying the bacterial outer membrane and assessing the presence of the protein using 
SDS-PAGE analysis and silver-staining as detailed in Section 2.7.3.2 and 2.7.3.3., and probing 
for the presence of OmpA at ~41 kDa using an anti-OmpA antibody, obtained from Dr Keiji 
Nagano (Aichi Gaukin University, Nagoya, Japan). This was achieved using the method of 
differential detergent centrifugation with approximate normalisation of proteins by use of 
identical amounts of starting material and careful processing. Figure 3.7 indicates the 
presence of OmpA protein in wild-type P. gingivalis, ∆ompA1 and ∆ompA2 mutants, but 
demonstrates a lower density of protein in the 41 kDa region in these mutants, as expected 
due to the loss of the OmpA1 or OmpA2 subunit and suggesting successful generation of 
∆ompA1 and ∆ompA2 mutants. No band is observed in the ∆ompA1A2 mutant, suggesting a 
successful deletion of the entire ompA operon.  
  
Figure 3.7 Silver staining assessment of the outer membrane of wild-type P. gingivalis and 
respective ∆ompA mutants. Outer membranes were purified and stained as described in 
Chapter 2.7.5 and 2.7.3.3. The OmpA proteins can be seen at ~41 kDa in wild-type, ∆ompA1 
and ∆ompA2 preparations but is missing in ∆ompA1A2 as indicated by the red arrow.  
An anti-OmpA antibody was used at a 1:5000 dilution as the primary antibody against 
OmpA proteins in the outer membrane samples. A secondary anti-rabbit-HRP-conjugated 
 
 
 
 
 
72 kDa 
54 kDa 
43 kDa 
34 kDa 
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antibody was used at 1:3000 dilution to detect for anti-OmpA antibody binding to OmpA 
proteins, and processed as according to Section 2.7.4. The Western blot can be seen in 
Figure 3.8, which shows the presence of the OmpA bands in the wild-type strain, but only 
one of the bands in the ∆ompA1 and ∆ompA2 samples, whereas both are absent from the 
∆ompA1A2 sample, confirming the deletion of the ompA operon. Unfortunately the 
antibody reacts with a number of non-specific bands in the strain, but these are consistent 
between all three strains indicating the confirmation of mutants as expected.   
 
Figure 3.8 Western blotting detection of OmpA protein in outer membrane preparations. 
α-OmpA antibody (1:5000 dilution) was used to probe for the presence of OmpA in outer 
membranes of wild-type P. gingivalis and ∆ompA mutants. The OmpA1 and OmpA2 
subunits can be seen as separate bands in the wild type preparation, whereas less OmpA 
can be seen in the single ∆ompA mutants. No OmpA is detected in the double mutant, as 
indicated by the red arrow.  
 
3.3.3 Phenotypic Analysis of P. gingivalis Wild-Type and ∆ompA Mutants 
3.3.3.1 Visualisation of Bacterial Cells through Transmission Electron Microscopy 
The OmpA protein is a vastly abundant protein in the cell membrane, comprising of ~2-3 x 
105 copies per cell in E. coli K12 (Smith et al., 2007), and has been shown to have a 
multifunctional role, one of which is within membrane structural integrity (Sonntag et al., 
1978; Klose et al., 1988).  The role of OmpA in P. gingivalis in structural integrity has been 
relatively unreported, with only one study demonstrating a role for OmpA (Iwami et al. 
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2007). Transmission Electron Microscopy (TEM) was used to demonstrate any effect of 
losing OmpA on the outer membrane gross morphology. 
Cultures were grown for 24 hours in broth culture, whereby the bacteria had reached 
stationary phase, and OD600 readings were similar in all strains (within 0.1). Cells were 
prepared for avaldite resin embedding and ultrathin sectioning (70-90 nm)  as detailed in 
Section 2.8.5.1, before being stained with uranyl acetate and lead citrate as described by 
Reynolds et al., (1963) and Section 2.8.5.2 (Reynolds, 1963). In these experiments, a  
disruption of the membrane was observed, as shown in Figure 3.9, whereby the membrane 
appears to have lost continuity and becomes wavy in some cells. This only appears in 
around 3 – 4 % of the population in the ∆ompA1 and ∆ompA2 mutants and around 4 – 6 % 
of the ∆ompA1A2 population (Figure 3.9B), although the harsh preparation steps of the 
samples caused a lot of the ∆ompA1A2 cells to lyse so the proportion of bacteria displaying 
the membrane disruptions is expected to be higher in the double mutant. This is in contrast 
to previous reports, which show a high level of membrane disruption, although the trend 
showing a more exaggerated phenotype in the double mutant remains the same. 
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Figure 3.9 TEM Imaging of wild-type and ∆ompA mutant strains of P. gingivalis. Liquid 
cultures (OD600 1.0) of P. gingivalis strains were fixed and dehydrated with ethanol before 
embedding in avaldite. Sections of embedded P. gingivalis were bound to formivar grids 
and stained using uranyl acetate and lead citrate before imaging using a Philips CM100 
Transmission Electron Microscope. Figure (A) demonstrates the observation of the 
disrupted membranes in the ∆ompA mutants that is not observed in the wild-type; 
however Figure (B) demonstrates how infrequently this is observed in a population, using 
∆ompA2 as an example. Scale bars are represented on the bottom left or right of every 
image. Black arrows indicate the presence of fimbriae, whereas red arrows indicate the 
cells with observed membrane disruptions. 
Due to the structure of the OmpA protein, which contains a β-barrel and a peptidoglycan-
associated C-terminal domain, the loss of membrane integrity is an expected observation as 
the protein is no longer present to assist in anchoring the outer membrane to the 
peptidoglycan layer.  
Interesting to note was the presence of the fimbriae in all of the mutants, as indicated by 
the black arrows in Figure 3.9A, implying the loss of the OmpA protein doesn’t have an 
effect on the production of fimbriae, which has previously been noted for E. coli OmpA 
(Teng et al., 2006). Also to note was the presence of outer membrane vesicle-like structures 
in the sections. These appeared to be present in higher levels in the mutants compared to 
the wild-type, and it is possible that these result in a loss of the membrane integrity with 
the loss of the major membrane protein OmpA, causing membrane blebbing. The number 
of vesicles present and their size distribution was investigated further in the next section.  
3.3.3.2 Assessment of Outer Membrane Vesicle Formation 
The formation of outer membrane vesicles is considered to be a mechanism of interaction 
with other species or the host, or for delivery of virulence factors (Kuehn and Kesty, 2005). 
Like other Gram-negative bacteria, P. gingivalis naturally produces outer membrane 
vesicles, likely through cell wall turnover and blebbing of the membrane (Ho et al., 2015). 
Proteomic analysis of these vesicles have shown the presence of membrane-associated 
proteins, such as the gingipains (Rgp, Kgp), fimbriae (FimA) and Haemagglutinin A (HagA), 
demonstrating a role for these vesicles to deliver important virulence factors and 
proteolytic enzymes (Imai et al., 2005; Nakao et al., 2014).  
Assessment of the vesicle number and size distribution was determined using a qNANO 
instrument, which quantified the number of vesicles produced by the bacteria. Vesicles 
were isolated from liquid cultures of P. gingivalis grown as described in Section 2.8.10, 
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before the culture precleared using differential centrifugation. Any resulting cellular debris 
was removed through further centrifugation and filtration, resulting in vesicle-containing 
preparations which were applied to the qNANO. The number and size of vesicles was 
determined by Tunable Resistance Pulse Sensing, whereby a voltage is applied to a pore 
stretched over the qNANO system and is filled with electrolyte, creating an ionic current. As 
the vesicle passes through the pore, a brief increase in electrical resistance occurs and a 
resistive pulse in created, which allows the particle volume to be precisely mapped. A rate 
of flow of the vesicles is also applied to allow detection of particle concentration. Due to 
the electron microscopy of ∆ompA mutants demonstrating a loss of membrane integrity 
with the loss of the OmpA protein, an increase in vesicle formation was expected, which 
was observed for the mutant strains, as shown in Figure 3.10. 
       
Figure 3.10 Vesicle formation by wild-type P. gingivalis and ∆ompA mutants. Vesicles 
were purified from liquid cultures (OD600 1.0) precleared through differential centrifugation. 
Cell-free supernatants were passed through 0.44 µm filtration to remove any remaining cell 
debris to ensure a pure vesicle sample. Bacterial vesicles were analysed using a qNANO 
instrument (iZON Science Ltd) using tuneable resistive pulse sensing (TRPS), and compared 
to calibration particles of a known size and concentration. The concentration of vesicles 
was normalised to the OD600 of the corresponding culture. Error bars ± SEM. Statistical 
significance was ** p < 0.01, as determined by One-Way ANOVA (n = 3). 
 
It can be seen in Figure 3.10 that there is a significant increase in the number of vesicles 
found in the ∆ompA1A2 culture, with a 9.4-fold increase in the number of vesicles 
observed. A 1.3- and 1.8- fold increase was observed in ∆ompA1 and ∆ompA2 mutants 
respectively, with statistical significance only for the ∆ompA2 mutant. All mutants produced 
vesicles around ~80 nm and no significant difference was observed in the size distribution 
 
         
A B 
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for any of the mutant strains (Fig. 3.10B), so only the number of vesicles produced was 
affected by the loss of the OmpA protein. Along with the TEM images, these data 
demonstrate that OmpA plays a role in the structural stability of the bacterial membrane 
and OMV production, most strikingly for double mutant. 
3.3.3.3 Assessment of Gingipain Activity 
The gingipain proteases have been implicated in the colonisation of host tissue through 
adhesion to the extracellular matrix proteins (Tokuda et al., 1996) or through indirect 
methods, such as processing the subunits of the fimbriae (Nakayama et al., 1996), the 
protein appendages also involved in host-cell adherence, as discussed previously in 1.6.6.3 
P. gingivalis contains two major types of gingipains, the Arg- gingipains, which can be 
subdivided into RgpA and RgpB, and the Lys-gingipains, Kgp. The bacterium also encodes an 
additional gene encoding a surface protein, Haemagglutinin A (HagA), which alongside 
RgpA and Kgp, contains adhesion domains that are thought to be involved in the adherence 
to the host (Kozarov et al., 1998). Studies have shown that an increase in gingipain activity 
causes a reduction in invasion of P. gingivalis, therefore it is important to understand the 
role of gingipains in the ompA mutants as the adhesion and invasion of the host may be 
affected by the loss of the gingipains, masking any effect of the OmpA protein loss.  Both 
whole cell (cell-associated gingipains, WC) and supernatant (secreted gingipains, S) assays 
were carried out to determine gingipain activities in wild-type P. gingivalis and ∆ompA 
mutant strains, which can be seen in Figure 3.11. 
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Figure 3.11 Whole cell and secreted gingipain activity of wild-type P. gingivalis and 
∆ompA mutants. Both whole cells (WC) and secreted (S) gingipain activity was determined 
for Lysine (Kgp)- and Arginine (Rgp)-gingipains. The OD600 of overnight liquid cultures was 
corrected to 1.0 and whole cell activity was determined colorimetrically, whilst secreted 
gingipain activity was determined fluorescently through the release of methyl-coumarin. 
Activity was measured as the average of three biological repeats (of 3 technical repeats), 
with Error bars representing ± SEM. Statistical significance was defined by ** p < 0.01, *** p 
< 0.005, *** p < 0.001, determined by 2way-ANOVA 
 
Figure 3.11 demonstrates a clear difference in whole cell gingipain activities for the 
∆ompA1A2 mutant, with a decrease of 50% and increase of 100% in Rgp and Lys gingipains 
activities respectively. A slight increase in whole-cell Rgp activity is observed for both 
∆ompA1 and ∆ompA2 mutants, with increases of 20% and 15% respectively for each 
mutant, however, no change in whole cell Kgp activity was observed. Secreted gingipain 
activities were largely unaffected in all mutants, with only a marginal increase in Rgp-
activity in the ∆ompA1A2 mutant. Secreted Kgp levels again changed slightly, with a subtle 
increase for ∆ompA2 (15 %) and larger decrease in ∆ompA1A2 Kgp (20 %) activities.  
Although differences in gingipain activities are observed, it is important to note that there 
appears to be little difference between ∆ompA1 and ∆ompA2 strains in gingipain activity, 
but large differences were observed between the single mutant phenotypes involved in 
host cell interaction observed later in this chapter. 
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3.3.3.4 Assessment of Sialidase Activity 
The sialidase enzyme of P. gingivalis is a cell surface-associated virulence factor that is 
thought to facilitate interaction with other periodontal pathogens through breakdown of 
carbohydrates and glycoprotein conjugates to allow attachment and enhance 
commensalism, leading to the formation of the biofilm (Aruni et al., 2011). Sialidases are 
glycosylhydrolase enzymes which cleave sialic acid for multiple purposes, such as nutrition 
or immune evasion (Li et al., 2012). Sialidases have been considered a major virulence 
factor in many organisms, such as Streptococcus pneumoniae, Vibrio cholerae and 
Corynebacterium diphtheriae which all colonise mucosal surfaces (Corfield, 1992), and have 
also been shown to be present in the major periodontal pathogens found in the red 
complex, Tanerella forsythia (Roy et al., 2011), which has been shown to be involved in the 
adherence to epithelial cell attachment (Honma et al., 2011), and Treponema denticola 
(Wyss et al., 2004), which is needed to scavenge sialic acids for growth and protects the 
bacteria from serum killing (Kurniyati et al., 2013). P. gingivalis is known to have a sialidase 
enzyme and related genes, and its role in virulence has been recently studied (Aruni et al., 
2011), with an increase in invasion and a decrease in adherence in sialidase mutants, so as 
with the gingipain activity, it is important to understand the effect of ∆ompA mutation on 
this virulence factor. Sialidase assays were carried out according to Materials and Methods 
Section 2.8.9.3, with cultures of wild-type P. gingivalis and mutant strains at an OD600 of 0.5 
and 1.0, and whole-cell sialidase activity read after 2 hours incubation, as shown in Figure 
3.12.  
 
Figure 3.12 Sialidase activity of wild-type P. gingivalis and ∆ompA mutants. Sialidase 
activity was determined as described in chapter 2.8.9.3. Liquid cultures of P. gingivalis wild-
type and mutant strains were prepared at two different OD600 concentrations and 
incubated with 0.1 mM MUNANAC for 2 h before the activity determined. Figure 12 
demonstrates the sialidase activity plotted as a relative fold increase compared to wild-type 
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(=1).  Activity was measured as the average of three biological repeats (of 3 technical 
repeats), with Error bars representing ± SEM.  
 
Figure 12 demonstrates clear increase in sialidase activity in the double ∆ompA1A2, with a 
2- and 5-fold increase in the OD 0.5 and OD 1.0 cultures respectively. However, due to the 
high inter-experimental variation, this was not a significant increase (p = 0.052 for wild-type 
– ∆ompA1A2 increase). Coupled to the significant increase in the vesicle number observed 
in this double mutant, this data is expected as cell surface-associated proteins are often 
observed in vesicles expelled from the bacterium (Iwami et al., 2007). No significant 
difference in sialidase activity was observed in either ∆ompA1 or ∆ompA2 mutants, similar 
to the gingipain activity, indicating neither is likely to be influencing any observed 
phenotypes of these mutants. 
3.3.3.5 Biofilm Assay of P. gingivalis Wild-Type and ∆ompA Mutants 
Biofilm formation is an important virulence factor for many microbes as it allows reduced 
susceptibility to antimicrobial agents, and can enhance pathogenicity in multispecies 
biofilms (pathogenic synergism) (Marsh, 2006). It is especially so for oral microbes as it 
forms the basis of plaque in vivo, and prevents removal by salivary fluid motion and 
protects from antimicrobial salivary proteins (Lamont and Jenkinson, 2000). Biofilm 
formation of P. gingivalis wild-type and ∆ompA mutant strains was examined using Crystal 
Violet staining of biofilm formed on polystyrene plates, as developed originally by 
Christensen et al., (1985) for various Staphylococcus strains (Christensen et al., 1985). 
Strains were grown statically for 72 h and initially the overall growth (planktonic and 
biofilm) of each strain was determined by observing the OD600 and the Crystal Violet 
staining applied as in Section 2.8.4 if all OD values were within 0.1 (10%). The biofilm was 
qualitatively assessed using light microscopy (x 400 magnification), which can be seen in 
Figure 3.13.  
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Figure 3.13 Biofilm formation in vitro of P. gingivalis and mutant ∆ompA strains. Cultures 
of P. gingivalis strains were seeded at OD600 0.05 and grown anaerobically for 72 hours 
before staining with 1% Crystal Violet. Images were taken of the formed biofilm using Nikon 
Eclipse TS100 microscope with a digital camera attachment at x400 magnification.  
 
It is important to note that in all mutant strains, the biofilm was more fragile and lifted 
easily from the plate bottom during washing, so extremely gentle washing was applied. 
Qualitative analysis of the Crystal Violet stain suggests that the formation of the biofilm by 
the ∆ompA2 and ∆ompA1A2 mutants has been abrogated with the loss of the protein. In 
the case of ∆ompA1A2 it appeared that no biofilm was formed, and also the ∆ompA2 
mutant demonstrated little to no biofilm. The ∆ompA1 mutant shows areas of biofilm 
formation, but not as coherent as the wild-type. The Crystal Violet was extracted using 
ethanol, and the biofilm formation assessed quantitatively by observing the absorbance 
(Abs575), as shown in Figure 3.14.  
 
Figure 3.14 Quantification of biofilm formation of ∆ompA mutants. Crystal Violet was 
extracted from stained biofilms and OD575 absorbance was measured using a TECAN Infinite 
200 Pro Plate reader (Tecan Group Ltd.). Figure 3.14 demonstrates the quantified biofilm of 
wild-type P. gingivalis and the ∆ompA mutants. Biofilm formation was determined relative 
to wild-type. Biofilms were quantified as the average of three biological repeats (of 5 
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technical repeats), with error bars representing ± SEM. Significance was applied using a 
students’ t-test (***p < 0.001 and ****p < 0.0001). 
 
The qualitative imaging of the biofilms is supported by the quantitative analysis using 
extracted Crystal Violet, which demonstrated a 4.5-fold and 8.8-fold reduction in the 
biofilm formed in the ∆ompA2 and ∆ompA1A2 mutant strains respectively, compared to 
only a 1.5-fold reduction in ∆ompA1 mutant biofilm formation. Because the ∆ompA2 
mutant showed a greater phenotype with the loss of biofilm formation, the next section 
aims to examine the role of ompA2 specifically by providing it on a plasmid to complement 
for the loss of ompA2 in trans to demonstrate the loss of biofilm formation was a result of 
the loss of the OmpA2 protein alone.  
3.3.4 Generation of an ∆ompA2 + pT-COW-A2 Complement Mutant 
In order to fully assess the role of the ompA2 gene in biofilm formation, a complementation 
construct was made using the ompA operon natural promoter and the ompA2 gene from 
wild-type P. gingivalis which was then cloned into the pT-COW plasmid (Fig. 3.15) before 
transformation into the ∆ompA2 mutant.  
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Figure 3.15 pT-COW plasmid map. The pT-COW plasmid (Gardner et al., 1996) was used to 
carry the ompA promoter fused to the ompA2 encoding gene for ∆ompA2 mutant 
complementation. The ompA2 complement construct was cloned into the tetC gene using 
BamHI and SalI restriction sites, indicated by the red *. 
 
The two DNA fragments were amplified using PCR with primers described in Table 2.7 in 
materials and methods section 2.3. This generated a 300 bp DNA fragment containing the 
natural ompA promoter (Figure 3.16A) and a 1100 bp fragment encoding the ompA2 gene 
(Figure 3.16B). The primers used to amplify these individual fragments contained “tails” of 
the other fragment to assembly the two fragments into a complement construct, which was 
generated through overlap extension PCR as detailed in Section 2.6.2.4. These primers also 
contained restriction enzyme sites (BamHI and SalI) so the construct could be cloned into 
the pT-COW vector. A successful construct was generated (Figure 3.16C), digested using 
BamHI and SalI (alongside restriction enzyme digest of the pT-COW plasmid) and cloned 
into pT-COW.  
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Figure 3.16 Agarose analysis of the construction of the ompA2 complementation 
construct. (A) Demonstrates the amplification of the ompA promoter region (300 bp) with a 
5’ BamHI restriction enzyme site and a 3’ ompA2 tail, (B) shows the amplification of the 
ompA2 gene (~1100 bp) with a 5’ reverse complement ompA promoter tail and a 3’ SalI 
restriction enzyme site and (C) demonstrates the two PCR fragments assembled into one 
construct with 5’ BamHI and 3’ SalI restriction enzyme sites (~1400 bp).  PCRs were carried 
out using Phusion™ polymerase enzyme as detailed in Section 2.6.2.3. 
 
Ligated plasmid was transformed into E. coli DH5α cells, and incorporation of the plasmid 
was determined through antibiotic selection on ampicillin-containing LB-agar plates. As the 
ompA2 complement construct was cloned into the tetracycline-encoding gene for E.coli 
(tetC), colonies growing on Ampicillin-containing agar were also streaked onto tetracycline-
containing LB-agar plates. If no growth occurred on the tetracycline plates, it was assumed 
that these colonies contained the pT-COW-A2 vector as the ompA2 complement gene 
construct would interrupt the tetracycline-encoding gene for E. coli. Plasmids from these 
colonies were extracted and confirmed for their correct incorporation of the complement 
construct by restriction digest BamHI and SalI (Figure 3.17A) and PCR using pT-COW 
designed primers (Figure 3.17B) as described in Materials and methods 2.6.2.6 and 2.6.2.3.  
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Figure 3.17 Confirmation of the ompA2 complementation insert in pT-COW. (A) 
Demonstrates the BamHI and SalI digest, with the insert at ~1400 bp, and (B) shows PCR 
confirmation of purified plasmid using pT-COW primers which amplify the tetC region of the 
plasmid (~2200 bp including insert). PCR was carried out using GreenTaq™ polymerase 
enzyme as described in chapter 2.6.2.3. 
 
The complementation construct was sequenced (Appendix I) to check for any mistakes, of 
which none were found, and the pT-COW-A2 complement plasmid was transformed into 
the P. gingivalis ∆ompA2 strain using the natural competency method described earlier in 
this chapter. Positive colonies containing the pT-COW-A2 plasmid were selected from 
tetracycline-containing BA plates (3 µg/ml), alongside wild-type P. gingivalis + pT-COW 
(empty vector) and ∆ompA2 + pT-COW (empty vector) colonies as positive and negative 
controls respectively.  
3.3.5 Biofilm Assay of ∆ompA2 Complemented Strain 
Because the ∆ompA2 mutant showed a similar phenotype to the ∆ompA1A2 mutant in 
biofilm formation, the ∆ompA2 +pT-COW-A2 complement strain was also assessed 
quantitatively for the formation of biofilm, to determine if the phenotype observed was 
due to the loss of the protein. All strains were measured for total growth (planktonic and 
biofilm), and corrections in the original total growth were applied, before determining the 
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biofilm formation of P. gingivalis +pT-COW, ∆ompA2 +pT-COW mutant and ∆ompA2 + pT-
COW-A2 complemented strain, as shown in Figure 3.18.   
 
Figure 3.18 Quantification of biofilm formation in the ∆ompA2 complement strain. Crystal 
Violet was extracted from stained biofilms and OD575 absorbance was measured using a 
TECAN Infinite 200 Pro plate reader, showing a partial restoration of the biofilm forming 
phenotype in the ∆ompA mutant complement. Biofilm formation was determined relative 
to wild-type. Biofilms were quantified as the average of three biological repeats (of 5 
technical repeats), with Error bars representing ± SEM. Significance applied using a 
students’ t-test (****p < 0.001). 
 
The in trans reintroduction of the ompA2 gene in the ∆ompA2 + pT-COW-A2 complement 
strain shows a partial, 2-fold, restoration of the ability of ∆ompA2 for formation of a biofilm 
(p < 0.001), however it did not fully complement compared to wild-type P. gingivalis 
containing the empty pT-COW vector (Fig. 3.18).  While there is no clear explanation for 
this, we performed experiments on separate clones of the ompA2 mutant, indicating that it 
any observed phenotype are not due to extraneous mutations.   These data indicate a role 
for ompA2 in biofilm formation on an inert surface. 
3.3.6 Detection of Major Fimbriae (FimA) on Outer Membrane Fractions of P. gingivalis 
Wild-Type and ∆ompA Mutants. 
As previously described, the fimbriae are the filamentous protein appendages extruding 
from the cell surface, made up of fimbrillin (FimA) subunits. The fimbriae have been 
reported to mediate adhesion to the host cell to allow colonisation  (Slots and Gibbons, 
1978; Njoroge et al., 1997; Nakagawa et al., 2002; Enersen et al., 2013) and are classed as a 
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major virulence factor of the bacterium. It has previously been shown in E. coli that the loss 
of OmpA influences the expression of the fimbriae (Teng et al., 2006). It was therefore 
important to determine whether or not the reduction in bacterial interaction with the host 
cell is due to the OmpA protein or interference in the production of fimbriae. The TEM 
imaging in Figure 3.9 shows the presence of fimbrial structures on the wild-type and all of 
the mutant bacterial strains, however an anti-FimA antibody was obtained from Professor 
Ashu Sharma (SUNY, University at Buffalo, USA) to fully determine the presence or absence 
of the fimbriae in the ∆ompA mutant strains.  
Outer membranes of wild-type and ∆ompA mutants were extracted using differential 
detergent centrifugation as previously described for the detection of OmpA in Western 
blotting (Section 3.3.2.1 and Materials and Methods 2.7.5), before cytoplasmic, inner 
membrane and outer membrane fractions were analysed through SDS-PAGE (Figure 3.19A). 
As observed in the SDS-PAGE gel, the protein concentration was relatively low so the bands 
were not well visible, and therefore the gels were silver stained (Fig. 3.19B) for higher 
clarity of protein bands. Corresponding gels were run with the same samples for Western 
blot analysis using an anti-FimA antibody (1:2000) to detect for the presence of fimbriae in 
the fractions, and the resulting Western blot can be seen in Figure 3.19C.  
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Figure 3.19 Cell membrane fractionation and detection of FimA subunits in P. gingivalis 
wild-type and ompA mutants. Cell fractions (outer membrane, cytoplasm and inner 
membrane) were run in parallel for Coomassie staining (A) and Western blot analysis (C). As 
the banding was weakly observable in the Coomassie stain, these gels were silver stained 
(B) for clearer observation.  The red arrow indicates the expected presence of FimA 
subunits when probed for using anti-FimA antibody (1:2000) with an anti-rabbit-HRP 
conjugated secondary (1:3000).  
 
Although the presence of the fimbriae was being determined by observing the outer 
membrane fraction, both the inner membrane and cytoplasmic fractions were included in 
the analysis to demonstrate the fractionation was successful, which is indicated by the 
difference in banding patterns between the three fractions.  These data also indicate that 
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while the outer membrane profile of the WT, ompA1 and ompA2 mutants are largely 
similar, the double ompA1A2 mutant is significantly altered. 
The size of the FimA subunit varies between 39 – 49 kDa depending on the genotype 
expressed by the P. gingivalis (Nakagawa et al., 2002), and in reference to the FimA 
detected on the Western blots in Figure 3.19C, the FimA subunits are on the smaller size of 
this scale. In the outer membrane, FimA is only detected in the wild-type, ∆ompA1 and 
∆ompA2 mutants, as indicated by the red arrow, and not in the ∆ompA1A2 mutant. Bands 
are detected in the inner membrane fraction at ~47 kDa, which may indicate the immature 
form of FimA, which has been observed at ~45-46 kDa previously (Sato et al., 2005). There 
appears to be no difference in the presence of the FimA subunit in the outer membrane 
fraction between the ∆ompA1 and ∆ompA2 mutants.   
3.3.7 OmpA-Host Cell Interaction 
The ability of P. gingivalis to interact with the host cell is key to the virulence and survival of 
the bacterium, allowing the progression into a chronic periodontal infection. This 
interaction begins with an adherence to the cell, which prevents removal of the bacteria by 
the mechanical action of the saliva, whilst allowing the bacteria to colonise the host and 
lead to invasion. Invasion of the host cell provides an intracellular location, protecting the 
bacteria from the host immune system, provides a nutrient-rich environment and 
facilitated replication leading to cell spreading, tissue destruction and the progression of 
the disease (Lamont et al., 1995). The adherence and invasion of P. gingivalis and the 
∆ompA strains was assessed using standard antibiotic protection assays which were first 
detailed by Lamont et al (1995) to determine the number of bacteria located intracellularly, 
and developed further by Suwannakul et al (2010) to allow the adhered bacteria to be 
enumerated (Lamont et al., 1995; Suwannakul et al., 2010). 
3.3.7.1 Antibiotic Protection Assay of P. gingivalis Wild-Type and ∆ompA Mutants 
Antibiotic protection assays were carried out to examine the role of the OmpA protein in 
interactions with human cells, specifically, the adherence and invasion of a gingival 
keratinocyte cell line, OK-F6, which is a specialised cell found in the epithelial layer. 
Antibiotic protection assays involve the incubation of P. gingivalis with an epithelial cell 
monolayer for 90 min to allow adherence and invasion of the cells by the bacteria. After 
this incubation, any bacteria that have not adhered or invaded the cells are removed by PBS 
washing. These cells are either lysed to give the total number of bacteria associated with 
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the cells (adhered and invaded) or metronidazole is applied to kill any extracellular bacteria 
(i.e. adhered bacteria), so that the number of bacteria that have invaded can be calculated.  
The OK-F6 cell line was chosen for study as it is derived from human oral epithelial cells, 
cells which P. gingivalis encounters during the infection process. The OK-F6 cells are also 
immortalised by affecting the p16INK4a cell cycle pathway. This allows extended growth 
without reaching senescence (Dickson et al., 2000), and in contrast to cells isolated from 
oral squamous cell carcinomas, targeted pathway deletions ensure the cells remain more 
similar to the native oral cell in terms of protein expression and are therefore more 
representative of the natural P. gingivalis infection. 
Standard antibiotic protection assays were carried out as detailed in Section 2.8.1, and 
originally by Lamont et al., (1995), but further developed by Suwannakul et al (2010) to 
include an analysis of intracellular levels of bacteria (Suwannakul et al., 2010). Multiplicity 
of infection (MOI) was chosen to be 1:100 (epithelial cells: bacteria) as this was determined 
as the optimum infectious dose for invasion of epithelial cells by Lamont (Lamont et al., 
1995). As mentioned above, the standard antibiotic protection assay allows the calculation 
of the number of bacteria that have invaded the cells as well as the total number of 
bacteria associated with the cells (adhered and invaded). This allows the calculation of the 
number of bacteria adhered to the cells by the subtraction of the invaded count from the 
total association count. The number of bacteria isolated from all three conditions (invaded, 
adhered and total association) is determined as a percentage of the total viable counts of 
each strain to eliminate any errors in that strain’s preparation (% Recovery), for example, if 
one strain has a lower number of bacteria in the sample applied to the host cells. Results 
from the standard antibiotic protection assays can be seen in Figure 3.20. 
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Figure 3.20 Bacterial adhesion and invasion of oral epithelial cells by P. gingivalis wild-
type and ∆ompA mutants. Bacterial strains were incubated with OK-F6 cells at 1:100 MOI 
as detailed in Chapter 2.8.1. Viable counts were taken for each strain and the number of 
bacteria recovered was determined as a % of the viable count. Invasion was defined as the 
percentage of the bacterial inoculum protected from metronidazole killing, whereas total 
association denotes the number of bacteria that adhere to and invade the OK-F6 cells. 
Adherence was determined by subtracting invasion CFUs from the total associated. Each % 
Recovery was corrected to the wild-type P. gingivalis total association (=1). Error bars ± 
SEM. Statistical significance was defined by * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p 
< 0.0001, determined by 2way ANOVA. Antibiotic protection assays were carried out in 
triplicate, with 3 counts per technical repeat observed (overall n = 27). 
 
Figure 3.20 shows that all isogenic mutants of P. gingivalis display a differential adherence 
to OK-F6 cells compared to wild-type, with ∆ompA1A2 displaying the least adherence. 
Adherence by ∆ompA mutants was reduced 2.1-fold, 2.45-fold and 13-fold for the ∆ompA1, 
∆ompA2 and ∆ompA1A2 mutants respectively compared to wild-type P. gingivalis (p < 0.05 
single mutants, p < 0.01 double mutant), demonstrating that the OmpA protein is 
implicated in the adhesion to the host cell. The ability for P. gingivalis to invade the host 
cell was also significantly affected by the deletion of the ompA operon (∆ompA1A2 
mutant), which demonstrated an 8.3-fold reduction in invasion compared to wild-type. 
Interestingly, the ∆ompA2 single mutant also demonstrated a significant reduction in the 
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invasive capability, showing a 10-fold reduction, as seen in Figure 3.20. No change to the 
number of ∆ompA1 bacteria capable of invading the host cell compared to wild-type was 
observed. These data therefore suggest the OmpA2 protein subunit is key in the interaction 
with the host epithelial cell rather than OmpA1.  
It is clear from the data that the entire OmpA1A2 protein is crucial in the interaction with 
the host due to the almost complete abrogation of adherence and invasion, but as the 
overall phenotype in this double mutant is vastly different from the wild-type (altered outer 
membrane profile, significant increases in vesicle formation and sialidase activity etc.), it 
would be difficult to determine if the effects seen by the loss of the OmpA protein is solely 
due to the mutation, or if it is due to its downstream effects. Therefore as the deletion of 
ompA2 had a greater effect on invasion and adhesion of the OK-F6 cells but showed similar 
phenotype to the wild-type, this mutant was investigated further. In order to test a specific 
role for OmpA2 in these host-cell interactions the pTCOW-A2 complementation plasmid 
was again employed (Section 3.3.4) and used in a standard antibiotic protection assay 
against OK-F6 cells and the levels of invasion and adhesion assessed, as shown in Figure 
3.21. 
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Figure 3.21 Bacterial adhesion and invasion of oral epithelial cells by wild-type P. 
gingivalis, ∆ompA2 mutant and ∆ompA2 mutant complement. Standard antibiotic 
protection assays were carried out as previously described in Chapter 2.8.1 with bacterial 
MOI 1:100. Wild-type and ∆ompA2 P. gingivalis strains carried empty pT-COW vectors as 
negative controls. All values were calculated as described in Figure 3.20, and % Recovery 
levels were corrected to wild-type P. gingivalis total association (=1). Error bars ± SEM. 
Statistical significance was defined by * p < 0.05, determined by students’ t-test. Antibiotic 
protection assays were carried out in triplicate, with 3 counts per technical repeat observed 
(overall n = 27). 
 
Figure 3.21 demonstrates that the complementation of the ompA2 gene restores the levels 
of invasion and adhesion to wild-type levels.  This was especially observed in the levels of 
invasion which was increased 14-fold in the complemented mutant compared to ∆ompA2 
invasion alone. This again supports the idea that the OmpA2 protein has a greater influence 
on the host cell interaction.  
3.3.7.2 Viability Of Mutants During Standard Antibiotic Protection Assay 
To confirm that the loss of adherence and invasive capabilities of the ∆ompA mutants was 
due to the loss of the OmpA protein (or singular subunits) from the cell membrane, not just 
due to a loss of membrane integrity causing the bacteria to be less viable in tissue culture 
media, the viability of the wild-type and mutant strains was determined through the time 
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course of the invasion assay. Figure 3.22 demonstrates that although there appeared to be 
high levels of variation between repeats, the viabilities of the mutant strains are not 
significantly different to the wild-type strain. This therefore indicated the loss of the protein 
does not have a particular effect on the viability of the bacterial cell. In addition, in each 
experiment, all invasion levels are compared to a viability control. 
 
Figure 3.22 Viability of P. gingivalis wild-type and mutant strains throughout the standard 
antibiotic protection assay. CFUs of the plated viability wells of P. gingivalis were corrected 
to wild-type viability (=1) and compared. No statistical difference was observed between 
strains. Error bars ± SEM. 
 
3.4 Discussion 
 The ability of P. gingivalis to interact with the host cell is a key virulence factor in the 
survival of the bacterium and the progression into a chronic periodontal infection. The 
OmpA protein of P. gingivalis has been implicated as important in this process by a number 
of previous studies. In a “hyperinvasive” subtype of the natural P. gingivalis population, 
gene expression of ompA was found to be upregulated in two strains of P. gingivalis tested 
(Suwannakul et al., 2010), whilst purified native OmpA heterotrimer prevented the 
interaction of wild-type P. gingivalis with endothelial cells (Komatsu et al., 2012). This 
chapter investigated the role for OmpA in host cell epithelial interaction, using both a 
∆ompA1A2 full heterotrimer mutation and single ∆ompA1 and ∆ompA2 mutants, alongside 
general phenotypic characterisation of these strains.  
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3.4.1 Phenotypic Characterisation of P. gingivalis and ∆ompA Mutants 
Mutants of ompA were generated in this study to understand the effects of the OmpA 
protein on the cell membrane itself and its interaction with the host and surrounding 
environment. The traditional method for introducing recombinant DNA to P. gingivalis for 
the generation of mutants is via electroporation (Yoshimoto et al., 1993; Smith, 1995) with 
many genetic studies of P. gingivalis creating isogenic mutants via this method (Salyers et 
al., 2000). However, the included steps in generating electrocompetent bacteria are 
laborious and for practical reasons, are carried out in an aerobic environment which causes 
physiological stress to the bacteria, whilst the electrical pulse can cause cell lysis resulting in 
reduced electroporation efficiency. A recent study by Tribble et al., (2012) observed the P. 
gingivalis ATCC 33277 strain was capable of horizontal DNA transformation, and therefore 
was “naturally competent”. This method involved fewer steps and less exposure to aerobic 
conditions, whilst vastly increasing the transformation efficiency (Tribble et al., 2012) and 
was therefore utilised in this study and compared with the traditional electroporation 
method to generate ∆ompA1 and ∆ompA2 mutants and a complemented ∆ompA2 + pT-
COW-A2 strain, alongside the electrocompetency method to determine the efficiency.   
Both linear and plasmid DNA was used in the transformation of P. gingivalis, and no 
significant difference was observed between the two. This was expected as P. gingivalis 
contains a ComF protein which translocates DNA across the membrane shows no bias 
between uptake of DNA from natural P. gingivalis sources and unmethylated DNA 
generated from PCR (Tribble et al., 2012), so the use of PCR-generated constructs for ompA 
mutation would not interrupt the efficiency of this method, nor would the origin of DNA 
being plasmid or PCR-generated affect the transformation efficiency. Linear DNA was a 
preferred choice of DNA origin as it would reduce the occurrence of a single crossover 
event whereby the erythromycin gene would be incorporated, but the gene of interest still 
retained in the chromosome creating a false positive. This was inspected for using PCR 
confirmations and not observed in the plasmid-containing transformations; however, the 
linear DNA-based origin was preferred.  
The transformation efficiency for generating the ∆ompA1 mutant was generally lower than 
∆ompA2 and overall fewer colonies were produced when introducing the externally 
generated construct of ∆ompA1::em. This was attributed to the design of the construct 
being based on a different P. gingivalis strain genome (W50 instead of ATCC33277), 
reducing the homology in the flanking regions to 93% (flank 1) and 96% (flank 2) which 
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reduced recombination efficiency. Despite this, the number of mutant colonies generated 
was overall higher when transforming P. gingivalis using the natural competency method 
which is expected to be due to the preparation steps of P. gingivalis for each 
transformation method. The electrocompetency method preparation involved multiple 
centrifugation steps in an aerobic environment, which causes physiological stress to the 
bacteria and may lead to cell death. Natural competency involves minimal centrifugation 
and minimal exposure to the aerobic environment, reducing the loss of viability and 
increasing the number of bacteria capable of uptaking DNA for transformation, and 
increasing overall mutant colony generation. During both ∆ompA1 and ∆ompA2 mutant 
generation, the natural competency method greatly surpassed the electrocompetency 
method in efficiency, with a 9-fold and ≥16-fold increase in colonies observed on 
erythromycin-containing BA plates, respectively. Because of these observations, natural 
competency has been deduced as the preferred method of P. gingivalis transformation and 
will be recommended for implementation in the lab as the future method of generating P. 
gingivalis mutants.  
The successful mutation of the ompA1 and ompA2 genes was confirmed through PCR and 
sequencing, however as the ompA genes are in an operon, there is the possibility of polar 
effects with the mutation, i.e. the loss of ompA1 may cause read-through problems leading 
to ompA2 not being expressed. The outer membranes of the wild-type and mutant strains 
were therefore purified and analysed using SDS-PAGE where if polar effects were observed, 
the ompA1 mutant would show a similar outer membrane protein profile to the double 
mutant. The protein bands observed were at the correct size for the presence of OmpA, 
with a prominent band in the wild-type outer membrane, fainter bands in the single 
mutants and no band observed in the double mutant. To further confirm this, the presence 
of OmpA in the wild-type and mutants was investigated using an anti-OmpA antibody. 
Bands were observed at the correct sizes in the wild-type strain and fainter in the single 
mutants, whereas no banding was observed in the double mutant, confirming the 
successful mutation without causing polar effects.  
The OmpA protein is a major outer membrane protein, contributing to a large proportion of 
the protein found on the surface of Gram-negative bacteria (Smith et al., 2007). Previous 
studies of the OmpA protein of P. gingivalis have indicated that the protein is key in 
stabilisation of the outer membranes (Sonntag et al., 1978; Klose et al., 1988), so electron 
microscopy was used to further characterise the effects of the loss of OmpA on the 
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membrane of P. gingivalis. Thin-section microscopy revealed “wavy” membranes in all 
three mutants, but to a larger extent in the double mutant. This agrees with previous 
observations of the disruption of the cell membrane integrity seen in the study by Iwami et 
al., however in contrast, this is only observed in a small percentage of the population, 
(Iwami et al., 2007).  As OmpA proteins are found to have a C-terminal domain that is 
predicted to associate with the peptidoglycan layer, the loss of membrane integrity and 
rigidity is a possibility with the loss of OmpA. Without the peptidoglycan-associated C-
terminal domain, the outer membrane is predicted to be no longer associated with the 
peptidoglycan layer via the OmpA protein, and therefore the rigidity of the membrane is 
lost. This C-terminal domain is conserved amongst many species’ OmpA protein, regardless 
of the similarity of the N-terminal domain  (De Mot and Vanderleyden, 1994) implying that 
the OmpA protein is an important structural protein in the cell envelope. 
As OmpA is implicated in the stability of the membrane, the number of vesicles produced in 
the mutant strains was investigated. Multiple groups have previously shown that a lack of 
OmpA in a variety of bacteria result in hypervesiculation, as observed in E. coli, Vibrio 
cholerae and Salmonella (Sonntag et al., 1978; Song et al., 2008; Deatherage et al., 2010). 
The outer membrane vesicle production of P. gingivalis and ompA mutants was using a 
qNANO, which assesses the number and size of vesicles produced. A slight increase in 
vesicle formation was observed in both single ΔompA1 and ΔompA2 mutants, with a large 
increase was observed in the double ΔompA1A2 mutant. This complies with general OmpA 
studies, as previously referenced above, however fewer vesicles are observed in the single 
mutants compared to Iwami et al studies in P. gingivalis ompA mutants, which is likely due 
to the shortened length of time these samples were grown for (16 – 24 h) whereas the 
Iwami et al., grew cultures for 48 h, and showed more vesicles were produced later in the 
growth stages (Iwami et al., 2007). Again, because the ΔompA1 mutant doesn’t display a 
vesicle-producing phenotype similar to that of the ΔompA1A2 mutant, it is likely that there 
is no polar effect in the protein expression in this mutant. 
The TEM provided contradictory results when observing the presence of fimbriae on the 
mutants. It appears that the fimbriae are unaffected by the loss of the OmpA protein in all 
mutants, however when using an anti-FimA antibody, no FimA subunits were observed in 
the ∆ompA1A2 mutant. Whilst this was not unexpected, due to previous data shown in E. 
coli which demonstrates the fimbrial expression is affected with the loss of OmpA, this 
proved contradictory here. It is more likely the fimbrial-like extrusions from the TEM images 
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are artefacts from the processing of the cells for electron microscopy. However, it is more 
important to note that no differences are seen in the fimbrial expression between the 
∆ompA1 and ∆ompA2 mutants, which excludes the possibility that the loss of adherence 
and invasion in the ∆ompA2 mutant compared to the ∆ompA1 mutant is due to the loss of 
fimbriae.  
3.4.2 Enzymatic Activity Profiling of Mutant Strains Indicate ompA2 Specific Phenotypes 
As the deletion of ompA has previously been shown to affect the expression of other 
virulence factors in E. coli, including a decrease in the expression of the fimbriae (Teng et 
al., 2006), the effects of the deletion of ompA1A2 and the single ompA1 and ompA2 genes 
on the expression of other major virulence factors of P. gingivalis was assessed.  
The Arg- and Lys- gingipains are proteases that are heavily implicated in the colonisation of 
the host tissue (Nakayama et al., 1996; Tokuda et al., 1996). Previous studies have 
demonstrated that an increase in gingipain activity can lead to a reduction in the invasion 
of P. gingivalis (Suwannakul et al., 2010), and therefore it was important for this study to 
determine if there are any effects on the gingipain activity due to the deletion of the ompA 
genes. As gingipains are both cell-associated and secreted, two different activity assays 
were used to investigate the activity of both the Arg- and Lys- gingipains. Significant 
changes to the gingipain activity were observed for all conditions (Arg- and Lys-, secreted 
and cell-associated) in the ∆ompA1A2 double mutant, however no significant change 
between the single ∆ompA1 and ∆ompA2 mutants were observed. This was important to 
note as the differential abilities of the ∆ompA1 and ∆ompA2 mutants in the interaction with 
the host is therefore not attributed to a change in bacterial-associated proteins that are 
also implicated in host cell adhesion, and therefore the effects of the deletion of the OmpA 
protein and individual subunits is likely due to the loss of protein itself.  
The sialidase activity of P. gingivalis and ∆ompA mutants was also investigated in this study 
as sialidases in other oral pathogens have been shown to be involved in the formation of 
biofilms (Roy et al., 2011) as well as the adherence to epithelial cells (Honma et al., 2011).  
It was important to determine again if the deletion of ompA had any further effects on 
other virulence factors which would mask the effects of OmpA on host cell interaction. 
Sialidase activity was increased in the double ∆ompA1A2 mutant, however no change was 
observed in the single ∆ompA1 and ∆ompA2 mutants. Similarly to the gingipain activity, the 
disruption by the loss of the entire OmpA1A2 protein complex causes changes to the outer-
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membrane associated sialidase proteins, but no difference is observed between the single 
∆ompA1 and ∆ompA2 mutants.  
The enzymatic assays were of importance in this study to determine if the effects seen by 
the loss of the OmpA protein were due to the protein itself or its downstream effects. As 
the loss of an integral outer membrane protein has major effects on the rest of the 
membrane, it was key to understand these effects on the hypothesis that OmpA is 
interacting with the host. As expected, the loss of the entire OmpA1A2 protein has multiple 
detrimental effects on the cell, showing a significant increase in vesicle formation, and 
therefore changes to gingipain and sialidase activity levels. It is impossible to segregate the 
changes in virulence factors of P. gingivalis with the loss of the entire OmpA1A2 protein as 
it is a major protein of the outer membrane, however as the ∆ompA2 mutant demonstrates 
a strong phenotype in the adherence and invasion of the host (as discussed later) that is not 
observed in the ∆ompA1 mutant, as well as little difference observed in the activities of 
sialidase and gingipains in both ∆ompA1 and ∆ompA2 single mutants, this suggests that the 
host-cell interaction phenotypes observed with ∆ompA2 and ∆ompA1A2 are due to the loss 
of protein, not downstream effects.  
3.4.3 Biofilm Formation by P. gingivalis and ∆ompA Mutants 
The formation of a biofilm by oral microbes is a central point in periodontal disease as the 
biofilm formed on tooth structures forms the basis of dental plaque (Cook, 1998).  Orme et 
al., (2006) identified an overexpression of OmpA in biofilm formation of E. coli, (Orme et al., 
2006), whilst the studies into the involvement of OmpA in biofilm showed a differential 
formation of biofilm on hydrophilic and hydrophobic surfaces, potentially mediated by the 
OmpA protein inducing the CpxRA two-component pathway, which regulates the 
expression of cellulose and influences biofilm formation (Barrios et al., 2006; Ma and 
Wood, 2009). 
The data presented in this chapter demonstrate a role for OmpA in P. gingivalis in the 
formation of the biofilm. A loss of the entire OmpA heterotrimeric complex, or the OmpA2 
subunit alone results in a significant reduction in the formation of a biofilm on the inert 
surface of a 96-well MTP, suggesting a specific role for the OmpA2 subunit in the 
interaction of P. gingivalis with the surrounding environment. Important to note was the 
equivalent level of growth between all wild-type and mutant strains over the 72-hour 
period, suggesting that there were no growth deficiencies in the different mutant strains of 
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bacteria compared to the wild-type and therefore the lack of biofilm formed was likely due 
specifically to the loss of OmpA.  The levels of biofilm formation were only partially restored 
using the ∆ompA2 + pT-COW-A2 complement strain, but a significant increase in biofilm 
formation was observed.  
More biologically relevant studies using 96-well MTPs coated in salivary mucin or purified 
saliva would provide a more accurate representation of OmpA-influenced biofilm 
formation, or even the overexpression of P. gingivalis OmpA in wild-type P. gingivalis to 
determine an increase in biofilm formation, would contribute to confirming the role of 
OmpA in biofilm formation. Multi-species biofilm formation assays using confocal 
microscopy would also contribute to a more biologically relevant study, as P. gingivalis is 
well known for interacting with other bacterial species in the oral cavity, such as 
Streptococcus gordonii (Lamont et al., 2002; Park et al., 2005), Treponema denticola 
(Yamada et al., 2005; Bao et al., 2014), especially for initial adherence, such as the 
interaction with the bridging pathogen, Fusobacterium nucleatum (Kolenbrander et al., 
2002; Kolenbrander et al., 2006), and provide a greater analysis of the role of OmpA in 
biofilm formation. 
3.4.4 P. gingivalis Invasion and Adhesion of Oral Epithelial Cells 
The ability of P. gingivalis to adhere to and invade host cells has been reported on 
numerous occasions (Njoroge et al., 1997; Chen et al., 2001; Chen and Duncan, 2004) and 
in both gingival epithelial cells (Lamont et al., 1995) and aortic endothelial cells (Komatsu, 
et al., 2012). Various studies have also shown the buccal epithelial cells contain a 
polymicrobial intracellular flora, including the presence of P. gingivalis whilst showing no 
inflammatory response (Rudney et al., 2001; Rudney et al., 2005), indicating that the 
bacteria communicate with one another to suppress the inflammatory response and 
remain undetected by the host immune system (Rudney and Chen, 2006). 
The invasion and adherence data was obtained through a standard antibiotic protection 
assay as first described by Lamont et al., (1995) with the addition of a metronidazole 
incubation step to kill extracellular bacteria so the number of invaded bacteria can be 
determined from the number of bacteria associated with the cell (i.e. adhered and 
invaded). The cell line chosen for the standard antibiotic protection assays was an oral 
keratinocyte cell line as this is the principal cell type that P. gingivalis will directly come into 
contact with in the oral cavity. The invasion and adherence to these cells was greatly 
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abrogated with the loss of the OmpA heterotrimer, as shown in the ∆ompA1A2 mutant 
resulting in very few cells being observed adhered to or invading the host cell. In contrast, 
very little difference in invasion of the ∆ompA1 mutant was observed with a 2-fold 
reduction in the adherence of the bacteria. A similar 2-fold loss of adherence in the 
∆ompA2 strain was observed; however the intracellular number of this mutant was similar 
to that of the double ∆ompA1A2 mutant, suggesting a potentially role for the OmpA2 
protein subunit in the internalisation of the bacterium, through possible stronger 
engagement of the host cell receptors. Previous reports of the OmpA protein binding host 
cell molecules (namely extracellular matrix molecules) have suggested the entire OmpA 
protein is necessary (Murakami et al., 2014), however the data presented here suggest a 
stronger role for the OmpA2 subunit in the interaction with epithelial cells.  As the 
phenotypes of the two single mutants show very little differences in enzyme activity 
(sialidases and gingipains) and fimbrial possession, but show significant differences in the 
ability to invade the host, this further supports the hypothesis that OmpA (more 
specifically, OmpA2) is involved in the host cell interaction.  
The role of OmpA2 in the adherence and invasion of the host was supported by the 
creation of an ΔompA2 + pT-COW-A2 complement strain. Standard antibiotic protection 
assays were carried out with all three strains to determine if the loss of adherence and 
invasion observed in the ΔompA2 strain was truly due to the loss of the protein. The 
complemented strain restored the levels of adherence and invasion to wild-type, 
supporting the hypothesis that the loss of invasion and adherence is specifically due to the 
loss of the OmpA2 protein in the single mutant. This is the first time a role for individual 
OmpA subunits has been observed in P. gingivalis. 
These data were obtained using only a single strain of P. gingivalis, whereas the oral cavity 
contains hundreds of species of bacteria, and it has been well documented that P. gingivalis 
interacts with other species such as Fusobacterium nucleatum in the colonisation of the 
host (Lamont and Jenkinson, 2000). Future work could include the analysis of multi-species 
standard antibiotic protection assays, with the inclusion of other oral pathogens such as F. 
nucleatum which would also help to determine if OmpA has a role in adherence and 
interaction with other bacteria as well as the host.  
These data are only presented on one cell line, whereas the bacteria would come in contact 
with many more cell types during the infection process. P. gingivalis has been shown to 
interact with endothelial cells (Deshpande & Khan 1998; Komatsu, et al., 2012), enhancing 
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the theory that P. gingivalis may be associated with cardiovascular disease (Marcus and 
Hajjar, 1993; Li et al., 2000; Kozarov et al., 2006). Future work would include the use of 
different cell lines in the investigation of P. gingivalis interaction with the host, for example, 
the use of primary epithelial cell lines as these would represent the infection process in the 
oral cavity more accurately.  
3.5 Summary 
In conclusion, this chapter has enforced the hypothesis that OmpA has a role in the 
integrity of the outer membrane, leading to an increase in vesicle production, and therefore 
an increase in the activity of membrane-associated enzymes with the loss of the entire 
OmpA1A2 protein. This chapter has also identified a novel role for OmpA2 in the 
interaction with the host, causing a significant decrease in the invasion and adhesion of the 
host when this subunit of the OmpA protein is lost, which is restored when a 
complemented strain of the mutant is employed. The ability of P. gingivalis to form a 
biofilm is also affected with the loss of OmpA2, highlighting a specific role for the OmpA2 
subunit in P. gingivalis virulence. These data also indicate a direct interaction between 
OmpA2 and a cellular factor on the host cell, which will be investigated further in Chapter 4.  
These findings are important as they have identified a specific protein that could be 
targeted therapeutically for the treatment of periodontal disease, by specifically targeting 
the keystone pathogen of periodontal disease, P. gingivalis.  
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Chapter 4  
Molecular Mechanism of OmpA Interaction with Host 
Epithelial Cells 
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4.1 Introduction 
Data from Chapter 3 indicated a strong possibility that the OmpA proteins of P. gingivalis 
are involved in the formation of biofilms and the adherence and invasion of the host, of 
which the data also identified a greater role for OmpA2 in these interactions. This chapter 
will aim to investigate the molecular determinants behind these interactions to further 
dissect the role of OmpA in the interaction with the host cell.  
The classic structure of OmpA conforms to a two-domain structure, with an N-terminal 
transmembrane β-barrel adjoined to a C-terminal peptidoglycan-associated domain (Wang 
2002). The OmpA of P. gingivalis was first discovered by Murakami et al (2002) as a 
heterologous trimer of OmpA1 and OmpA2 subunits (around 40 and 41 kDa respectively) 
and determined to exhibit the same structure, sharing a high structural homology to E. coli 
OmpA (Murakami et al., 2002; Nagano et al., 2005; Yoshimura et al., 2009). The importance 
of P. gingivalis OmpA has been implicated in host cell interaction through limited studies, 
namely in the interaction with host endothelial cells (Komatsu et al., 2012) but also by its 
upregulation of expression in hyperinvasive subpopulations of the bacteria (Suwannakul et 
al., 2010) and more strongly through data presented in Chapter 3 of this study, and 
therefore forms the basis of the hypothesis in this chapter.  
Data presented in the previous chapter demonstrates a role for OmpA in host-cell 
interaction through the loss of the protein leading to a loss of invasion and adherence of 
oral epithelial cells (Fig. 3.20).  Again as presented in the previous chapter, the OmpA2 
protein subunit appears to perform as the dominant subunit in the interaction with oral 
epithelial cells, this chapter will investigate further into the role for OmpA2 in this host-
pathogen interaction. 
In this chapter, the interaction of OmpA, specifically the OmpA2 subunit is explored 
through overexpression of the protein and structural modelling analysis of the OmpA 
protein. This is built upon by the identification of structural features of the OmpA2 protein 
that lead to direct interactions with the host cell.  
4.2 Aims 
The specific aims of this chapter are to investigate the interaction of OmpA, and specifically 
the OmpA2 subunit through overexpression of the protein and structural analysis of the 
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OmpA protein. This is built upon by the identification of structural features of the OmpA2 
protein, and the investigation of direct interaction with the host cell.  
4.3 Results 
4.3.1 OmpA1 and OmpA2 Protein Overexpression 
To determine the role of OmpA in interaction with the host, it was necessary to attempt to 
produce soluble recombinant versions of the protein that then be used in a number of 
assays aimed at probing whether OmpA proteins directly interact with host-cells.  For 
example, in immunofluorescence assays to examine if OmpA binds to cell surfaces or in 
more direct assays by attempting immunoprecipitation or pull-down assays to detect 
binding and identify human protein interaction partners. As previously discussed, the 
OmpA protein of P. gingivalis is composed of two different subunits in a heterotrimer. 
These subunits were cloned and overexpressed individually and purification attempted to 
determine if there was a role for host cell interaction for each subunit. 
4.3.1.1 His-tag Protein Purification 
Initially, the OmpA1- and OmpA2-expressing E. coli (DE3 C41) were provided by Dr Graham 
Stafford, whereby the gene encoding the OmpA1 or OmpA2 protein was inserted into 
pET15b plasmid to be expressed with an N-terminal Hexa-His tag. The E. coli C41 strain was 
chosen for protein overexpression as it has been shown to be a stable strain, easily 
transformed and capable of expressing recombinant proteins that would otherwise prove 
toxic to the cell (Dumon-Seignovert et al., 2004). The His-tag is comprised of a short 6-
histidine residue extension to the protein which will allow binding to  immobilised metal 
affinity chromatography media as the negatively charged hexa-his tag will interact with high 
affinity with a immobilised divalent cation, (in this case Ni2+) to allow purification of the 
recombinant OmpA protein (Hochuli et al., 1987).  
Cultures of E. coli C41 for OmpA1 and –A2 overexpression were grown to OD600 0.6 before 
induction with IPTG and grown for 4 h at 37°C as described in Materials and Methods 
Section 2.7.1. Cells were harvested and lysed, before centrifugation was carried out to 
separate soluble and insoluble fractions. Outer membrane proteins are often particularly  
insoluble due to the hydrophobic residues being exposed during overexpression without 
the presence of their usual chaperones, which leads to aggregation and insolubility in the 
aqueous environment of the cytoplasm (Seddon et al., 2004). Several research groups have 
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successfully purified the OmpA protein in other bacterial species (Prasadarao et al., 1996; 
Serino et al., 2007; Martinez et al., 2014), demonstrating that although it is not without its 
issues, it is still possible to purify outer membrane proteins. Figure 4.1 demonstrates both 
OmpA1 and OmpA2 subunits overexpress well in these conditions, however, most of the 
OmpA1 and OmpA2 protein was found in the insoluble fraction after lysis and fractionation 
(Figure 4.1B).  
 
Figure 4.1 SDS-PAGE showing the overexpression of the OmpA1 (A) and OmpA2 (B) 
protein subunits. E. coli DE3 (C41) strains containing the pET15-ompA1 or –A2  plasmid for 
overexpression were grown in large batch cultures and induced using IPTG for protein 
expression as described in Chapter 2. Uninduced and induced lanes display 1 ml samples 
removed from the culture, pelleted and resuspended in SDS-loading dye, and denote the 
cells before IPTG induction and 4 h post induction when cells were harvested. Cells were 
lysed using a French Pressure Cell and centrifuged to determine the solubility of the 
protein, resulting in the insoluble and soluble fractions. The large protein band at ~41 kDa 
denotes the presence of the OmpA protein, and is shown here to be insoluble after 
overexpression. 
 
Because the purification of the protein was using the His-tag on Nickel-coated resin, 
solubilising reagents were used to solubilise the OmpA1 and OmpA2 found in the cell lysate 
insoluble fractions. Urea (8 M) was used to solubilise the pellet after centrifugation of the 
cell lysate, and the protein was purified from the Ni2+-NTA resin, as shown in Figure 4.2.   
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Figure 4.2 SDS-PAGE analysis of the purification profile of His-OmpA1 (A) and His-OmpA2 
(B) after urea solubilisation. Insoluble fractions post cell lysis were solubilised in 8M urea 
for 4 h (4°C) before centrifugation and the supernatant applied to Ni2+-NTA resin pre-loaded 
into a Poly-Prep Gravity Flow Column (BioRad). His-OmpA-bound resin was washed twice 
(PBS, 120 mM NaCl, 20 mM imidazole) followed by elution buffers of PBS, 120 mM NaCl, 
and either 150 mM imidazole (elution 1 and 2) or 200 mM imidazole (elution 3, 4 and 5). 
Uninduced and induced samples of the cells before lysis were included for OmpA1 as a 
reference for ensuring protein expression as the expression was lower than His-OmpA2 (Fig 
4.1). The His-OmpA1 can be seen clearly as the strong bands at ~41 kDa in the induced 
sample and the elution fractions, whereas His-OmpA2 can be seen as the major band at ~41 
kDa in Elution fractions 1-5.  
 
High yields of protein could be purified after solubilisation in urea, especially seen in 
OmpA2 (Figure 4.2B), which demonstrates a high level of overexpression of the protein in 
the pET15b vector in E. coli DE3 C41. The SDS-PAGE gels also demonstrate mostly a high 
level of purity in the purifications. However, when the purified protein elution fractions 
were then dialysed into PBS to remove all imidazole and urea and to allow re-folding of the 
protein to a native state, all protein precipitated and became insoluble once again, as 
shown in Figure 4.3.  
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Figure 4.3 SDS-PAGE analysis of the dialysis of His-OmpA1 and His-OmpA2. Elution 
fractions were pooled and dialysed in PBS dialysis buffer (PBS, 120 mM NaCl) for 16 h at 
4°C. The contents of the dialysis tubes were centrifuged and the supernatant (soluble 
fraction) and the pellet (insoluble fraction) were analysed. In both cases, protein 
aggregated during dialysis and become insoluble.  
 
4.3.1.2 GST-tagged Protein Purification 
The solubility of a proteins during overexpression can be assisted through the fusion to 
other proteins, such as Glutathione-S-Transferase (GST), or Maltose Binding Protein (MBP) 
which stabilise the folding of the recombinant protein and help to increase the solubility 
(Biosciences, 2001). As well as increasing the solubility, the addition of the GST-tag is also 
advantageous as it can be removed using Thrombin, so a pure version of the protein can be 
used in downstream experiments. To increase OmpA1 and A2 protein solubility, the genes 
expressing these proteins were amplified through PCR using Phusion HF™ polymerase 
enzyme (Figure 4.4A) using primers from Table 2.9 and 2.10 which contained BamHI and 
EcoRI restriction enzyme tails, and ligated into pGEX-4T3 vector which encodes the 26 kDa 
GST fusion protein. Initially the pGEX-OmpA1 and pGEX-OmpA2 plasmids were transformed 
into DH5α and colonies that appeared on LB-Ampicillin plates had the plasmid extracted 
and then digested with BamHI and EcoRI restriction enzymes. The specific banding pattern 
of plasmid and insert was analysed and successful insert incorporation was observed 
(Figure 4.4B). 
 
 
 
  
72 kDa 
55 kDa 
43 kDa 
34 kDa 
OmpA1 OmpA2 
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Figure 4.4 Cloning of ompA1 and ompA2 for GST-tagged protein overexpression. The 
ompA1 and ompA2 genes were amplified using Phusion HF™ enzyme in a PCR reaction 
detailed in Chapter 2.6.2.3. before being analysed on a 1 % agarose gel (A). After ligation, 
transformation, clone selection after colony PCR, plasmids were extracted from positive 
colonies for ampicillin resistance and digested using BamHI and EcoRI and analysed on a 1% 
agarose gel (B). All plasmids showed incorporation of the insert (~1200 bp) into the plasmid 
(~5000 bp), as demonstrated by the two bands present on the agarose gel.  
 
Plasmids were sequenced to ensure no mistakes were found in the sequence transcript 
which would result in misfolded or truncated and inactive protein upon expression. All 
pGEX-ompA1 and pGEX-ompA2 plasmids demonstrated a correct sequence, so one plasmid 
for each protein subunit was chosen and transformed into E. coli DE3 C41 for protein 
overexpression. Small 5 ml overnight cultures of E. coli DE3 C41 + pGEX-ompA1 or –A2 were 
used to determine optimal expression conditions through different incubation 
temperatures (post IPTG induction), which were 37°C for 4 h, as previously used for His-
tagged protein overexpression and ~24°C for 16 h (overnight). The protein expression was 
determined at these temperatures, as shown in Figure 4.5. 
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Figure 4.5 SDS-PAGE analysis of GST-OmpA1 and GST-OmpA2 protein expression at 37°C 
(A) and ~24°C (B). The overexpression of the protein was carried out as described in 
Materials and Methods 2.7.1.1, however in smaller (5 ml) cultures. A 1 ml sample was 
removed before induction with IPTG (uninduced) and 4 hours after induction with IPTG (0.1 
mM) (induced), before being pelleted by centrifugation and resuspension in an appropriate 
volume of SDS-PAGE loading buffer. GST-tagged protein appears as a band ~67 kDa, and 
can be observed as the prominent bands in (B) in both OmpA1 and OmpA2 induced 
samples.  
 
The concept behind using a lower temperature is to reduce the rate of protein expression 
to prevent aggregation and the formation of inclusion bodies, leading to insolubility of the 
protein (Sørensen and Mortensen, 2005). Figure 4.5A demonstrates a minimal 
overexpression of protein at 37°C, whereas induction and growth at ~24°C does display 
production of protein (Figure 4.5B), albeit less efficiently than previously observed with His-
tagged OmpA. The solubility of the protein at these temperatures was then determined 
after cell lysis using a French Pressure Cell and centrifugation to separate soluble and 
insoluble fractions. The soluble and insoluble fractions are shown in Figure 4.6B. 
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Figure 4.6 SDS-PAGE analysis of GST-OmpA1 and –A2 overexpression (A) and insoluble 
and soluble cell lysis fractions (B). E. coli DE3 C41 + pGEX-OmpA1 or –A2 was grown as 
detailed in Materials and Methods 2.7.1.1, and a samples taken before induction with IPTG 
(Uninduced), then the batch culture was induced with 0.1 mM IPTG and grown ~20°C for 16 
h, before a sample was taken (induced). Cells were lysed using a French Pressure Cell and 
centrifuged to separate cell debris and insoluble proteins (insoluble) from soluble proteins 
in the cell (soluble). As before with His-tagged overexpression, the majority of the OmpA 
protein can be observed in the insoluble fraction, denoted by the large band ~67 kDa in 
both OmpA1 and OmpA2 induced and insoluble fractions (A). As the insoluble fractions 
contained a high concentration of protein and skewed the other fractions, the OmpA1 and 
OmpA2 insoluble fractions were diluted 10-fold and run alongside undiluted soluble 
fractions in (B). Samples in (B) were analysed on the same gel, but cropped here for clarity.  
 
From Figure 4.6A, it is clear that the GST-tagged protein is being expressed, as seen as the 
band at ~67 kDa (26 kDa GST tag + 41 kDa OmpA protein) however as before with the His-
tag, the majority of the protein is insoluble. Due to the high level of protein in the insoluble 
lane, the other lanes are distorted, so the insoluble fraction was diluted 1:10 before being 
re-analysed in Figure 4.6B. A minor amount of protein appears to be soluble (more so in 
GST-OmpA2) as indicated by the arrow, so the soluble fraction was applied to a 
glutathione-bound resin column to purify any GST-tagged OmpA1 and –A2 protein. The 
soluble fraction was incubated with the glutathione resin for 4 h to increase binding of the 
GST-tagged protein, before being passed through a column, washed and the protein eluted 
with 10 mM reduced glutathione. Figure 4.7 shows the SDS-PAGE analysis of the eluted 
OmpA1 and OmpA2 proteins. 
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Figure 4.7 GST-tagged purification of OmpA1 (A) and OmpA2 (B). OmpA protein was 
overexpressed as described in Chapter 2.7.1.1. and cells lysed through a French Pressure 
cell before the soluble fraction was applied to glutathione (GSH) resin. After incubation for 
4 hours at 4°C, GST-tagged protein was eluted using 20 mM reduced glutathione. After 
purification, the leftover resin was also applied to the SDS-PAGE gel to determine if all 
protein had been eluted. GST-OmpA1 and OmpA2 can be seen as the prominent band ~67 
kDa. Smaller bands at ~26 kDa can be observed in both gels which equate to the GST tag 
being cleaved.  
 
Figure 4.7 shows purification of a low concentration of OmpA1 and OmpA2 protein, as 
demonstrated by the bands at ~67 kDa; however dialysis again led to most of the protein 
precipitating. Elution fractions were pooled and dialysed, and some protein was observed 
in the soluble fraction post dialysis for OmpA2, as seen in Figure 4.8B, but the yield per 
elution fraction was determined to be too low for any experimental use. 
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Figure 4.8 Dialysis of purified GST-OmpA1 (A) and GST-OmpA2 (B). Elution fractions for 
each protein were pooled and dialysed in one dialysis tube in dialysis buffer Tris-HCl 
(pH7.4), 120 mM NaCl. After 24 hours agitation at 4°C, the contents of the dialysis tube 
were centrifuged and the supernatant (soluble fraction) and the pellet (insoluble fraction) 
were analysed using SDS-PAGE, as shown here.  
 
The dialysed GST-OmpA2 fractions showed a detectable amount of soluble protein but at a 
low concentration in a large volume, so the protein concentrated using a VivaSpin® 6 
column (GE Healthcare) which decreased the volume from 10 ml to 500 µl. Using a BCA 
assay, the protein concentration was determined to be 301.6 µg / ml.  
4.3.2 GST-tagged OmpA2 Interaction With Oral Epithelial Cells 
The GST-OmpA2 protein was then used to determine if there is any direct interaction 
between OmpA and the host oral epithelial cells using immunofluorescence. A monolayer 
of OKF6 cells was seeded onto coverslips and grown to 70 % confluency. The cells were 
incubated with BSA to prevent any non-specific binding before being incubated with the 
GST-OmpA2 protein at 30 µg/ml or 30 µg/ ml GST for 4 h before the protein was removed 
and the cells were fixed using paraformaldehyde and anti-GST Tag antibody (Alexa Fluor® 
488 conjugate) applied to detect the GST-tag. Cell membranes were stained using either 
CellMask™ Plasma Membrane Stain (ThermoFisher Scientific) (Figure 4.9A) or Wheat Germ 
Agglutinin-Texas Red® conjugate (ThermoFisher Scientific) (Figure 4.9B) and the coverslips 
were mounted using a DAPI mount to detect the cell nuclei. Immunofluorescence 
microscopy analysis of the OmpA2 protein interaction with the oral epithelial cells can be 
seen in Figure 4.9. 
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Figure 4.9 GST-Tagged OmpA2 protein applied to OK-F6 cells, epithelial cell membranes 
stained with CellMask™ Plasma Membrane Stain (A) or Wheat Germ Agglutinin-Texas 
Red® (B).  PBS only and GST-only (30 µg / ml) are used as negative controls. OmpA2 (30 µg / 
ml) can be seen (green) to be interacting with the OK-F6 cell monolayers (cell membranes 
red, nuclei DAPI stained blue). Ant-GST antibody was used at 1:3000 concentration, 
CellMask™ at 1:1000 and Wheat Germ Agglutinin at 1:1000. 
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The immunofluorescence images clearly suggest an interaction between the purified 
OmpA2 protein and the host cell. The CellMask™ cell membrane stain only partially stains 
the cell membranes as the membranes only appear to be marginally larger than the nuclei 
themselves, whereas the Wheat Germ Agglutinin stain indicates the membranes more 
accurately. Despite the membrane stain, in both cases, the GST-OmpA2 protein can be 
clearly seen to directly interact with the host cell, with green fluorescently-labelled OmpA2 
protein apparently binding in the peri-nuclear region. This would need to be further 
analysed through confocal microscopy to investigate this interaction further. A GST-only 
control was used to show the binding is specifically seen with the OmpA2 protein rather 
than occurring due to the presence of the GST protein.    
These immunofluorescence images were generated from two separate experiments with 
three technical repeats per condition. The GST-OmpA2 protein was very unstable and 
precipitated between the CellMask™ and Wheat Germ Agglutinin experiment, even when 
stored at -20°C, and after the Wheat Germ Agglutinin staining experiment, the protein was 
no longer detectable via SDS-PAGE analysis. Further attempts to purify GST-OmpA1 or GST-
OmpA2 proved unsuccessful, with little to no soluble protein produced so these interaction 
studies could not be repeated to statistically relevant levels (i.e. n = 3), and therefore 
further experimental analysis of the OmpA interaction with the host is needed, but was not 
possible given the insolubility and lability of the protein. 
4.3.3 Investigation into Increasing Protein Solubility 
Various conditions were applied during the protein purification process to attempt to 
increase solubility of the protein. Firstly, the addition of the detergent CHAPS to the cells 
from the start of the purification process (before cell lysis), which disrupt the lipid 
membrane increasing the solubilisation of the proteins (Radford, 1970), whilst increasing 
the purity of the purified proteins (Hong Lu et al., 2001). CHAPS was chosen as it can be 
removed using dialysis due its small micellar molecular weight and high critical micellar 
concentration (Sigma Aldrich, 2008), so will not disrupt the membranes of the host cells 
during interaction studies (Pierce Thermo Scientific, 2010). Another method to increase 
solubility of the protein during the purification process was to determine the Isoelectric 
point (pI) of the proteins and use purification buffers at an opposing pH (GE Healthcare, 
2010; Coutard et al., 2012). Proteins are generally less soluble at the pH at which the 
protein has no net charge (the pI value), therefore using buffers at a different pH to the pI is 
thought to help increase solubility of the protein (Coutard et al., 2012). The pI values for 
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OmpA1 and OmpA2 (without the signal sequence) were 8.61 and 7.69 respectively, so a 
purification buffer at pH 6 was used. However, neither of these methods appeared to 
increase the solubility and no soluble protein was recovered after purification (not shown). 
4.3.4 Investigation of OmpA Dialysis 
As the issues with solubility of the protein appear to be hindered by the loss of solubility 
during the dialysis of the protein, this part of the process was analysed to increase 
solubility. Studies in the literature provided various viable techniques to encourage 
solubility of the protein during the dialysis process and are explored in this section. The His-
tagged protein was chosen for further analysis as it provided a greater yield of protein on 
overexpression compared to the GST-tagged OmpA. 
Stepwise dialysis involves the slow decrease in concentration of the urea used to initially 
solubilise the protein (Bagby et al., 2001). The concentration is gradually decreased from 8 
M to 0 M urea in 2 M increments (i.e. 8 M > 6 M > 4 M > 2 M > 0 M) every 4 hours so that 
the protein can reach an equilibrium at each urea concentration. The intermediate 
concentrations of urea theoretically will allow sequential refolding of the protein with the 
prevention of aggregates forming (Maeda et al., 1995; Tsumoto et al., 2010).  
The addition of the charged amino acids, L-arginine and L-glutamate to the dialysis buffer 
was shown to increase solubility of various proteins up to 9-fold whilst increasing their 
stability long-term (Golovanov et al., 2004). These amino acids were added to the dialysis 
buffer (140 mM PBS, pH 6), each at 50 mM to determine if they increase the solubility of 
the OmpA proteins during dialysis.  
As it appears that proteins are more likely to aggregate at higher concentrations (Kiefhaber 
et al., 1991; Philo and Arakawa, 2009; Lebendiker and Danieli, 2014), it was hypothesised 
that if the proteins were diluted in their elution fractions before dialysis, they would be less 
likely to aggregate. This was hypothesised much the same as a slower production of protein 
is expected to produce more soluble protein due to less protein aggregating when the 
temperature during E. coli overexpression was lower (Schein, 1989; Vasina, 1997). The 
protein was diluted 5-fold before dialysis to determine if this would increase solubility.  
Medium-scale protein purification was carried out, growing 500 ml of E. coli (DE3) C41 + 
pET15-OmpA1 or –A2 per dialysis condition (6 conditions total). Cultures were grown to 
OD600 0.6 – 0.8 before being cooled to room temperature, induced with 0.1 mM IPTG and 
grown for a further 16 h at ~24°C as this was shown to be a more optimal growth 
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temperature (as shown in Figure 4.5 previously). Purification of the overexpressed protein 
was carried out as previously described, with the insoluble protein being solubilised in 8 M 
urea (pH 6, away from the pI of either protein) and purified on Ni2+-NTA resin in 150 mM 
imidazole. An example of the purification demonstrating the typical yield for this trial can 
be seen in Figure 4.10. 
 
Figure 4.10 Purification profile of His-OmpA2. Protein was overexpressed and purified as 
described in Materials and Methods 2.7.1.1. Resin-bound protein was washed in 20 mM 
imidazole and protein then eluted in 200 mM imidazole. His-OmpA2 can be seen as the 
prominent bands at ~41 kDa. Bands are also observed ~26 kDa which are likely to be 
degraded protein.   
 
Despite using protease inhibitors in the buffers used in the resuspension of the cell pellet 
and cell lysis, some protein degradation was observed, as seen in the band at ~26 kDa.  
The elution fractions were pooled and dialysed using stepwise, addition of 50 mM L-
arginine and L-glutamine and dilution of the elution fractions 5-fold, as described earlier in 
this section. Combinations of these were also trialled, i.e. the addition of L-arginine and L-
glutamine coupled to stepwise dialysis and diluted elutions with stepwise dialysis. The gel 
images seen in Figure 4.11 demonstrate the success of the dialysis trial for both OmpA1 and 
OmpA2, as shown by the soluble (Supernatant or “S”) and insoluble (Pellet or “P”) fractions 
once the contents of the dialysis tubes have been centrifuged.  
 
 
 
             
72 kDa 
43 kDa 
54 kDa 
34 kDa 
26 kDa 
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Figure 4.11 Dialysis trials of His-OmpA1 (A) and His-OmpA2 (B) protein after purification. 
Various dialysis conditions were used to increase protein solubility. After dialysis, the 
protein was removed from the dialysis tubing and centrifuged to separate soluble protein 
(S) from the precipitated protein (P). His-tagged protein appears as the band ~41 kDa, 
whereas degraded protein can be seen ~26 kDa. The SDS-PAGE image of OmpA2 dialysis (B) 
also includes a protein elution sample pre-dialysis for reference (His-OmpA2 Pre-dialysis). 
Red arrows indicate fractions containing soluble protein  
 
The pellet (P) after centrifugation demonstrates the protein that has aggregated and 
precipitated during dialysis, becoming insoluble and therefore unusable for further 
experiments. In all conditions for OmpA1, no soluble protein was observed in the soluble 
fraction (S) in any of the five conditions after dialysis. In the case of OmpA2, extra lanes 
were used to show the soluble and insoluble fractions after dialysis when the samples from 
the original one-step dialysis were used (i.e. all urea was removed in one step), as well as 
the tested conditions. The addition of L-arginine and L-glutamine had no effect on 
increasing the solubility of the protein, with all the protein precipitating through dialysis, 
even when stepwise dialysis was employed. The only conditions that increased solubility 
during dialysis were the diluted protein coupled to stepwise and the diluted dialysis alone 
as seen in the soluble fractions in lanes “Diluted One-step” and “Diluted Step-wise” 
respectively, indicated by the red arrows. The concentrations of these two soluble fractions 
were analysed to determine if a viable amount of soluble protein could be produced for 
interaction studies, however in both cases a very low yield (< 50 µg / ml) of protein was 
measured, even after concentration using a Vivaspin® 6 column, thus making the 
overexpression and dialysis of OmpA1 and OmpA2 an impractical method for to study the 
161 
 
interaction of the OmpA protein with the host cell, and other methods were then 
researched.  
4.3.5 OmpA Protein Structure Prediction 
Due to the insoluble nature of the OmpA protein, a different approach to examining 
whether there exists an interaction with the host cell was undertaken using software 
protein structure modelling. Bioinformatic analysis using two different programmes, Phyre2 
and RaptorX, both identified 8 N-terminal transmembrane β-sheets which were predicted 
to form a transmembrane β-barrel domain, alongside a C-terminal predicted peptidoglycan 
associated domain, as shown in Figure 4.12. Both programmes predicted similar structures, 
indicating the protein structure was correctly predicted.  
 
Figure 4.12 In silico analysis of OmpA1 and OmpA2 protein structure. The protein 
structure was predicted using RaptorX (A) and Phyre2 (B).  
 
         
   
 
OmpA1 OmpA2 
OmpA1 OmpA2 
A) 
B) 
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The predicted structure for P. gingivalis OmpA resembles high structural similarity to the 
OmpA protein of E. coli which also shows the classical two-domain structure of the N-
terminal β-barrel and C-terminal peptidoglycan-associated globular domain (Bremer et al., 
1982; Koebnik et al., 2000). The N-terminal sequence similarity of P. gingivalis and E. coli 
OmpA proteins is relatively low, when amino acid sequences are compared through Clustal 
Omega. However, a high homology is observed in the C-terminal peptidoglycan-associated 
domain, shown as the percentage identity matrix (% identity) in Table 4.1.  
Table 4.1 OmpA sequence homology between P. gingivalis and E. coli in the N- and C-
terminal domains 
 OmpA1 OmpA2 
 N-terminal C-terminal N-terminal C-terminal 
Escherichia coli OmpA 26.95% 58.3% 29.7% 60.4% 
% similarity generated through the Percentage Identity Matrix when comparing sequences 
through Clustal Omega. 
 
4.3.6 Barrel Overexpression  
A previous study by Martinez et al., (2014) demonstrated increased solubility of the protein 
during overexpression if a truncated version using only the β-barrel domain was expressed 
for the OmpA of Coxiella burnetii (Martinez et al., 2014). Due to the insolubility of the 
whole P. gingivalis OmpA protein, this hypothesis was employed in this study. A truncated 
version of OmpA1 and OmpA2 was produced, with primers to amplify the residues of 
OmpA121-245 and OmpA222-236 designed as shown in Table 2.11 and 2.12, and in Figure 4.13. 
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Figure 4.13 Schematic of full OmpA1 /A2 protein and truncated versions for recombinant 
protein overexpression of the β-barrel. Amino acid residue numbers indicate the location 
of each protein domain (signal sequence, β-barrel and PG-associated), with red indicated 
OmpA1 residue numbers and blue indicating OmpA2 residue numbers. Truncated β-barrel 
domains for recombinant protein overexpression are also shown with His-tag location for 
protein purification.  
 
PCR reactions were carried out to amplify the truncated version of the ompA1 and ompA2 
genes with BamHI and NdeI restriction digest tails for cloning into pET15b for His-tagged 
expression. Successful PCRs were determined on a 1% Agarose gel, as shown in 
Figure 4.14A before the PCR constructs were digested using their respective enzymes, 
cleaned up and cloned into the pET15b plasmid according to Materials and Methods 
Section 2.6.2.6. Ligation reactions were transformed into E. coli DH5α strain and colonies 
incorporating the plasmid were selected using LB plates containing Ampicillin. Correct 
incorporation of the truncated gene insert into the plasmid was determined by using 
Bioline Plasmid Miniprep kits and enzyme digests (using the restriction enzymes used to cut 
the original PCR constructs), or using a PCR amplification with T7 primers that target the 
flanking regions around the cloning site and this amplify any inserts present. Agarose gel 
analysis was then used to determine the particular banding pattern of insert incorporation 
into the plasmid, as shown in Figure 4.14B and C 
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Figure 4.14 Cloning of truncated OmpA121-245 and OmpA222-236 into pET15 plasmid for His-
tagged Expression. Three PCR reactions for the amplification of each protein insert were 
carried out (A), before ligation into BamHI and NdeI-digested pET15b plasmid and 
transformed into E. coli DH5α. Colonies were examined for the incorporation of the pET-
OmpA121-245 or –OmpA222-236 plasmid through isolation of the plasmid and restriction 
enzyme digestion (B) or PCR (C). Only two colonies had the plasmid extracted for restriction 
enzyme digest confirmation, and as indicated by the lower arrow both contained the insert. 
All colonies chosen for PCR were positive for the insert, as demonstrated by the band at 
~650 bp, demonstrating successful incorporation of OmpA1 and OmpA2 into pET15b for 
overexpression. 
 
Once a successful colony of E. coli DH5α was identified as containing the plasmid with the 
truncated ompA1 or ompA2 gene insert, the plasmid was isolated through a Bioline Plasmid 
Miniprep, sequenced and then transformed into DE3 C41, BL21 and BL21-Rosetta 
expression strains of E. coli. Overexpression of E.coli + pET15b was carried out under 
several conditions, initially different expression strains were tested to determine which 
strain would produce the highest yield of protein, as shown in Figure 4.15.  
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Figure 4.15 Overexpression of His-OmpA121-245 (A) and His-OmpA222-236 (B) in different 
expression strains. Expression of the truncated OmpA protein was carried out according to 
Chapter 2.7.1, and 1 ml aliquots were removed at 2 h, 4 h and 24 h post induction with 0.1 
mM IPTG to determine expression levels of the protein. No expression of His-OmpA222-236 
was observed in BL21 Rosetta strain (B) so this was not employed as an expression strain 
for His-OmpA121-245. Truncated OmpA1 and OmpA2 appear as the dominant band ~26 kDa. 
 
Strain C41 was chosen as the expression strain as it produced a higher yield of protein. BL21 
Rosetta was not used to determine OmpA1 overexpression as the growth was retarded in 
multiple attempts at overexpression; often taking up to 12 h to reach OD 0.6 (compared to 
2-3 h for C41 and BL21) so was discarded as a strain option and not shown on the gel in 
Figure 4.15A. Once the expression strain was chosen, two different expression conditions 
were used to determine greatest yield, which were 37°C for 4 h post induction with 0.1 mM 
IPTG, and at 24°C for 16 h post induction with 0.1 mM IPTG, shown in Figure 4.16. 
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Figure 4.16 Overexpression of His-OmpA121-245 (A) and His-OmpA222-236 (B) at different 
induction temperatures. E. coli C41 expressing His-OmpA121-245 (A) and His-OmpA222-236 was 
grown to OD600 0.6 before a sample was removed (Uninduced) and induced with 0.1 mM 
IPTG for 4 h at either 37°C or 24°C before a sample removed (Induced). Expression of the 
truncated OmpA proteins can be seen as the band at ~26 kDa. 
 
Overexpression in strain DE3 C41 was trialled at both 24°C and 37°C, as shown in 
Figure 4.16, which shows only mild induction of the protein in both conditions, however for 
both OmpA121-245 and OmpA222-236, expression appeared to be increased at 24°C, so this 
temperature was chosen for overexpression of the β-barrel of both OmpA1 and OmpA2.  
Expression of the OmpA121-245 and OmpA222-236 proteins was carried out at the conditions 
optimised, before the cells were lysed and purified via the His-tag as described in Materials 
and Methods, Section 2.7.1.2. The soluble fraction of the lysed cells was incubated with the 
Ni2+-NTA resin for 4 h at 4°C and fractions of protein were eluted using imidazole, as 
demonstrated in Figure 4.17.  
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Figure 4.17 Purification of His-OmpA121-245 (A) and His-OmpA222-236 (B) protein. Truncated 
OmpA proteins were purified from Ni-NTA Resin as described in Chapter 2.7.1.2, using 200 
mM imidazole in the elution buffer. His-OmpA121-245 and His-OmpA222-236 purified protein 
can be seen as the dominant bands at ~26 kDa.  Bands of ~75 kDa also appear which is 
likely to be trimerised protein.  
 
As previously seen with OmpA protein expression, multiple bands were observed in the 
elution fractions, despite using DTT to dissociate any protein dimers and trimers. As the 
protein size of the extra band was ~75 kDa, it was expected to be a trimer of the protein 
subunits. Dialysis of the protein again resulted in insolubility of the majority of the protein, 
as shown in Figure 4.18, including under step-down dialysis and after the protein had been 
diluted pre-dialysis. A small amount of protein remained soluble after step-wise dialysis, 
but when the concentration was determined using a BCA assay, the concentration was not 
high enough for any downstream assays (<30 µg / ml). 
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Figure 4.18 Dialysed His-OmpA121-245 and His-OmpA222-236 after purification. Truncated 
OmpA proteins were dialysed after purification using Step-down dialysis as described in 
Chapter 4.3.4. The contents of the dialysis tubing were centrifuged after dialysis to separate 
precipitated protein (insoluble) from the supernatant (soluble). Most of the truncated 
OmpA proteins precipitate, however some soluble protein remains, as seen at ~26 kDa. 
 
4.3.7 Identification of Extracellular Protein Loops of OmpA2  
Due to the insolubility of the protein in both full and truncated forms, more information 
was determined from the structure to allow the study of OmpA-host interactions. As the 
results from Chapter 3 indicated clearly that OmpA2 displayed the largest influence on cell 
interaction within the P. gingivalis OmpA protein (as shown by a reduction in adherence 
and a significant loss of invasion displayed by the ∆ompA2 mutant but not seen in the 
∆ompA1 mutant) further interaction studies with the host were decided to only involve the 
OmpA2 protein subunit.  
The predicted structure of OmpA2 identified loops exposed between β-sheet strands, as 
shown schematically in the truncated version of the OmpA2 in Figure 4.19. Due to the 
orientation of the protein predicted using TMPRED, these loops would appear 
extracellularly and exposed on the surface of the protein. Previous studies in various Gram-
negative bacteria indicate these surface-exposed loops to be involved in a variety of 
functions, such as the extracellular loops of the OmpA-like proteins found in Neisseria 
gonorrhoeae and Coxiella burnettii have been shown to be involved in host cell interaction 
(Serino et al., 2007; Martinez et al., 2014), whereas the extracellular loops of E. coli OmpA 
act as a phage docking receptor (Koebnik, 1999). It was therefore hypothesised that these 
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protein loops might be involved or even sufficient for any interaction with human cells, as 
these loops would be the section of the protein that was exposed and potentially able to 
interact with the host.  
 
Figure 4.19 In silico analysis of the OmpA2 protein and identification of extracellular 
loops. Structural modelling of OmpA2 identified four extracellular loops between β-sheets, 
shown here as L1-L4 with the location in the protein sequence denoted by the subscript 
numbers. N-terminal α-helix and C-terminal peptidoglycan associated domain have been 
removed for display purposes here. 
 
As the OmpA protein from E. coli is the most understood of the OmpA-family proteins, 
most OmpA proteins discovered are compared in their similarity to the E. coli OmpA, as has 
been done for P. gingivalis OmpA here. However, using an intensive search through Phyre2, 
the bioinformatic analysis of the structure of P. gingivalis OmpA demonstrates the OmpA-
like protein with the highest homology comes from Klebsiella pneumoniae. The OmpA of K. 
pneumoniae confers resistance to antimicrobials (Llobet et al., 2009), potentially after 
interaction with the extracellular loops, due to their external location, although this has not 
been shown experimentally. The structure of the β-barrel of OmpA is generally found to be 
highly conserved across many species, whereas the sequence and size of the extracellular 
loops are highly variable and more suited to the function of the protein (Pautsch and 
Schulz, 1998; Schulz, 2002). Sequence alignment of the two OmpA subunits of P. gingivalis 
and the OmpA protein of K. pneumoniae demonstrate this, with little sequence similarity 
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between the two but with the location of the β-sheets and extracellular regions matching 
well between the sequences of K. pneumoniae and OmpA2 but less so with OmpA1 as 
highlighted by the black arrows (β-sheets) and green bars (extracellular loop regions) 
(Figure 4.20).  
 
Figure 4.20 Bioinformatic analysis of P. gingivalis OmpA structure. The OmpA2 
(PGA2_MATURE) subunit β-sheets and extracellular loops location in the sequence 
compared to the closest structural match, K. pneumoniae OmpA (2K0L:A). Black arrows 
indicate the β-sheet location, whilst green indicates the extracellular loops. The top line of 
arrows indicates K. pneumoniae OmpA features, whilst the lower line represents P. 
gingivalis OmpA2 features. OmpA1 (PGA1) features are not displayed, but the sequence is 
included to demonstrate the sequence similarities and differences between OmpA1 and 
OmpA2 subunits. The C-terminal domain (residues 215-391 (A1) or 214 – 380 (A2)) has 
been removed from these sequences for clarity.  
 
The sequences of the predicted extracellular loops from P. gingivalis OmpA2 were 
extracted from the sequence and labelled L1, L2, L3 and L4 (Table 4.2), and then 
commercially purchased from CovalAb (Cambridge, UK), with a Biotin tag for downstream 
applications. The biotin moiety was chosen for the tag as it is a small molecule, which 
would reduce any significant interference in any peptide-cell interactions, and has a very 
high specificity for its avidin molecule. This would give the potential to immobilise these 
peptides via the biotin tag should any interaction occur. Only the extracellular loops from 
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the OmpA2 subunit were purchased alongside a scrambled peptide, which was designed to 
be a complete scramble of peptide 4, i.e. overall contained the same amino acids but none 
in the same position and the distribution of charged amino acids was changed to ensure a 
complete sequence alteration.  
Table 4.2 Sequence of extracellular loops of the OmpA2 protein 
 Sequence 
Peptide 1 (L1) 
GMALSGWNNDVDFVDRLS 
Peptide 2 (L2) 
GFDIYGFPQGSKERNHNYFGNAHLDFM 
Peptide 3 (L3) 
YKFHSENANGEKVGSKDDMTG 
Peptide 4 (L4) 
QAFAGKMNFIGTKRGKADFPVM 
Scrambled  
RINFMAGMPGFADTVGKAKQKF 
A Biotin tag was added to the N-terminal end of the peptide. The names “peptide” and 
“loop (L)” are used interchangeably throughout. 
 
4.3.8 Analysis of the Extracellular Loops of P. gingivalis OmpA2 Interactions with Oral 
Epithelial Cells 
Due to the effect on invasion and adhesion shown by the deletion of the ompA2 gene, and 
the difficulties determined in overexpressing the OmpA2 protein, the purchased peptides 
were used in place of overexpressed protein to investigate the molecular basis of 
interaction between OmpA2 and human oral epithelial cells. An initial modified standard 
antibiotic protection assay was established, which involved carrying out a normal standard 
antibiotic protection assay as described in 2.8.1, but with the addition a pre-incubation step 
of the OK-F6 cell monolayer with each peptide individually (at a concentration of 50 µg/ml) 
for 60 min (post 2% BSA incubation and washing), before peptides were washed off and the 
cell monolayer was incubated with wild type P. gingivalis for 90 min and then the cells 
processed as usual. Results can be seen in Figure 4.21.  
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Figure 4.21 Effect of a pre-incubation of OmpA2 extracellular loops on adherence and 
invasion of wild type P. gingivalis. The OK-F6 cells were pre-incubated with 50 µg / ml 
individual peptides (1 h), before removal and application of wild-type P. gingivalis (MOI 
1:100) and the standard antibiotic protection assay carried out as detailed in Chapter 2.8.2. 
Total association refers to all bacteria adhered to and invaded the OK-F6 cells, whereas 
invade refers to the number of internalised bacteria post incubation with 200 µg / ml 
metronidazole to kill external adhered bacteria. The effect of peptides on adherence and 
invasion was determined relative to no peptide, and statistical significance was accepted if 
p < 0.05. Antibiotic protection assays were carried out in triplicate, with 3 counts per 
technical repeat observed (overall n = 27). Error bars represent ± SEM. *** p < 0.001, **** 
p < 0.0001, determined by 2way-ANOVA. 
 
The invasion of wild-type P. gingivalis into the host cell monolayer was significantly reduced 
(between 3.2- and 6.5-fold) in the presence of the peptides (p < 0.005 peptides 1 and 2, p < 
0.001 peptides 3 and 4), indicating that the peptides of OmpA2 are interfering with the 
ability of P. gingivalis to invade the host. The adherence of the bacteria to the host was not 
significantly reduced for any of the peptides, potentially indicating that the peptides do not 
hinder the binding of the bacteria. This almost opposing result to what was expected could 
be due to two factors, the first being that the P. gingivalis are utilising two different 
pathways in adherence and invasion of the host, and the peptides are only interfering with 
the pathway involved in the invasion, or potentially more likely, because the peptides are 
only applied briefly and then removed before the bacteria were added, the host cell 
receptors could be processing the peptides causing protein turnover and removal of the 
peptide from the receptor allowing the bacteria to bind. As this process would take time, 
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the delay in access to the host cell receptor would cause a decrease in the number of 
bacteria that were internalised in the 90 min time frame. This hypothesis was tested by a 
second modification of the standard antibiotic protection assay, by the addition of 
individual peptides (50 µg/ml) to the 90 min bacterial incubation step as well as the pre-
incubation step as used for Figure 4.21 to prevent peptide turnover once they had been 
removed. Incubation with OmpA2 extracellular loops throughout the standard antibiotic 
protection assay significantly decreased the ability of wild type P. gingivalis to adhere to 
and invade the oral epithelial cells, as shown in Figure 4.22. 
 
Figure 4.22 Effect of the presence of extracellular loops throughout the standard 
antibiotic protection assay. Individual peptides (50 µg/ml) were pre-incubated with the OK-
F6 cells for 1 h, before cells washed and the peptides applied again individually (50 µg/ml) 
with the wild type P. gingivalis (MOI 1:100), and the standard antibiotic protection assay 
carried out as previously detailed in Chapter 2.8.2. The effect of peptides on adherence and 
invasion was determined relative to no peptide, and statistical significance was accepted if 
p < 0.05. Antibiotic protection assays were carried out in triplicate, with 3 counts per 
technical repeat observed (overall n = 27). Error bars represent ± SEM. ** p < 0.01 *** p < 
0.001, **** p < 0.0001, determined by 2way-ANOVA 
 
The presence of peptides 1-4 caused a significant reduction the wild-type P. gingivalis 
adherence (between 2.7 - 5.7-fold) and invasion (between 2 – 4.9-fold) of the host cell 
when applied individually. Peptide 4, with sequence QAFAGKMNFIGTKRGKADFPVM, 
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demonstrated the greatest effect in disrupting wild-type P. gingivalis adhesion and 
invasion, with a 5-fold reduction (p < 0.001).  
Incubation with all four extracellular loops simultaneously was also examined, whereby the 
total concentration of peptides was 50 µg / ml (i.e. 12.5 µg/ml each peptide), which had no 
effect on the ability of wild-type P. gingivalis to adhere and invade the oral epithelial cells 
(Figure 4.23), suggesting the effect was dependant on a higher concentration of each 
individual peptide. 
 
Figure 4.23 Standard antibiotic protection assay in the presence of combined peptides. 
Peptides were combined to 50 µg/ml total concentration, and were pre-incubated with the 
OK-F6 cells for 1 h, before cells washed and the peptides applied again (50 µg/ml total) with 
the wild type P. gingivalis (MOI 1:100), and the standard antibiotic protection assay carried 
out as previously detailed in Chapter 2.8.2. The effect of peptides on adherence and 
invasion was determined relative to no peptide. No statistical significance was observed in 
the levels of invasion, adherence or total association in the presence of the peptides. 
Antibiotic protection assays were carried out in triplicate, with 3 counts per technical 
repeat observed (overall n = 27). Error bars represent ±SEM. 
 
As peptide 4 had the greatest effect on the adherence and invasion of the host, this peptide 
was used in comparison to the scrambled peptide to determine if the interaction with the 
host cell receptors was specific or just due to the presence of non-specific binding of the 
peptide or biotin moiety. The standard antibiotic protection assay was carried as out 
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previously described as used for the invasion in the presence of peptides and the results 
can be seen in Figure 4.24. No significant difference in adherence and invasion of the oral 
epithelial cells was observed between no peptide controls (with 2% BSA) and the scrambled 
peptide, whereas a significant decrease of at least 2-fold was observed in the ability of wild-
type P. gingivalis to adhere and invade when peptide 4 was included, against both no 
peptide and the scrambled peptide. As the scrambled peptide was also designed with a 
Biotin-tag, this eliminates the idea that it is the Biotin moiety binding the host as no 
difference in adhesion or invasion in the presence of the scrambled peptide was observed. 
As no difference was seen in the scrambled peptide in comparison to the addition of no 
peptide, this also demonstrates that the binding and interruption of adhesion and invasion 
of wild-type P. gingivalis seen in the addition of peptide 4 is a specific and direct interaction 
of peptide 4 with the host. 
 
Figure 4.24 Comparison of peptide 4 and scrambled peptide on adherence and invasion of 
oral epithelial cells. Peptides were included in both the pre-incubation step and incubation 
with wild-type P. gingivalis as described in Figure 4.22. The effect of peptides on adherence 
and invasion was determined relative to a pre-incubation with 2% BSA and no peptide, and 
statistical significance was accepted if p < 0.05. No significant difference was observed 
between no peptide and the scrambled peptide, whereas a significant reduction in 
adherence and invasion was observed for peptide 4 against both no peptide and the 
scrambled peptide. Antibiotic protection assays were carried out in triplicate, with 3 counts 
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per technical repeat observed (overall n = 27). Error bars represent ± SEM. * p < 0.05 ** p < 
0.01 *** p < 0.001, **** p < 0.0001, determined by one-way ANOVA 
 
To ensure the effect of reduced invasion and adherence in the presence of the peptides 
was due to the peptide itself engaging the host receptors, not due to the peptide causing 
detrimental effects on the bacteria and the host, the viabilities throughout the assay were 
determined for both the OK-F6 cells and the P. gingivalis bacteria. In the presence of the 
highest concentrations of each peptide (50 µg/ml), no significant change in the viability can 
be seen in either the oral epithelial cells or the bacteria, confirming that the results 
observed are due to the action of the peptide.  
 
Figure 4.25 Viability of OK-F6 and P. gingivalis in the presence of the peptides. Peptides 
were applied to OK-F6 cells and P. gingivalis cells in the conditions that would be found 
during the standard antibiotic protection assay. Viability of OK-F6 cells was determined by 
recovering the cells and determining the number of live and dead cells stained with Trypan 
blue and the percentage viable cells calculated. The viability of P. gingivalis in the presence 
of peptides was determined by calculating the CFUs recovered after incubation with the 
peptide for the duration of the standard antibiotic protection assay and compared to the 
starting CFU count. No significant difference was observed between no peptides and the 
inclusion of peptides (n=3). 
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4.3.9 Peptide-Coating of Microspheres Directs Interaction with Oral Epithelial Cells 
To further examine the host-cell interaction with the OmpA2 protein extracellular loops, 
the ability of the peptides to direct interaction of fluorescent inert latex beads with oral 
epithelial cells was determined. Yellow-green fluorescent microspheres which were coated 
in NeutrAvidin® for binding of the Biotin tag on the peptide were purchased from Life 
Technologies. The particular size of 1 µm was chosen for the microsphere size as this 
resembles the native size of P. gingivalis so the adherence of any microsphere via the 
OmpA2 peptides would partially mimic the adherence of a bacterium. Peptide-coated 
microspheres were then incubated with a monolayer of oral epithelial cells in a 96-well 
MTP and then washed thoroughly to remove any unbound microspheres and the 
fluorescence was read directly. BSA-coated microspheres were also included as a negative 
control for non-specific adherence as well as a scrambled peptide-coated microsphere, as 
shown in Figure 4.26.  
 
Figure 4.26 Fluorescence determination of peptide-coated Microspheres bound to OK-F6 
cells. Microspheres coated in OmpA2 extracellular loop peptides were applied to 
monolayers of OK-F6 cells at a MOI of 1:100 and incubated at 37°C for 4 h before washing 
and the fluorescence levels determined. Increased fluorescence denotes the binding of the 
peptides to the oral epithelial cell monolayer, relative to the BSA-coated microsphere 
control. The scrambled peptide-coated microspheres were also examined as a control. 
Fluorescence was measured as the average of three biological repeats (of which had 3 
technical repeats), with Error bars representing ± SEM. Statistical significance was accepted 
if p < 0.05. * p < 0.05 ** p < 0.01 *** p < 0.001, **** p < 0.0001, determined by One-way 
ANOVA.  
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All peptides demonstrate a clear increase the binding of the microspheres to the host cell, 
suggesting that a direct interaction between the extracellular loops of the OmpA2 protein 
and the oral epithelial cells. This increase in fluorescence was between 1.8- and 3.8- fold, 
with significance for peptide 2 (p < 0.001) and peptide 4 (p < 0.01) only. Similar to the 
modified standard antibiotic protection assays with the included peptide steps, peptide 4 
shows the greatest effect. Interestingly, although no effect for combined peptides was 
observed when used in the standard antibiotic protection assays, an increase in binding to 
host cells was observed in this assay, with an increase in fluorescence of 2.3-fold (p < 
0.0001). As peptide 4 showed the greatest increase in fluorescence, and therefore the 
greatest increase in host-cell interaction, the scrambled version 
(RINFMAGMPGFADTVGKAKQKF) of peptide 4 was used to determine if the binding of the 
extracellular loops to the host was specific. When compared to peptide 4, the scrambled 
peptide showed an 8-fold lower detection in fluorescence, and a 2-fold decrease in 
fluorescence when compared to the BSA-coated microspheres (Figure 4.26B), suggesting 
the interaction of peptide 4 with the host cell is specific to the sequence. 
4.3.10 Immunofluorescence of OmpA2 Extracellular Loops Interaction with Oral Epithelial 
cells  
As peptide 4 had shown the greatest effect in binding to the host both in interruption of 
wild-type P. gingivalis binding coupled to an increase in fluorescence when binding to a 
monolayer of host cells, immunofluorescence studies were undertaken to determine any 
direct binding of the peptide 4-coated beads to the host cell. To visualise the binding of the 
peptide-coated microspheres to the host epithelial cell, a monolayer of cells was seeded 
onto coverslips in a 24-well MTP. Peptide-coated microspheres were incubated with the 
cells before thorough washing to remove any unbound microspheres. The cells and any 
adhered beads were fixed with paraformaldehyde and cell membranes stained using WGA-
Texas Red® conjugated fluorescent antibody. Figure 4.27 demonstrates an increased 
binding of peptide 4-coated microspheres to the cells. 
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Figure 4.27 Immunofluorescence imaging of peptide-bound microspheres interaction with 
oral epithelial cells. Peptide 4-bound microspheres were examined for interaction (P4), 
compared to BSA-coated (BSA) and scrambled peptide-coated (P4-S) microsphere controls. 
AlexaFluor® 488 (green) shows peptide-bound Microspheres, WGA-Texas Red® (red) shows 
cell membranes and DAPI (blue) shows cell nuclei. Scale bars are indicated in the lower 
right hand corner.  
 
These images show clearly a significant increase in the number of microspheres bound to 
the host cell when coated in peptide 4 compared to BSA and scrambled peptide bound 
microspheres. This indicates that the peptide 4 is sufficient to allow direct binding of the 
microsphere to the host, and therefore suggests the OmpA2 protein is sufficient at binding 
to the host directly. When the number of microspheres bound to the host in each condition 
is determined, there is an increase of 6-fold with the microspheres coated in peptide 4, 
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compared to BSA-coated microspheres (Figure 4.28). An even greater increase is observed 
compared to scrambled peptide-coated microspheres, in compliance with the fluorescence 
data already observed. 
 
Figure 4.28 Enumerated peptide-coated microspheres interaction with OK-F6 cells. The 
number of microspheres bound to OK-F6 cells was calculated as the average from images 
from three technical repeats. Error bars represent ±SEM, and statistical significance was 
accepted if p < 0.05. ** p < 0.01 *** p < 0.005, determined by students’ t-test 
 
These data suggest that all four extracellular loops of OmpA2 are sufficient for host-cell 
interaction, and particularly peptide 4 is capable of directing binding of inert molecules to 
the host cell. Together, this suggests that there is a direct interaction between the OmpA2 
extracellular loops and molecules found on the surface of the human oral epithelial cells.  
4.4 Discussion 
As outlined in section 4.1, OmpA is an integral outer membrane protein, predicted to be 
found on all Gram-negative bacterial membranes (Beher et al., 1980). The OmpA protein 
has the predicted structure of a conserved N-terminal β-barrel, displaying extracellular 
loops between each β-sheet, and a C-terminal peptidoglycan-associated domain (Schulz, 
2000). Large variations are observed in the extracellular loops (Pautsch and Schulz, 1998), 
however the β-barrel appears conserved, indicating strong selection pressure (Wang, 
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2002). This chapter has investigated the role of P. gingivalis OmpA in its interaction with 
the host, and in particular, the role of the extracellular surface loops in this interaction. 
To characterise the relationship between the OmpA protein and its biological function, one 
of the fundamental steps is the purification of the protein. The standard method of protein 
purification relies on overexpression of the protein, lysis of the expression cells, binding the 
protein to a matrix, washing the matrix and finally elution of the protein. Many variables 
exist within these basic steps to increase the purity and yield of the protein, and were 
explored in depth in this chapter to attempt to purify pure and soluble OmpA protein.   
Initially, recombinant OmpA was overexpressed using a polyhistidine-tag for purification. 
The His-tag is one of the most widely used affinity tags, allowing one-step purification of 
the protein through immobilised metal-ion affinity chromatography (IMAC) (Hage, 1999). 
The imidazole side chain of the histidine amino acids have a high affinity for the 
immobilised chelated metals (Ni2+) on a nitrilotriatic acid (NTA) ligand support (Porath, 
1992), which immobilises the protein on the Ni2+-NTA resin where it can be recovered to a 
high level of purity using an imidazole eluent. The use of a His-tag for purification was 
initially chosen as it is a small tag that can be used under native and denaturing conditions 
(Porath, 1992) and although the idea cannot be completely excluded, the His tag is unlikely 
to interfere with the protein activity and therefore does not need to be removed for 
downstream applications (Terpe, 2006). The gene encoding OmpA1 and OmpA2 protein 
was provided already in a plasmid that would produce a His-tagged protein upon 
expression, and the OmpA1 and OmpA2 protein were successfully expressed to a very high 
yield, as seen within Figure 4.1. However, due to the high concentrations of protein 
produced during overexpression in E. coli coupled to the unfavourable conditions in the 
cytoplasm, hydrophobic proteins (e.g. the β-barrel of the OmpA protein) often partially fold 
before aggregating in dimers and multimers (Hong Lu et al., 2001). This lead to the 
overexpressed OmpA protein forming inclusion bodies and therefore produced insoluble 
protein. It was possible to recover the insoluble OmpA protein through solubilisation of 
pellet using high concentrations of urea; however solubilisation of the protein leads to the 
need of dialysis to remove the solubilising reagent. Dialysis of the OmpA1 and OmpA2 
protein lead to further protein aggregation and precipitation, which resulted in an unfolded 
and inactive protein which was therefore redundant for any downstream interaction 
studies.  
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Other purification protein tags can be employed to increase the solubility of the protein, 
such as fusion to glutathione-S-transferase (GST) or maltose-binding protein (MBP) (Lichty 
et al., 2005; Nilsson et al., 1997). Such fusion tags are popular as they act both to increase 
the solubility of the recombinant protein as well as acting as an affinity tag to allow one-
step purification (Frangioni and Neel, 1993). This is beneficial over other fusion tags such as 
thioredoxin (TRX) or ubiquitin (Ub) which require an additional affinity tag for purification 
of the protein (Marblestone et al., 2006). As the study by Marblestone et al (2006) 
demonstrated little difference in increased solubility between one-step purification fusion 
tags (MBP and GST), GST was chosen for fusion to the OmpA1 and –A2 protein for 
purification. GST is a 26 kDa protein originating from Schistosoma japonicum, first described 
by Smith et al (1986) and then subsequently inserted into a pGEX-vector for use as a 
recombinant protein affinity tag (Smith et al., 1986; Smith and Johnson, 1988). The GST tag 
is not only useful for easy detection of the protein in downstream studies, but it can help to 
protect against intracellular cleavage by host cell proteases (Arnau et al., 2006) and helps to 
stabilise the recombinant protein and increase its solubility (Terpe, 2006), and has been 
shown to successfully increase solubility in a number of cases (Dümmler et al., 2005; Kim & 
Lee 2008; Phansopa et al., 2015).  
In the case of increasing solubility for the OmpA1 and OmpA2 proteins in this study, the use 
of the GST-fusion tag increased solubility only marginally. After dialysing the protein, only 
the GST-OmpA2 remained partially soluble, and after combining and concentrating the 
soluble fractions, a minimal amount of protein remained. This soluble protein was enough 
to perform interaction studies with the host cell with technical repeats. Both of these image 
sets using CellMask™ and WGA-Texas Red® membrane stains demonstrated the ability of 
the OmpA2 protein to adhere to the host cell, providing encouraging results that the 
OmpA2 protein subunit is involved in P. gingivalis interaction with the host epithelial cells, 
as previously indicated in the ompA mutants in Chapter 3.  However due to the technical 
difficulties with the OmpA purification, the interaction studies in this chapter utilised 
peptides of the extracellular loops instead of purified protein.  
Dialysis is needed after the purification of the protein to remove the solubilising and elution 
reagents and to refold the protein. Protein refolding is a process that leads to a 
conformational change from a disordered and flexible state in the denaturant conditions, to 
a folded and compact state in an aqueous buffer (Tsumoto et al., 2003). Ideally, by removal 
of the denaturing solution the aqueous buffer should force the protein to collapse into the 
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compact structure; however this often leads to misfolding and aggregation, as seen with 
the OmpA1 and OmpA2 proteins here. Once the urea was removed from the protein 
elutions in dialysis, the OmpA proteins had no flexibility to refold correctly and precipitated 
becoming insoluble again. This was the case for the His-tagged proteins, and the OmpA 
protein remained insoluble after dialysis and therefore could not be used in any further 
experimental analysis.  
As the insolubility after dialysis appeared to be the major hindrance in protein purification, 
various methods of dialysis were trialled to determine a method which would increase the 
likelihood of soluble protein after dialysis.  Initially, stepwise dialysis was attempted which 
involved the gradual decrease in the concentration of urea to create intermediate levels of 
folding whilst still allowing protein flexibility and solubility until complete folding has 
occurred (Maeda et al., 1995; Tsumoto et al., 2003). This involved decreasing the 
concentration of Urea from 8 M to 0 M Urea in the dialysis buffer over the space of 24 
hours, from 8 M to 6 M, then 4 M and 2 M before all urea was removed completely so in 
theory the protein would be soluble (Tsumoto et al., 2010). Unfortunately, this method of 
dialysis was unsuccessful and the protein precipitated after dialysis.  
As previously detailed, reviews of the literature indicated proteins are likely to aggregate 
when a high concentration of them is reached (Kiefhaber et al., 1991; Lebendiker and 
Danieli, 2014), lending favour to the idea of reducing the temperature whilst proteins are 
expressed to reduce expression and therefore the potential for aggregating (Schein, 1989; 
Vasina, 1997). This idea was then taken further into the aggregation of the protein 
determined in the dialysis, and therefore that the high concentration of protein during 
dialysis increases the likelihood of protein aggregation and precipitation. This method to 
increase solubility post dialysis provided some success as protein was detected in the 
soluble fraction after dialysis. However, even after increasing the protein concentration 
through a Vivaspin® column, the concentration was still too low to provide a viable method 
for purification of soluble OmpA protein for downstream experiments.  
Another method of dialysis that was trialled to increase solubility was to include the amino 
acids L-arginine and L-glutamate in the dialysis buffer. The theory behind this was explained 
by Golovanov et al (2004) which demonstrated a 9-fold increase in solubility of the protein 
after dialysis in the presence of 50 mM L-glutamate and L-arginine (Golovanov et al., 2004). 
The amino acids are thought to perform a similar role to stepwise dialysis by suppressing 
the aggregation of refolding intermediate proteins, leading to an increased yield of overall 
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correctly folded protein (Hong Lu et al., 2001). Arginine is a positively charged amino acid, 
and alone is effective at increasing protein solubility but is needed at a much higher 
concentration (Clark, 2001; Hamada et al., 2009). Glutamate, a negatively charged amino 
acid, was previously found to increase aggregation of lysozyme after dilution out of 8 M 
urea, but suppresses aggregation after the addition of thermal stress (Shiraki et al., 2002).  
When applied together, the charges of these amino acids are thought to interact with 
oppositely charged groups on the surface of the protein, whilst the aliphatic region of the R 
group side chains are thought to cover the hydrophobic regions of the protein, reducing the 
“stickiness” which is thought to cause the aggregation of the protein (Golovanov et al., 
2004). Golovanov et al showed that together, the concentrations of L-arginine and L-
glutamine can be reduced to 50 mM and still be effective at increasing the stabilisation of 
the proteins of interest, and therefore the method was applied in the dialysis in this 
chapter. The addition of the L-arginine and L-glutamine alone had no effect on the solubility 
of the protein during dialysis, and when coupled to stepwise dialysis, no soluble protein 
was observed.  
Additives to the purification buffers exert their effects through either the enhancement of 
the native stability of the protein, or by destabilising the aggregates formed during 
overexpression (Bondos and Bicknell, 2003). The list of additives to the protein purification 
buffers and to the dialysis buffers is extensive and an impractical list to conquer (Bagby et 
al., 2001; Clark, 2001; Hamada et al., 2009) some of which is shown in Table 4.3, and to 
date, no single standard model exists to provide the perfect conditions for protein solubility 
and refolding. Alternatively, the protein could have been exported to the periplasm during 
expression which is usually used for proteins needing the correct formation of disulphide 
bonds (Bessette et al., 1999) or for especially toxic proteins (Saida et al., 2006), but has 
been shown to increase purification of insoluble proteins (Rosano et al., 2014; Dow et al., 
2015). However, this method is not always possible for all proteins, and periplasmic 
protease proteins can lead to proteolysis, resulting in fragmented and redundant proteins 
(Niazi and Brown, 2015). This is something that was not attempted in this body of work due 
to the progression into the structural models being produced, but will be kept in mind for 
future protein purifications. Due to the insolubility of the protein and impracticality of 
investigating every method to produce soluble proteins, alternative methods to study the 
interaction between OmpA and the host cells were explored.   
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Table 4.3 Collation of the most widely used additives for protein purification 
enhancement 
Additive Property Reference 
Tween 20 / 80 Detergent (Kerwin et al., 1998; 
Kreilgaard et al., 1998) 
Nonidet P-40 Detergent (Zoueva et al., 2002) 
Glycine Amino Acid (H Lu et al., 2001) 
L-arginine, L- glutamate Amino Acid (Golovanov et al., 2004) 
Sucrose Sugar (Kerwin et al., 1998; Webb 
et al., 2001) 
Glucose, Lactose Sugar (Arakawa and Timasheff, 
1982) 
Ethylene glycol, xylitol, 
mannitol, inositol, sorbitol 
Sugar alcohol (Gekko and Morikawa, 1981) 
Glycerol Sugar alcohol (Gekko and Timasheff, 1981) 
MgSo4, (NH4)2SO4, Na2SO4, 
Cs2SO4 
Kosmotope (order creator) (Neagu et al., 2001) 
NaCl, KCl Weak kosmotrope (Neagu et al., 2001) 
CaCl2, MgCl2, LiCl, RbCl, 
NaSCN, NaI, NaClO4, NaBr 
Chaotrope (disorder creator) (Neagu et al., 2001) 
Urea Chaotrope (disorder creator) (H Lu et al., 2001; Edwin et 
al., 2002) 
 
As there was no success in purifying soluble protein, the structures of the OmpA protein 
subunits were determined using online software protein prediction tools. Both OmpA1 and 
OmpA2 displayed the typical structure of an OmpA protein (Pautsch and Schulz, 1998; 
Pautsch and Schulz, 2000), with an N-terminal 8-stranded β-barrel and a C-terminal 
peptidoglycan-associated globular domain. Processing the structure through multiple 
structure prediction tools gave highly similar results, all indicating this same structure. 
Orientation software programmes such as TMPRED indicated the orientation of the subunit 
in the membrane and identified surface exposed loops which would be potentially involved 
in the interaction with the host. The sequence of these loops in the protein subunit was 
strongly indicated when both Phyre2 and RaptorX predicted the same placement in the 
protein sequence for the extracellular loops. Actual structure demonstration through 
crystallisation would be clearly beneficial, especially to confirm the location of these loops, 
however due to the insoluble nature of the protein, this is not practical. However, there is 
high confidence in the structure prediction by both homology studies (Iwami et al., 2007) 
and the high confidence (99.6 - 100%) in the model assigned by the Phyre2 software. 
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The extracellular loops of the OmpA2 protein were utilised in invasion assays and 
demonstrated that these loops are sufficient and specific in the interaction with the host. 
Invasion and adhesion of wild-type P. gingivalis was interrupted in the presence of these 
loops, which was not observed in the presence of a completely scrambled peptide of 
peptide loop 4. Additionally, when bound to fluorescent microspheres the synthetic 
peptides were capable of directing interaction of these inert microspheres with human 
epithelial cells. This again was not seen when the microspheres were coated in with BSA or 
the Biotin-tagged scrambled peptide, reinforcing the specific interaction seen with the 
extracellular loops of OmpA2.  
The interaction of the extracellular loops with the host cell display a novel finding for P. 
gingivalis but have been shown in a range of human pathogens. The extracellular loops of 
the meningitis-causing strain of E. coli (K1) have been shown to be important in the 
invasion of brain endothelial cells in a number of cases (Prasadarao, et al., 1996; Maruvada 
& Kim 2011), but more specifically, pathogenicity is reduced when mutations are 
introduced into loops 1 and 2 (Mittal and Prasadarao, 2011). The loops are not only needed 
for adherence and invasion, but further studies in E. coli  K1 show a mutation in the 
extracellular loops lead to reduced survival in dendritic cells and macrophages (Mittal et al., 
2011). This would be an interesting line of investigation in future work of this study, to 
determine if the predicted extracellular loops of P. gingivalis interact with other cell lines, 
such as endothelial cells or cells associated with the immune system. The human pathogen 
known for causing Q fever, Coxiella burnetii, also demonstrates an interaction with the host 
specifically attributed to the extracellular loops, with a significant loss of internalisation into 
lung epithelial cells with the deletion of loop 1, suggesting a direct interaction with the host 
cell receptors, and its role is primarily to interact with a cognate receptor at the surface of 
the host (Martinez et al., 2014). These studies suggest an integral importance for the 
extracellular loops in the interaction with human cells, but these observations are not 
limited to human pathogens. Work explored by Weiss et al (2008) demonstrated that with 
the introduction of recombinant E. coli K1 OmpA can convert a usually symbiotic 
relationship between Sodalis glossindius and its host, the tsetse fly (Glossina morsitans) to a 
pathogenic one. This body of work also used comparisons of the extracellular loops of the 
pathogenic E. coli and symbiotic S. glossindius to determine the substitutions and insertions 
in the sequence for loop 1 which were not observed in the OmpA found associated with the 
pathogenic E. coli (Weiss et al., 2008).  
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Combining the previous studies in the extracellular loops of other pathogen bacteria to the 
novel data generated from the extracellular loops of the OmpA2 protein of P. gingivalis in 
this results chapter, these demonstrate a role for the OmpA extracellular loops in the 
interaction of bacteria and the host, which contributes to the idea that this may be a 
widespread mechanism of host cell interaction.  
The data presented in this chapter demonstrates evidence that the OmpA protein, 
specifically the OmpA2 subunit, is directly involved in the interaction with the host. The 
question still remains as to what the potential cognate receptor on the host would be. 
Studies attempting to identify the P. gingivalis OmpA host cell receptor are limited. In the 
case of endothelial cell invasion by P. gingivalis, evidence was provided by Komatsu et al 
(2012) that OmpA may interact with these cells via E-selectin (Komatsu et al., 2012). 
However, there is only weak expression of E-selectin on epithelial cells so this may not be 
the case (Pietrzak et al., 1996).  
The host cell receptor for E. coli OmpA with the most evidential support is Gp96, a cell 
surface glycoprotein related to heat shock proteins (Prasadarao et al., 1996). Multiple 
studies have shown the E. coli K1 meningitis-causing OmpA mediated interactions with 
brain endothelial cells (BMECs) via the Gp96 receptor (Prasadarao, 2002; Prasadarao et al., 
2003), but more specifically, further studies demonstrated the extracellular loops 1 and 2 in 
particular were important in gp96 receptor interaction (Mittal and Prasadarao, 2011; Mittal 
et al., 2011). 
The receptor for OmpA has also been implicated in the strains of E. coli (AIEC strains, 
specifically LF82) that contribute to Crohn’s disease, the chronic intestinal diseases 
developed due to abnormal inflammatory responses to intestinal microbiota in humans 
(Strober et al., 2007; Xavier and Podolsky, 2007).  Using pull down assays, OmpA was shown 
to bind Gp96, and an ∆ompA mutant showed reduced invasion levels. This reduction in 
invasion was restored to wild-type level in the ∆ompA mutant when the intestinal epithelial 
cells were pre-treated with enriched OMVs containing OmpA (Rolhion et al., 2010; Rolhion 
et al., 2011), demonstrating a direct engagement of the gp96 receptor by OmpA of E.coli 
K1.   
Gp96 appears to be a popular receptor for host-pathogen interactions, with many bacteria 
utilising it for adherence and subsequent entry to the cell, including OmpA-mediated 
interaction in E. coli as discussed previously, Staphylococcus aureus Bap-Gp96 interactions 
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(Valle et al., 2012) and Listeria monocytogenes Vip surface factor-mediated interaction 
(Cabanes et al., 2005) to name a few. Gp96 is highly expressed in intestinal epithelial cells 
(Rolhion et al., 2010; Rolhion et al., 2011) and in brain endothelial cells (Prasadarao, 2002; 
Mittal and Prasadarao, 2011), which supports the idea that it is the potential cognate 
receptor on the host in those cases; however there is little evidence that oral epithelial cells 
express this receptor or that P. gingivalis utilises it.  
There is therefore the potential to utilise these peptides generated from the extracellular 
loops of the OmpA2 protein to perform binding assays to identify the host cell receptor for 
the P. gingivalis OmpA protein. This would involve immobilising the peptides on Avidin-
coated resin and capturing interacting partners from epithelial cell lysates passed over the 
resin, with mass spectrometry to identify the partners. It would also be interesting to 
mutate the loops of the OmpA2 protein to investigate a loss of interaction with the host to 
confirm the role of the OmpA2 protein, and whether these extracellular loops are as 
important when the whole protein is present in vivo. Further analysis of the extracellular 
loops interaction with the host would be to investigate if there is any interaction with other 
cell types. Considering P. gingivalis interacts with endothelial cells (Deshpande and Khan, 
1998; Deshpande et al., 1998), and more recently has been shown to interact with these 
cells via the OmpA protein (Komatsu et al., 2012), it would be interesting to determine if 
these extracellular loops are involved in the interaction with other cell types through 
repeating the peptide inclusive standard antibiotic protection assays with different cell 
types. 
Further analysis of these peptides would provide the potential to utilise them as new 
therapeutic agents to aid the prevention of the onset of chronic periodontal diseases 
caused by P. gingivalis.  
4.5 Summary 
In conclusion, whilst not achieving the purification of a high yield of overexpressed OmpA 
protein, these data presented here have identified extracellular surface regions of the 
OmpA2 protein subunit and have shown direct interaction with the host cell through 
multiple assays. These data therefore have indicated a potential role for these peptides and 
suggest a possible role for the use of these surface protein derived peptide loops in a 
therapeutic role as anti-adhesive peptides to prevent P. gingivalis–caused periodontal 
disease.  
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Chapter 5 
Preliminary Characterisation of the Putative OmpH/Skp Locus 
of P. gingivalis 
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5.1 Introduction  
The outer membrane proteins from Gram negative bacteria are synthesised in the 
cytoplasm and then must be translocated across the inner membrane to the periplasm in 
an unfolded state (Manting and Driessen, 2000; Driessen et al., 2001). Chaperone proteins 
are needed to assist the translocation of proteins across the periplasm, and to either then 
assist the folding of the protein or to deliver them to a folding system which will then insert 
the protein into the outer membrane (Missiakas et al., 1996; Missiakas et al., 1997; Danese 
and Silhavy, 1998). Multiple chaperone proteins have been identified and extensively 
studied, which can be seen later in Table 5.1. 
The seventeen kilodalton protein (Skp), also known as OmpH or HlpA, is a homotrimeric 
periplasmic chaperone protein that specifically interacts with unfolded outer membrane 
protein intermediates to maintain the solubility and stability during the passage across the 
periplasm (Laura Hirvas et al., 1990; Missiakas et al., 1996). More recently, two Skp-like 
genes have been identified in P. gingivalis, named ompH1 and ompH2 which were found as 
part of the “signature set” of genes upregulated in the hyperinvasive subset of the P. 
gingivalis population (Suwannakul et al., 2010). Currently, very little is known about the 
OmpH proteins of P. gingivalis, but these genes are predicted to function as a chaperone 
protein for delivering proteins to the Bam complex, an outer membrane assembly unit, as 
indeed they are thought to be in other organisms, with most studies being conducted in 
E.coli. The Bam complex (BamABCDE) is responsible for folding the β-barrel of outer 
membrane proteins, with BamA (also known as Omp85) being the central component 
conserved across all Gram-negative species (Hagan et al., 2011). This complex, based on 
evidence from other organisms such as E. coli is therefore potentially involved in the 
assembly of the OmpA heterotrimer in P. gingivalis. (Patel et al., 2013). A schematic 
representation of the Bam/Omp85 complex and the putative role of the OmpH-proteins is 
illustrated in Figure 5.1, based on evidence from E. coli Bam/OmpH secretion. The OmpH 
chaperone receives the unfolded protein from the Sec-secretion system, and translocates it 
across the periplasm in an unfolded state before delivery to the Bam complex where the 
protein is folded, modified and inserted into the outer membrane.  
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Figure 5.1. Schematic representation of the OmpH chaperone delivery of protein to the 
Bam complex. OmpH and SurA receive unfolded proteins from the Sec secretion system on 
the inner membrane (IM) and delivers the protein to the Bam complex in the outer 
membrane (OM) where they are processed, folded and inserted into the outer membrane.  
 
The chaperoning of proteins across the periplasmic space is an important but complex 
process, and unsurprisingly contains multiple proteins for successful translocation and 
processing of the protein to be inserted into the outer membrane. The initial step in 
characterising the OmpH proteins and their role in protein chaperoning in P. gingivalis was 
to determine how they fit into a larger system and determining the similarity of the 
processes in comparison to a well understood chaperone system, such as the one found in 
E. coli. A comparison of the presence of well-known chaperone proteins in E. coli and 
associated proteins to P. gingivalis can be seen in Table 5.1.   
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Table 5.1 Common chaperone and related proteins found in E. coli and P. gingivalis for 
comparison 
Protein in 
E.  coli  
Role  Name in P. gingivalis 
SurA Major chaperone and PPIase involved in 
the biogenesis of OMPs (e.g. LamB, OmpA, 
OmpC, OmpF), assisting with folding as 
well as chaperoning. (Lazar and Kolter, 
1996; Rouvière and Gross, 1996) 
PG0415 
DegP Predominantly a protease and a heat shock 
protein activated by high temperatures 
(Lipinska et al., 1989; Georgopoulos, 1990), 
but has chaperone activity at low 
temperatures (Skorko-Glonek et al., 2007) 
PG0593 – HtrA 
FkpA Chaperone and PPIase, specifically 
involved in the folding of LptD (LPS-
assembly protein) and FhuA (outer 
membrane transporter for ferrichrome-
iron)  (Ramm and Pluckthun, 2000; 
Schwalm et al., 2013) 
PG0708 
Skp Chaperone involved in the biogenesis of 
OMPs (e.g. OmpF, OmpA), member of the 
holdase family of proteins (preventing 
protein aggregation) (Chen and Henning, 
1996; Missiakas et al., 1996; De Cock et al., 
1999) 
PG0192/3 – OmpH 
SecA Part of the Sec secretion pathway, needed 
to secrete proteins across the cytoplasmic 
membrane in an unfolded state  (Oliver 
and Beckwith, 1982; Akimaru et al., 1991) 
PG0514 
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BamA (YaeT) Part of the BamABCDE complex, an outer 
membrane pore-forming assembly factor 
complex. (Voulhoux et al., 2003; Wu et al., 
2005; Webb et al., 2012) 
PG0191 – Omp85 
LolA Lipoprotein-specific periplasmic carrier - 
Directly transfers lipoproteins from 
cytoplasmic (inner) membrane to the outer 
membrane (Matsuyama et al., 1995) 
Not found 
HdeA Highly flexible chaperone allowing binding 
to multiple targets to prevent aggregation, 
also involved in stress response and acid-
resistance (Tapley et al., 2009) 
Not found 
DsbA Periplasmic folding catalyst, required for 
the formation of double bonds (Bardwell et 
al., 1991) 
Not found 
Spy Chaperone involved in suppressing protein 
aggregation and aids protein refolding 
(Quan et al., 2011) 
Not found 
E. coli proteins were investigated for the presence in P. gingivalis using a standard protein 
BLAST against the P. gingivalis ATCC 33277 genome. If no homologues were identified, 
protein sequences were then submitted to cDART to determine any conserved domain 
architectural similarities, of which proteins that had no homologous presence in BLAST also 
had no conserved domains in P. gingivalis and therefore denoted “not found”. 
 
In E. coli, outer membrane proteins are translated in the cytoplasm and targeted for 
secretion via the Sec system, where they are translocated across the inner membrane to 
the periplasmic space (Thome and Müller, 1991). The chaperone protein SurA is expected 
to act as a chaperone/folding catalyst, which assists with folding of outer membrane 
proteins immediately after export through the Sec system (Missiakas et al., 1996; Missiakas 
et al., 1997) before delivery to the Bam complex for processing and insertion into the outer 
membrane (Webb et al., 2012). The predominant role for DegP is as a protease enzyme, 
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working alongside the SurA chaperone, whereby it degrades unfolded proteins in the 
periplasm (Strauch and Beckwith, 1988). It also has an essential role in survival of E. coli at 
elevated temperatures (Lipinska et al., 1989). DegP also displays a minor role acting as a 
holdase-type chaperone at low temperatures (<28°C), by preventing the aggregation of 
certain substrates (Skorko-Glonek et al., 2007) and preventing their degradation by other 
proteases during the transport across the periplasm (Krojer et al., 2008). The P. gingivalis 
genome contains homologues of all of these proteins found in the major chaperone system. 
FkpA has been shown to act as a periplasmic chaperone to prevent aggregation of proteins 
(Saul et al., 2004), and has been recently shown to act cooperatively with Skp and SurA in 
the folding of LptD and FhuA (both outer membrane proteins) (Schwalm et al., 2013). Skp 
itself has been shown to act as a holdase, preventing the aggregation of proteins rather 
than playing an active role in the folding of the outer membrane proteins (Walton and 
Sousa, 2004), and has already been shown to be important in the chaperoning of over 30 
envelope proteins (Jarchow et al., 2008). As the deletion of the skp gene shows only 
diminution of outer membrane proteins in E. coli rather than a complete loss from the 
outer membrane, it is expected to act as a minor chaperone (Chen and Henning, 1996). 
5.2 Aims 
Previous work by Suwannakul et al (2010) demonstrated that a particular set of genes that 
are differentially regulated in a hyperinvasive subset of the P. gingivalis population. It was 
theorised that these genes are involved in either the invasion process or in the survival of 
the bacterium within the host. Of particular notice was the identification of the Skp-related 
OmpH protein of P. gingivalis as being potentially important in the interaction with the 
host, therefore this chapter will focus bioinformatics investigation on this particular 
chaperone protein, followed by characterisation of the ∆ompH mutant and investigation 
into the OmpH proteins and their effect on P. gingivalis virulence and interaction with the 
host. As previous work in E. coli has demonstrated evidence that OmpA is chaperoned by 
the OmpH protein (Chen and Henning, 1996; Schäfer et al., 1999; Patel et al., 2009; Walton 
et al., 2009), the link between OmpH and OmpA in P. gingivalis will also be investigated in 
this chapter.  
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5.3 Results 
5.3.1 Bioinformatic Analysis of OmpH 
The two ompH1 and ompH2 genes (also known as PGN_0300 and PGN_0301 or PG0192 and 
PG0193) are predicted to potentially form an operon with coding sequences PGN_0296 – 
PGN_0299 upstream of the ompH genes (Taguchi et al., 2016), as seen in Figure 5.2.  
 
Figure 5.2 Location of the ompH1 and ompH2 genes in the P. gingivalis genome. The two 
genes are located downstream of the BamA β-barrel assembly outer membrane protein 
(Omp85), indicated by the *.  
 
Protein family (Pfam) analysis of the amino acid sequences of OmpH1 and –H2 subunits of 
P. gingivalis show significant matches to the OmpH-like family of proteins, although the 
identity of the sequences to E. coli Skp is relatively low (26.17% and 20.89% for OmpH1 and 
–H2 respectively). The two P. gingivalis OmpH subunits also displays relatively low 
sequence homology to each other, at only 22.2% similarity.  
 
Figure 5.3 Alignment of E. coli Skp with P. gingivalis OmpH1 and H2 proteins. Red 
indicates high consensus between sequences, with blue indicating low consensus. The 
consensus sequence is listed below the three protein sequences and demonstrates a low 
sequence homology between E. coli and P. gingivalis Skp and OmpH proteins.  
 
The amino acid sequences of the individual OmpH subunits were further analysed through 
transmembrane structure prediction software programmes to determine the topology of 
the protein. Using DAS software (http://www.sbc.su.se/~miklos/DAS/) both the OmpH1 
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and OmpH2 subunits were predicted to possess a transmembrane helix at the N-terminal 
end (Phe8 – Ser23 for OmpH1 and Leu6 – Lys21 for OmpH2), following a signal sequence. 
Using another software tool, TMpred, produced results that complied with this, with 
OmpH1 showing a transmembrane helix from residues 8-27 and OmpH2 at residues 6-21. 
This suggests that a small section of these proteins may be anchored in the membrane of P. 
gingivalis, with the rest spanning the periplasm. However, when using TMHMM software, 
only OmpH1 demonstrates the presence of a transmembrane α-helix, as previously 
reported by Taguchi et al (2016). The prediction of the protein structure of OmpH1 and 
OmpH2 singular subunits using Phyre2 suggests a similar protein structure as observed for 
E. coli Skp, which has been suggested as forming a “jellyfish”- type architecture, with a 
body-domain and long α-helices forming the tentacles, as shown in Figure 5.4. The Skp 
proteins of E. coli have been shown to form a homotrimer (Walton and Sousa, 2004; 
Korndörfer et al., 2004), which contributes to the function of Skp.  
  
 
Figure 5.4 Protein structure prediction of P. gingivalis OmpH1, OmpH2 and E. coli Skp. P. 
gingivalis OmpH1 (A) and -H2 (B) structure predictions using Phyre2 (black arrows 
indicating the predicted transmembrane α-helix), and E. coli Skp (C) from crystal structure 
determination.  
 
This trimeric structure formed by E.coli Skp has been suggested as a necessity for binding 
the β-barrel of outer membrane proteins deep into the cavity of the trimer, with the 
“tentacles” wrapping around the chaperoned protein to prevent aggregation and stabilise 
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the protein during the translocation across the periplasm (Walton et al., 2009), and may be 
the case for P. gingivalis OmpH due to their structural similarities, although the trimeric 
formation of OmpH has not yet been investigated. 
5.3.2 Generation of an ompH1H2 Mutant 
As the ompH1, -H2 genes are expected to form a complex, both genes were deleted to 
determine the effects of the loss of the entire protein on the P. gingivalis outer membrane 
and virulence. The ompH1H2 mutant was generated to study the effects on P. gingivalis 
biology and its ability to interact with human cells. Similar to the attempt to generate the 
∆ompA1 mutant, the assembly of a knock out construct through PCR assembly yielded no 
triplet construct, despite the many PCR conditions attempted. Therefore, a knock out 
construct was designed with two flanking regions of 1000 bp upstream and downstream of 
the OmpH1H2 coding region, and with the erythromycin resistance gene inserted at the 
corresponding ATG start codon of ompH1, and the TAA stop codon at the stop codon of 
ompH2 to knock out the whole OmpH1H2 protein, before synthesis through GeneArt™.  
The coding sequences upstream and downstream the ompH operon were also analysed to 
determine if there would be any read-through effects caused by the deletion of the operon. 
Upstream of ompH1 encodes Omp85 (also known as YaeT or BamA, see Fig. 5.2.) which is 
an integral member of the BamABCDE complex involved in the assembly of β-barrels in the 
outer membrane, and is an essential gene. Disruption of this gene during the deletion of 
OmpH would result in non-viable cells and therefore this is not a concern as no triple 
mutants of ompH1H2 and omp85 would be produced. Downstream of the ompH operon 
contains a 327 bp non-coding region before encoding a transposase unrelated to the ompH 
operon, so no read-through effects were predicted to be observed in the deletion of the 
operon.  
The synthesised knock out construct was initially blunt-end cloned into pJET1.2/blunt 
vector for storage, and transformed into DH5α for amplification. Plasmids were isolated 
from positive colonies selected on LB plates supplemented with ampicillin. Positive 
plasmids for the insert were then used for transformation into wild-type P. gingivalis 33277 
through all four methods (plate-to-plate, plate-to-liquid, liquid-to-plate and liquid-to-liquid) 
as previously described in materials and methods 2.6.4. 
The different methods of transformation were assessed for their efficiency, as previously 
described in the generation of ∆ompA1 and ∆ompA2 mutants in Chapter 3.3.2. Again, 
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overall the natural competency method proved to generate more colonies than the 
electrocompetency method. However, the overall efficiency was minimal, with multiple 
transformation attempts yielding no colonies. As many attempts at transformation 
produced no colonies, the methods were dissected further.  
The original electroporation involves the growth of a large liquid broth (20 ml) before 
preparation of the cells, electroporation and then the cells plated onto plain BA plates for 
24 h before transferral to erythromycin-containing plates for selection. The original natural 
competency method involved inoculating 1 ml BHI with bacteria obtained from a 3-day old 
plate to OD600 ~2.0 before adding DNA and plating on plain BA plates for 24 h before 
transferring to erythromycin-containing plates. General laboratory observation 
demonstrated the P. gingivalis cultures appeared to grow better in liquid broth than plates, 
so this was incorporated into the design of the new transformation methods. The origin of 
the starting cultures for transformation by natural competency was investigated to 
determine if P. gingivalis taken from either 3-day old plates or liquid cultures would 
produce a higher yield of mutants, whilst the 24 h recovery incubation post DNA 
transformation was investigated on plain BA plates and liquid BHI with supplements to 
determine which would produce more mutants for both electrocompetency and natural 
competency. In all methods, after the 24 h recovery in BHI broth or BA plates, the P. 
gingivalis was transferred to erythromycin-containing BA plates for 2 weeks for the growth 
of P. gingivalis mutants. Two different cultures were set up for each method and the 
efficiency of the method was determined as an average number of colonies observed on 
the erythromycin-containing plates after 2 weeks incubation. The different methods under 
investigation can be seen diagrammatically in Figure 5.5.  
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Figure 5.5 Schematic representation of the optimisation of P. gingivalis transformation 
methods. The transformation of P. gingivalis is performed via two main methods, natural 
competency and electroporation, with optimisation of these methods detailed in this 
Figure. 
 
Electroporation yielded no mutants in either condition, similar to the creation of the 
∆ompA mutants. Natural competency yielded mutant colonies in 3 out of the four 
conditions, and if the starting culture was from a liquid culture rather than a plate, a 
greater number of colonies were observed on the erythromycin-containing BA plates, and 
even more colonies were observed if the recovery 24 h was in a liquid culture, as seen in 
Table 5.2.  
 
 
 
 
 
 
 
200 
 
Table 5.2 Transformation efficiency of each method of transformation for P. gingivalis 
Method of transformation Colonies µg-1  
Electroporation – liquid 24 h recovery 0 
Electroporation – plate 24 h recovery 0 
Natural competency - plate-to-plate 0 
Natural competency - plate-to-liquid 1.2 
Natural competency - liquid-to-plate 13.6 
Natural competency - liquid-to-liquid 24.4 
The concentration of DNA in all methods was between 250-270 ng / µl, so the efficiency of 
transformation was expressed as the number of colonies produced per overall DNA input 
concentration.  
 
DNA from several colonies in each condition was purified and PCRs were carried out using 
various combinations of primers from Table 2.8 to determine the successful homologous 
recombination of the erythromycin resistance cassette into the P. gingivalis genome, 
thereby knocking out the ompH operon. Analysis of PCR products on agarose gel indicated 
multiple positive colonies, with one shown in Figure 5.6.  
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Figure 5.6 PCR analysis of the generation of a ∆ompH1H2 mutant. DNA was isolated from 
P. gingivalis eryR colonies growing on erythromycin-containing BA plates using the Wizard® 
Genomic DNA Purification Kit (Promega).  Multiple combinations of primers were used to 
assess the deletion of the ompH operon. F1-eryR primers generate the flanking region 
upstream and the erythromycin cassette (1800 bp), eryR primers generate the erythromycin 
cassette (800 bp) and eryR – F2 generate the erythromycin cassette and the downstream 
flanking region (1800 bp). DNA was extracted from both wild-type (WT) P. gingivalis and 
the mutants in question (∆H). No bands were observed in the wild-type DNA-containing 
PCRs as they do not possess an erythromycin gene, whereas all PCRs were positive for the 
mutant at the correct sizes.  
 
DNA products from the PCR were analysed using sequencing to determine correct mutation 
of the ompH operon and confirmed that all colonies tested contained deletion of the 
ompH1 and ompH2 genes with replacement by the eryR cassette.  These also appeared to 
be identical so one was selected for further analysis in this chapter. 
5.3.3 Morphological analysis of ∆ompH1H2 
The first and most obvious observation of the ∆ompH1H2 mutant was the morphology of 
the colonies. The colonies observed on the erythromycin-containing plates after 
transformation appeared much larger than wild-type P. gingivalis, as shown in Figure 5.7. 
These colonies also appeared to be brown and glossy, rather than the small black colonies 
usually seen with wild-type P. gingivalis.   
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Figure 5.7 ∆ompH1H2 mutant morphology. Wild-type (left) colonies appear as small black-
pigmented colonies compared to the large, brown colonies observed for ∆ompH1H2 (right). 
The white scale bar represents 1.5 cm, indicating a vast difference in size between the two.  
 
After replating these colonies for further growth, it was also observed that the ∆ompH1H2 
mutant grows much slower on BA-plates, and takes an increased length of time to darken 
whilst still retaining the glossy appearance, as shown in Figure 5.8.  
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Figure 5.8 Time lapse of growth of P. gingivalis wild-type and ∆ompH1H2 mutant. Plates were photographed every other day (d) until 7 days, and then 
again after another week (14 d). Each plate was removed from the anaerobic cabinet to be photographed in a non-sterile environment, therefore plates 
contain contamination from other microorganisms, however this did not affect the growth so was no major concern.  
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Wild-type colonies turn black after 3 days, but more apparently so after 5 days. The 
∆ompH1H2 colonies remain brown and glossy until 14 days, where they apparently darken 
but still remain glossy, indicating a potential change to the surface characteristics due to 
the loss of the OmpH protein. 
5.3.4 Protein Profiling of the ∆ompH1H2 Mutant 
As the initial morphological study of the ∆ompH1H2 colonies demonstrates a potentially 
altered surface profile it could be possible that the outer membrane protein profile was 
altered.  This can he hypothesised since colony pigmentation in particular is known to be 
defined in P. gingivalis by the action of secreted and membrane associated proteins such as 
gingipains.  Therefore, the proteins in the outer membrane affected by the loss of OmpH 
were investigated further. A general observation of the outer membrane proteins was 
investigated through the purification of the outer membrane as detailed in Materials and 
Methods 2.7.5, and analysed on an SDS-PAGE gel, as seen in Figure 5.9 
 
Figure 5.9 SDS-PAGE analysis of purified outer membranes of wild-type and ∆ompH1H2 
P. gingivalis. Liquid cultures were grown and adjusted to OD600 1.0 before the membranes 
purified by differential detergent centrifugation before being applied to the SDS-PAGE 4-
15% pre-cast gradient gel. DTT was applied to the SDS-loading buffer and samples boiled 
before loading so proteins were denatured in this analysis. Particularly obvious differences 
between the wild-type and ∆ompH1H2 membrane proteome are highlighted with red 
arrows. 
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The SDS-PAGE analysis demonstrates a significant alteration to the outer membrane in the 
∆ompH1H2 mutant compared to the wild-type. Many proteins appear to be absent from 
the outer membrane, suggesting that these proteins might be clients of the OmpH 
chaperone.  While speculative, the sizes of proteins of interest are around ~41 kDa 
(potentially OmpA), or ~48 kDa (potentially the gingipains), which are marked with an 
asterisk on the gel arrow. However, in multiple instances there appears to be proteins 
found in the sample which are not present in the wild-type. These proteins may be present 
in these samples due to aggregation of pre-processed proteins (i.e. because they are not 
chaperoned to the outer membrane for processing) and pelleting during centrifugation, and 
therefore they appear in the outer membrane sample preparation. Further analysis of 
these proteins would be necessary to identify which proteins are no longer in the outer 
membrane and therefore indicative of being chaperoned by the OmpH proteins.  
As previous studies have identified E. coli Skp as being involved in the assembly of OmpA 
(Bulieris et al., 2003; Patel et al., 2009; Qu et al., 2009; Walton et al., 2009), coupled to the 
potential loss of the protein band in the ∆ompH1H2 outer membrane preparation at ~41 
kDa in Figure 5.10 and OmpA being a major protein of interest in this project, the 
appearance of OmpA in the outer membrane in ∆ompH1H2 mutants was probed using 
Western blotting. The OmpA antibody was previously used to probe for the presence of 
OmpA in the outer membrane of the ∆ompA single and double mutants in Chapter 3 (Fig. 
3.8), and a similar protocol was followed here for ∆ompH1H2 mutants. Figure 5.10 
demonstrates the SDS-PAGE analysis of the outer membrane preparations and the Western 
blot corresponding to the SDS-PAGE gel.  
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Figure 5.10 SDS-PAGE (A) and anti-OmpA Western blot (B) of outer membrane 
preparations from wild-type P. gingivalis and ∆ompA and ∆ompH mutants. Outer 
membrane preparations were prepared as previously described and analysed on an SDS-
PAGE gel (A) alongside probing for the OmpA protein using an anti-OmpA antibody (1:1000) 
(B).  
 
Previous attempts at SDS-PAGE analysis of membrane preparations from the ∆ompA1A2 
and ∆ompH1H2 double mutants often show a fainter band marking on the gel, so twice as 
much protein was loaded to ensure any protein being detected in the Western blot. 
Ultimately, no protein band was observed in the corresponding anti-OmpA Western blot in 
the ∆ompA1A2 and ∆ompH1H2 membrane preparation samples, indicating the possibility 
of OmpA being a client of the OmpH chaperone in P. gingivalis. 
5.3.5 Assessment of the Integrity of the Outer Membrane in the ∆ompH1H2 Mutant: 
Imaging and Vesicle Counts 
As the P. gingivalis OmpH chaperone protein is likely to translocate proteins across the 
periplasm to the outer membrane, outer membrane integrity assays were carried out to 
determine the effects of the loss of the chaperone protein on the integrity of the outer 
membrane. The outer membrane integrity and morphology was determined through two 
methods, transmission electron microscopy (TEM), as was performed for the ompA mutant 
morphology (which led to assessment of the outer membrane vesicles) and also through 
thiazole orange membrane integrity assays.  
TEM was carried out as previously described in Materials and Methods 2.8.5, and checked 
for contamination through Gram-staining. Pure cultures of wild-type P. gingivalis and 
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∆ompH1H2 were prepared and sectioned for TEM. Images generated can be seen in Figure 
5.11.  
 
Figure 5.11. P. gingivalis wild-type and ∆ompH1H2 membrane morphology assessed via 
TEM imaging. Wild-type (left) and ∆ompH1H2 (right) images were taken at various 
magnifications, and represented by the scale bars at the bottom left of each image. Red 
arrows indicate cells of interest with significantly altered morphology. 
 
From the TEM images, it is immediately apparent differences are observed between the 
wild-type and ∆ompH1H2 strains in the number of vesicles observed with the ∆ompH1H2 
mutant appears to produce a higher number of vesicles than the wild-type. Alongside the 
increase in extracellular vesicles, the ∆ompH1H2 mutant also appears to have a similarly 
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wavy membrane morphology in a significant proportion of the cells as observed previously 
in the ∆ompA mutants, although in this instance this occurs in a higher proportion of the 
population than previously observed, between 20-25% of the population compared to 3-4% 
seen for ompA mutants. Interesting to note were the cells indicated by the red arrows, 
which appear to have vesicle-like structures intracellularly.  
As the number of vesicles produced in the ∆ompH1H2 mutant appeared much larger, the 
number of vesicles produced by both the wild-type and the mutant was assessed using the 
qNANO as previously described. The count and the size of the vesicles can be seen in Figure 
5.12. 
 
Figure 5.12 Assessment of OMVs of P. gingivalis wild-type and ∆ompH1H2 mutant. Figure 
(A) demonstrates the raw count of vesicles (adjusted to the bacterial OD and calculated per 
ml of bacteria), whilst (B) compares the size of the vesicles observed. Vesicles were isolated 
from overnight liquid cultures as previously described and the raw count observed 
expressed on a log scale. Error bars represent ± SEM, and significance was assigned if p < 
0.05 as determined by student’s t-test. ** p < 0.01 (n=3). 
 
The raw count demonstrates that the ∆ompH1H2 mutant produced 10-fold more vesicles 
than the wild-type mutant (Fig. 5.12A, log scale). The average size of the vesicles produced 
is significantly larger (25%) than the wild-type, as shown in Figure 5.12B, where there 
appears to be a significant size shift in the vesicle diameter compared to the wild-type, 
suggesting a greater disturbance in the membrane integrity. 
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Together these data support the idea that the OmpH proteins are important chaperone 
proteins found in P. gingivalis, and the clients of these chaperones may be important in 
maintaining the integrity of the bacterium’s membrane. 
5.3.6 Assessment of the Integrity of the Outer Membrane in the ∆ompH1H2 Mutant: 
Assessment of Permeability Using a Fluorescent Dye. 
The second method utilised to study the membrane integrity of the ∆ompH1H2 mutant was 
using thiazole orange coupled to stress-inducing conditions. Thiazole orange (TO) is a 
synthetic dye made up of two aromatic ring systems connected via a bond which, when 
bound to nucleic acids, becomes restricted causing an intense fluorescence (Nygren et al., 
1999). The most common uses for TO are in the detection of DNA in flow cytometry, 
especially in detecting reticulocytes (Lee et al., 1986) or in general use for detection of DNA 
in gel electrophoresis (Rye et al., 1992). For this investigation, TO was adapted as a detector 
for the permeability of the bacterial membranes, as an increase in fluorescence would 
indicate a higher permeability in the membranes, indicative of a lesser membrane integrity. 
Liquid cultures of P. gingivalis were grown according to materials and methods 2.4.2, and 
the cells washed thoroughly in phosphate buffer to remove any extracellular DNA from 
lysed cells.  In order to test membrane integrity the cells were tested for exclusion of the 
dye using 2-conditions, namely a low (0.001 % SDS) and high (0.025 % SDS) levels of 
detergent induced membrane stress. These were applied to the cells, and the rate of 
uptake of TO into the cells was measured for the wild-type and ∆ompH1H2 mutant. The 
background rate of fluorescence was measured for 10 s before the TO dye was added and 
the change in fluorescence measured as a fluorescence trace (Fig. 5.13A). The rate of 
fluorescence uptake was determined from the trace, and plotted as the rate of uptake of 
TO (Fig. 5.13B) between the wild-type and ∆ompH1H2 mutant in normal and stressed 
conditions. 
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Figure 5.13 Membrane integrity assay using Thiazole Orange. Fluorescence of the wild-
type and ∆ompH1H2 mutant cells was followed during the addition of the thiazole orange 
(A), whereby the sharp increase in fluorescence intensity corresponds to the addition of TO 
at 15 s. Figure (B) demonstrates the rate of TO uptake for wild-type and ∆ompH1H2 mutant 
cells (n=3). Error bars represent ±SEM, with significance assigned if p < 0.05 as determined 
by student’s t-test. * p < 0.05. ** p < 0.01, **** p < 0.0001. 
 
The fluorescence trace shows an increase in fluorescence in both strains when the stress 
agent (SDS) is applied to the cells, however it also shows a slower increase in fluorescence 
for the ∆ompH1H2 mutant than the wild-type cells, in both non-stressed and stressed 
conditions. As the membranes of the ∆ompH1H2 mutant were expected to be weaker and 
therefore would let more TO dye into the cells, this was the opposite of what was expected. 
In the original hypothesis that the membrane integrity would be weaker in the ∆ompH1H2 
mutant, this should demonstrate a higher rate of TO uptake in the mutant. However, what 
is actually observed is that the ∆ompH1H2 mutant displays a significantly lower rate of 
uptake of the fluorescent dye. This may indicate that the OmpH chaperone delivers a 
protein to the outer membrane that is involved in the translocation of substrates across the 
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membrane into the cells, and the loss of the chaperone has removed this possible 
transporter from the membrane.  
5.3.7 Assessment of Virulence Factor Production in the ∆ompH1H2 Mutant 
To attempt to determine the clients of the OmpH chaperone protein, various proteinaceous 
virulence factors of the ∆ompH1H2 mutant were investigated. The sialidases of P. gingivalis 
were previously described as being important in the virulence of the bacterium in Chapter 
3.3.3.4, so the activity of these enzymes was studied here. Sialidase activity of the whole 
cells were assessed as previously described in Materials and Methods 2.8.9.3, and 
determined as a fold-change compared to wild-type activity, as seen in Figure 5.14.  
 
Figure 5.14 Sialidase activity of wild-type and ∆ompH1H2 P. gingivalis. Whole cell sialidase 
assays were assessed on liquid cultures of the two P. gingivalis strains as previously 
described in Materials and Methods 2.8.9.3. Sialidase activity of the ∆ompH1H2 mutant 
was determined as a fold-change relative to wild-type (=1). Error bars represent ±SEM, with 
significance assigned if p < 0.05 as determined by student’s t-test. *** p < 0.001.  
 
Similar to the sialidase activity of the ∆ompA mutants, the sialidase activity of the 
∆ompH1H2 mutant was four-fold higher than the wild-type P. gingivalis. This coupled to the 
increase in the number of vesicles as seen in here in section 5.14, and the increase in 
vesicle numbers observed for the ∆ompA1A2 mutant in Results Chapter 3.3.3.2 may 
suggest a greater number of sialidase enzymes being found on the vesicles, which often 
contain proteins from the outer membrane. This increase in sialidase activity also suggests 
that the sialidase protein is unlikely to be translocated across to the outer membrane by 
the OmpH chaperone. 
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As previously described, the gingipains are major virulence factors of P. gingivalis, and are 
highly active extracellular and surface proteinases. Recently, the gingipains have been 
shown to contain a C-terminal domain (CTD) which targets them for secretion through the 
Sec apparatus and the PorSS secretion system (the type IX secretion system), where they 
are processed and inserted into the cell surface or secreted into the extracellular space 
(Glew et al., 2012; Sato et al., 2013). The gingipain activity in the ∆ompH1H2 mutant was 
investigated here, to determine if the secretion of the gingipains is affected by the loss of 
the OmpH chaperone.  
Gingipain activity was assessed as previously described in Materials and Methods 2.8.9, and 
the activity of the whole cells was determined for both Rgp and Kgp-gingipains, as shown in 
Figure 5.15. 
 
Figure 5.15 Whole cell Rgp and Kgp gingipain activity of wild-type and ∆ompH1H2 
P. gingivalis. Liquid cultures of P. gingivalis strains were grown and adjusted to OD600 1.0 
and the appropriate substrate added for Rgp or Kgp before the activity read over 30 mins. 
The rate of activity was determined by subtracting the Abs405nm value at 1 min from 6 min 
when the rate of activity was still linear and plotted as a relative value compared to the rate 
of wild-type (=1). Significance was assigned if p < 0.05 as determined by student’s t-test. 
*** p < 0.001, **** p < 0.0001 (n=3). 
 
Whole cell gingipain activity was reduced 2.5- and 1.5-fold for Rgp and Kgp activity 
respectively. This reduction in activity suggests that the gingipain pre-proteins are 
transported across the periplasm by the OmpH chaperone proteins before being processed 
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and inserted into the outer membrane and this data potentially identifies a client of the 
OmpH chaperone, although further investigation is required. 
5.3.8 Assessment of General Virulence of the ∆ompH1H2 Mutant 
As the importance of OmpH in the ability for P. gingivalis to interact with the host cell was 
originally indicated by the 4-fold upregulation in expression of the ompH genes in the 
hyperinvasive subset of the P. gingivalis population by Suwannakul et al (2010), the invasive 
and adhesive capabilities of ∆ompH1H2 P. gingivalis mutant was assessed in this study 
using standard antibiotic protection assays as previously described.  
 
Figure 5.16 Standard antibiotic protection assay of wild-type P. gingivalis and ∆ompH1H2 
mutant. Standard antibiotic protection assay (A) was carried out as previously described. 
Bacterial strains were incubated with OK-F6 cells at 1:100 MOI and viable counts were 
taken for each strain and the number of bacteria recovered was determined as a % of the 
viable count. Invasion was defined as the percentage of the bacterial inoculum protected 
from metronidazole killing, whereas total association denotes the number of bacteria that 
adhere to and invade the OK-F6 cells. Adherence was determined by subtracting invasion 
CFUs from the total associated. Each % Recovery was corrected to the wild-type P. 
gingivalis total association (=1). The overall viability of the two strains was determined in 
(B) by calculating the bacterial counts at the end of the standard antibiotic assay and 
determining these as a percentage of the counts used to infect the cells, and made relative 
to the wild-type viability (=1). Error bars ± SEM. Statistical significance was defined by * p < 
0.05, *** p < 0.001 and **** p < 0.0001, determined by students’ t-test. 
 
The ability of the ∆ompH1H2 mutant to adhere to the cells has been almost completely 
abrogated, whilst the invasive capabilities are also significantly reduced. This was expected 
due to the changes to the outer membrane proteome, and indicates the OmpH chaperone 
protein is responsible for translocating proteins to the outer membrane involved in the 
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interaction with the host cell. The adherence and invasive capabilities resemble what is 
seen for the ∆ompA1A2 double mutant, and considering there is a loss of detectable OmpA 
in the outer membrane preps (Fig. 5.10), this loss in the ability to adhere to an invade the 
host may be due to the loss of OmpA, supporting the idea the OmpA of P. gingivalis is a 
client of the OmpH chaperone, however, this would need further investigation to confirm.  
The viability of the ∆ompH1H2 mutant was significantly lower compared to the wild-type 
during the standard antibiotic protection assay, and this was expected as the outer 
membrane has been significantly altered in the ∆ompH1H2 mutant. As the values for 
adherence, invasion and total association are determined as a percentage of the overall 
viability of that strain, this should not have had any masking effects on the values produced 
for invasion and adherence.  
As the ability for P. gingivalis to form a biofilm is a key virulence factor, the biofilm forming 
capabilities of the ∆ompH1H2 mutant was also determined. Biofilms were grown for 72 h in 
a 96-well polystyrene plate as previously described, and the overall growth was determined 
before analysis of the biofilm commenced. In 6 out of 9 experimental repeats, the overall 
growth of the ∆ompH1H2 mutant was much lower than the wild-type, suggesting the 
effects of the loss of the OmpH chaperone proteins impedes the growth of the bacteria, 
which may influence the biofilm formation. The three experimental repeats that had similar 
levels of overall growth (biofilm and planktonic) were analysed for the biofilm formation 
through Crystal Violet staining and extraction, alongside visual imaging, as seen in Figure 
5.17. 
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Figure 5.17 Biofilm formation of wild-type P. gingivalis and the ∆ompH1H2 mutant. 
Biofilms were grown for 72 hours before the planktonic cells were removed and the 
resulting biofilm stained with 1% Crystal Violet. Biofilms were imaged under x400 
magnification, and the Crystal Violet extracted using ethanol, and the Abs575 determined. 
The absorbance of the Crystal violet for the ∆ompH1H2 mutant was determined relative to 
wild-type Crystal Violet extraction absorbance (=1).  Error bars ± SEM. Statistical 
significance was defined by *** p < 0.001 as determined by students’ t-test.  
 
The ability of the ∆ompH1H2 mutant to form a biofilm is greatly reduced, similar to what 
was previously observed for the ∆ompA1A2 mutant. The mutant appears to no longer 
adhere to the plate well, and biofilm formation is visually abrogated. When the Crystal 
Violet was extracted, the quantifiable amount of biofilm that the ∆ompH1H2 mutant 
formed was 14-fold less than the wild-type. This indicates that proteins in the outer 
membrane needed for biofilm formation may be chaperoned by the OmpH proteins, but 
similarly, as the biofilm in the ∆ompA1A2 mutant was reduced 8.8-fold, this apparent loss 
of biofilm in the ∆ompH1H2 mutant may be due in part to the loss of the OmpA protein.   
These data together suggest that the OmpH protein is essential in chaperoning proteins 
involved in the virulence of the bacteria.  
5.4 Discussion 
In Gram negative bacteria, around one in five of the proteins transcribed are targeted for 
the outer membrane (Goemans et al., 2014). Newly synthesised proteins destined for the 
outer membrane through the Sec machinery need a chaperone protein to escort them 
through the periplasm to reach the outer membrane (Hagan et al., 2011). As these proteins 
enter the periplasm in an unfolded state, they are much more likely to aggregate in the 
aqueous environment, and therefore folding pathways exist to prevent the aggregation and 
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also assist the folding of these outer membrane proteins (Entzminger et al., 2012). These 
chaperone pathways have been studied at great length in E. coli, with the major chaperone 
pathway involving the SurA protein and the secondary pathway consisting of the Skp and 
DegP proteins (Sklar et al., 2007). Analysis of Gram-negative genomes using the SEED 
analysis tool, applied to the national microbial pathogen data resource database 
(http://www.nmpdr.org/FIG/wiki/view.cgi) which is supported by protein entries from 
KEGG, NCBI, UniProt etc., demonstrates the appearance of these three proteins in a vast 
number of bacteria, with nearly all Gram-negative genome entries containing the SurA 
protein, and slightly fewer containing the Skp and DegP proteins demonstrating these 
proteins are widely used for protein chaperoning across the periplasm.  
Bioinformatics analysis of P. gingivalis demonstrated all three of these chaperone-related 
proteins are observed in P. gingivalis (Skp – PG0192/3 or OmpH1/2; SurA – PG0415; DegP – 
PG0593) indicating a similar pathway to E. coli for the delivery proteins through the Sec 
pathway to the outer membrane across the periplasmic compartment. The importance of 
the OmpH of P. gingivalis was identified previously by Suwannakul et al (2010), who 
observed a signature set of genes that are differentially regulated in a hyperinvasive subset 
of the P. gingivalis population (Suwannakul et al., 2010). Within this set of genes, PG0193 
(OmpH2) was upregulated 4-fold in the highly invasive subset, indicating an involvement in 
delivering proteins to the outer membrane that are involved in adherence to and invasion 
of the host cell.  
Outer membrane proteins found upregulated in this signature gene set include PG0063 and 
PG1058, both putative outer membrane proteins with no assigned function yet. As these 
proteins are upregulated 6.3- and 4.65-fold in the hyperinvasive population of P. gingivalis 
(Suwannakul et al., 2010), they may be involved in the adhesion and invasion of the host 
and may be clients of the OmpH chaperone. Another outer membrane protein upregulated 
in this gene set is the TonB-dependant receptor, hmuR, which is a hemin-binding protein 
(Simpson et al., 2000), and may be important in scavenging in the hemin-limiting 
environment inside the host cell.  
The function of these outer membrane proteins and their relation to the invasion of the 
host is an exciting area to investigate further in future work on this project. Creation of null 
mutants in these genes has already begun, but due to time constraints, no further analysis 
has occurred. Through these mutants, investigation of their ability to invade the host cell 
could potentially provide new insights into proteins needed for host cell interaction and 
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therefore potentially allude to new therapeutic targets to combat P. gingivalis-associated 
periodontal disease. 
The creation of the ∆ompH1H2 mutant proved to be unsuccessful for a number of 
attempts, and therefore allowed some optimisation of the methods of P. gingivalis 
transformation found in the literature. The traditional method of mutagenesis of P. 
gingivalis involves introducing the DNA via electroporation (Yoshimoto et al., 1993), 
however this method involves multiple time-consuming steps, increasing the amount of 
aerobic exposure the bacterium has, followed by reduction in viability with the electric 
pulse and reducing the efficiency of this method. More recently, a mutagenesis method 
was developed which exploits the natural competency found in the P. gingivalis bacterium 
(Tribble et al., 2012), which limits the aerobic exposure and eliminates the need for the 
electric pulse, resulting in a higher number of viable cells for DNA uptake. Although this 
natural competency method was successful for the creation of ∆ompA1 and ∆ompA2 
mutants, initial attempts at the creation of ∆ompH1H2 proved ineffective.  
As the electrocompetency method requires a high number of bacteria to begin with, liquid 
cultures of wild-type P. gingivalis were used for the electroporation as previously 
described. Optimisation of the method involved the post-introduction of the DNA 
incubation as either in a liquid culture or on a BA-plate, before transferral to an 
erythromycin-containing plate for generation of the mutants. Optimisation of the natural 
competency transformation method involved the preparation of the wild-type P. gingivalis 
starter cultures from either a liquid culture or from a 3-day old BA plate, and after the 
introduction of the DNA, incubating for 24 hours either on in a fresh BHI broth or on a BA-
plate before transferral to erythromycin-containing BA-plates. Successful mutant colonies 
were only produced using starter cultures from a liquid origin in the natural competency, 
and no colonies were observed in the electrocompetency. Liquid starter cultures were also 
more successful at generating colonies for the knock out mutagenesis of ompA1 and 
ompA2 mutants, showing a development and optimisation of existing mutagenesis 
methods of P. gingivalis. 
General characterisation of the ∆ompH1H2 mutant demonstrated an altered colony 
phenotype when growing on BA-plates, with a much larger colony size and a glossy 
appearance. The colonies also required a longer growth period to turn from brown to black, 
potentially indicating a potential client of the OmpH chaperone related to hemin-
acquisition. When the outer membrane protein profiles of the wild-type bacteria to the 
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∆ompH1H2 mutant were compared, an obvious difference in protein banding was observed 
between the two which suggests the OmpH protein is involved in the chaperoning of 
multiple outer membrane proteins. Further analysis of the outer membrane proteins 
affected by the loss of the OmpH protein involved the probing for the OmpA protein 
specifically, as many papers have previously reported the loss of OmpA in an E. coli skp 
mutation (Chen and Henning, 1996; Missiakas et al., 1996; Schäfer et al., 1999; Bulieris et 
al., 2003).  Using an anti-OmpA antibody, no OmpA protein was observed in the purified 
outer membranes of P. gingivalis ∆ompH1H2, suggesting this protein is translocated across 
the periplasmic space via the OmpH chaperone.  
As mentioned previously folding and insertion of OmpA in E. coli has been shown to be 
assisted by Skp/OmpH, but there also is a requirement for LPS in the insertion of the 
protein into the membrane. Previous studies have shown the folding of OmpA into 
phospholipid bilayers occurs (Surrey and Jähnig, 1995; Surrey et al., 1996) but the kinetics 
of this folding are relatively slow. The Skp/OmpH protein is capable of binding OmpA and 
keeping it unfolded, but this inhibits the folding of the protein and insertion into the 
membrane. The Skp-OmpA complex therefore interacts with the LPS and the Bam complex 
to facilitate OmpA insertion into the membrane where folding can occur (Bulieris et al., 
2003). It would be interesting to determine if this is the case for P. gingivalis OmpH/OmpA 
interactions. 
When the bacteria were visualised through TEM, the most striking difference in the 
phenotype of the ∆ompH1H2 mutant was the presence of intracellular vesicle-like 
structures. At present we have no idea what these might be but it is tempting to 
hypothesise that these might be inclusion bodies containing proteins that have been 
targeted for secretion to the outer membrane but remain stuck in the cytoplasm where 
they potentially aggregate and appear as these structures in the cell. Another apparent 
difference between wild-type and ΔompH1H2 was the vast increase in vesicle production, 
which was supported by performing vesicle counts with the qNANO. This increase in the 
number of vesicles is likely due to the loss of integral outer membrane proteins that would 
usually anchor the outer membrane to the peptidoglycan layer. One of these proteins lost is 
likely to be the OmpA protein, as this hypervesiculation was observed in the ∆ompA1A2 
mutant in Chapter 3.3.3.2 as well as in previous studies (Nagano et al., 2005), coupled to 
the loss of detectable OmpA in the purified outer membranes of ∆ompH1H2 when probed 
with anti-OmpA antibody during Western blotting.  
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Due to the apparent loss of significant proteins from the outer membrane, leading to 
hypervesiculation and the “wavy” membranes observed in the TEMs, the integrity of the 
membrane was assessed using a dye that increases in fluorescence when encountering 
DNA, i.e. a higher level of fluorescence would be observed if the cell membrane integrity 
was limited by the loss of outer membrane proteins. Surprisingly, there was no difference 
in the membrane integrity between the wild-type cells and the ∆ompH1H2 mutant, even 
when stress to the membrane was applied. Indeed the opposite was observed, whereby 
instead of seeing a higher rate of uptake of the dye in the mutant, it was observed that the 
dye entered the mutant cells at a lower rate. This was hypothesised to be due to the loss of 
a protein transporter on the outer membrane of the cell so less of the dye is transported 
into the cell, although this is unconfirmed experimentally. Future work on the identification 
of the proteins that are chaperoned by the OmpH protein may reveal outer membrane 
protein transporters that would explain this phenomenon.  
During the course of this part of my work a paper was published (Taguchi et al., 2016) 
where the authors had produced a mutant of the ompH1 gene and assessed its phenotype. 
This work originally identified only the OmpH1 protein subunit (not OmpH2) to contain a 
transmembrane helix, but only assessed this through one prediction software programme.  
However, bioinformatics analysis of both subunits through 3 different programmes 
suggested that both subunits contained an α-helix transmembrane domain in two out of 
three cases. Taguchi et al., only created an ∆ompH1 strain and suggested that ∆ompH2 was 
an essential gene as a viable mutant could not be made. However in the case of the work 
presented here, this seems not to be the case as an entire ∆ompH1H2 mutant has been 
created (Taguchi et al., 2016). Taguchi et al also identified the co-transcribed operon that 
ompH is encoded by, containing genes PGN_0296, PGN_0297, PGN_0298, PGN_0299 
(which bioinformatic analysis in this work identified it as Omp85, or BamA, which is also 
found in the Skp-encoding operon of E. coli), and the two ompH genes (PGN_0300 and 
PGN_0301).  
Taguchi et al also provided a general characterisation of the phenotype found in the 
∆ompH1 mutant. Cell lysates and outer membrane preparations showed a much less 
dramatic alteration in the outer membrane protein profile than seen in the double 
∆ompH1H2 mutant that is observed in this work, suggesting that the OmpH2 protein may 
have a much larger client set of proteins to be chaperoned to the outer membrane than 
OmpH1, or that the two OmpH protein subunits work as a complex to chaperone a large 
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number of proteins to the outer membrane. Identification of the client set of protein for 
OmpH is a major part of the future work of this project, and it would be interesting to 
determine if OmpH1 and OmpH2 had a different set of specific proteins, or if it relies on 
both OmpH1 and OmpH2 protein subunits to be present in a complex. The phenotypic 
analysis by Taguchi et al also demonstrated a loss in pigmentation and haemagglutination 
which lead to the possibility that the presence of properly processed gingipains had been 
lost due to the ompH1 mutation. Work in this chapter also concurred with this loss in 
gingipain activity, showing similar levels of reduction. Taguchi et al related the reduction in 
gingipains to the presence of a C-terminal domain in the gingipain proteins which targets it 
to the PorSS pathway of secretion (Seers et al., 2006). MALDI-TOF analysis in their study of 
the ∆ompH1 culture supernatants demonstrated the presence of several immature forms 
of CTD-containing proteins amongst others, suggesting that the OmpH protein may act as 
the chaperone protein for the PorSS pathway of secretion (Taguchi et al., 2016). Homologs 
of the OmpH protein exist in various Gram–negative bacteria, as previously discussed 
(Chapter 1.6.13.), including B. fragilis which does not have a PorSS system (Narita et al., 
2014), and the fact that proteins such as OmpA do not possess a CTD but (as shown in this 
study) but appear to be a client of the OmpH chaperone complex suggest that it is likely 
that the OmpH chaperone complex doesn’t act solely as the chaperone for the PorSS 
pathway but more as a general non-specific chaperone.  
Future work would involve the confirmation of the OmpA protein being a client of the 
OmpH chaperone, as observations here have indicated it is. Using anti-OmpA antibody used 
in this study, future experiments could investigate the presence of OmpA on the surface of 
∆ompH1H2 P. gingivalis using fluorescence microscopy, to allow a native visualisation of 
what is expected from the lack of protein on the Western blot. Previous studies have shown 
that the aggregation of overexpressed E. coli OmpA is prevented in the presence of buffers 
containing Skp trimers, which are then assessed using size exclusion chromatography to 
demonstrate a 1:1 binding between Skp and OmpA (Walton et al., 2009), which could be 
applied to the OmpA and OmpH proteins of P. gingivalis to determine binding. As the study 
by Walton et al also demonstrates the β-barrel of the OmpA protein is bound inside the 
cavity of the trimeric Skp to prevent aggregation (Walton et al., 2009), the deletion of 
certain sections of the P. gingivalis OmpA protein could be investigated to determine 
initially if OmpH binds OmpA, and also if it acts via similar mechanisms.  
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Further investigation into the characterisation of the ∆ompH1H2 mutant involved the 
investigation of the virulence of the bacteria through biofilm formation and standard 
antibiotic protection assays. The loss of the OmpH chaperone protein in P. gingivalis has led 
to a significant reduction in the ability for P. gingivalis to form a biofilm, an essential part of 
the formation of dental plaque, and this ability of P. gingivalis to form a biofilm allows the 
contribution of the bacterium to shift the balance of microflora in dental plaque from a 
healthy to disease associated state when major ecological pressures arise (Marsh, 2003), 
leading to periodontitis.  This loss in biofilm formation would remove the contribution of P. 
gingivalis in the progression of the imbalance of bacteria to the disease associated state, 
and reduce the severity of the disease, as P. gingivalis has been ascribed a keystone 
pathogen of periodontal disease (Hajishengallis et al., 2012). Identification of the proteins 
that are chaperoned by OmpH would allow investigations into the proteins involved in the 
biofilm formation, and therefore contribute to the understanding of the ability of P. 
gingivalis to cause disease and potentially identify therapeutic targets to block biofilm 
formation and reduce the capacity for disease. 
The ∆ompH1H2 bacteria also had a significant reduction in the ability to adhere to and 
invade the host cell, an essential virulence factor in the progression of periodontal disease. 
The invasion of the host is critical for P. gingivalis to remain hidden from the host immune 
system whilst replicating intracellularly and persisting to lead to a chronic infection 
(Hajishengallis, 2010). The loss of the OmpH protein led to a greatly significant reduction in 
the ability for the bacteria to adhere to the host cells and a major reduction in the invasion 
of the host, indicating proteins chaperoned by OmpH to the outer membrane are essential 
in the ability for P. gingivalis to interact with the host.  
 With this loss of biofilm and invasive capabilities in mind, it would therefore be ideal to 
identify the proteins that are affected by the loss of OmpH, which would lead to the 
identification of the proteins that are chaperoned by OmpH. This would be performed using 
purified outer membranes of both wild-type and ∆ompH1H2 and investigating which 
proteins differ using mass spectrometry. This work was started during this project but due a 
lack of time, it could not be investigated fully. Alternatively, affinity chromatography with 
immobilised OmpH could be employed to ascertain the clients of the OmpH chaperone 
protein, and identify the proteins of interest by mass spectrometry identification of the 
altered proteins identified by SDS-PAGE. This work was begin during this project, with the 
identification of a few potential candidates on the SDS-PAGE seen in Figure 5.9, however, 
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these were only observations and need to be identified fully in future work. Once the 
proteins that interact with the OmpH chaperone are identified, they would be investigated 
for their function on the outer membrane and could then be used as a target for 
therapeutic agents. This could eventually lead to the design of an agent to specifically 
target P. gingivalis as it is considered to be the keystone pathogen of periodontal disease 
(Hajishengallis et al., 2012), leaving the rest of the healthy-related microflora viable and 
maintaining the homeostasis within the oral cavity.  
5.5 Summary 
In conclusion, this chapter has enforced the hypothesis that OmpH has a role in the 
chaperoning of proteins to the outer membrane and the deletion of the OmpH proteins 
leads to a distinctly different phenotype due to the loss of integral outer membrane 
proteins. This chapter has determined a significantly altered outer membrane protein 
profile, and identified the loss of multiple outer membrane proteins which opens up the 
exciting opportunity to identify these proteins that act as clients of the OmpH chaperone. 
This chapter has also potentially identified OmpA and gingipains as proteins that are 
chaperoned by the OmpH protein, as demonstrated by a loss of detectable OmpA on the 
outer membrane of the ∆ompH1H2 mutant and a reduction in the gingipain activity. This 
chapter demonstrated a significant loss of virulence in the ∆ompH1H2 mutant and 
therefore identification of proteins lost from the outer membrane could lead to exciting 
new possibilities for potential therapeutic drug targets to combat periodontal disease.  
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Chapter 6 
 Discussion & Future Prospects 
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6.1 Summary of Major Findings 
The work described in this thesis has provided a deeper understanding of the molecular 
mechanisms behind P. gingivalis major outer membrane protein, OmpA, and its interaction 
with the host, followed by a preliminary characterisation of the putative periplasmic 
chaperone, OmpH.  
Unpublished data from Suwannakul et al (2010) demonstrated an upregulation of the 
ompA1 and ompA2 genes in a hyperinvasive population of P. gingivalis (Suwannakul et al., 
2010), indicating the potential involvement of the OmpA protein in adherence and invasion 
of the host cell. This data also identified a set of genes that were differentially regulated in 
this hyperinvasive subset of the population, which identified the putative OmpH chaperone 
protein as being upregulated four-fold, signifying potential importance in invasion, and thus 
produced the basis for the third chapter investigation. 
The hypothesis behind the importance of OmpA was developed through the apparent 
involvement of OmpA in adherence and invasion of the host for several species, including 
E.coli K1 (Prasadarao et al., 1996; Shin et al., 2005), N. gonorrhoeae (Serino et al., 2007), 
and indeed with P. gingivalis OmpA involvement in endothelial cell invasion (Komatsu et al., 
2012). This coupled with the fact that surface exposed proteins are potentially the first line 
of interaction with human surfaces and cells means the importance of understanding their 
molecular biology is key to understanding the basis of host-pathogen interactions and in 
this cases periodontal disease. As the health of the oral cavity is an extremely complicated 
balance of host and bacterial factors, this study into investigating the disease-causing 
bacterium at the molecular level and determining specific proteins involved would allow a 
the design of particular therapeutic agents to for a targeted defence against the pathogen, 
reversing dysbiosis and repopulating the commensal bacteria to return once again to a 
healthy periodontium.   
As a prelude to a final discussion I have summarised the major findings from each part of 
the thesis. 
6.1.1 Chapter 3: Role of the ompA Gene Cluster in Host-Cell Interactions and Biofilm 
Formation 
This chapter focussed on the effects of the deletion of the ompA1A2 operon and its 
individual ompA1 and ompA2 genes. The following major results and conclusions were 
drawn: 
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 In determining an effective mutagenesis method for P. gingivalis, 
electrocompetency and natural competency techniques were employed to 
introduce DNA for the creation of the ompA1 and ompA2 mutants. Natural 
competency demonstrated a significantly higher number of colonies produced per 
µg of DNA used, regardless of the origin of the DNA (plasmid or linear). As this 
method of transformation proved to be much more efficient, it was therefore 
implemented in the laboratory as a standard method of transformation for oral 
anaerobic bacterial mutagenesis and is used by many of the group members.  
 TEM was used to study the effects of the deletion of the OmpA protein from the 
outer membrane. This demonstrated an instability of the membranes with the loss 
of the protein, with “wavy” membranes observed in a small number of the 
population. As the structure of the OmpA protein involves a β-barrel located in the 
outer membrane, linked to a peptidoglycan-associated domain, this loss of an outer 
membrane protein that would anchor the outer membrane to the bacterial cell, 
creating this membrane instability. The TEM images also displayed the presence of 
outer membrane vesicles, of which a significantly higher number were produced in 
the ompA1A2 mutant, and a slight increase in the ompA1 and ompA2 mutants. This 
supports the idea that the OmpA protein plays an important role in the stability of 
the P. gingivalis membrane, and agrees with similar data shown by others (Iwami et 
al., 2007). 
 The ability of P. gingivalis to form a biofilm is an important virulence factor, as this 
ability contributes to the formation of biofilms on tooth structures, leading to the 
accumulation of dental plaque. Biofilm formation was assessed to understand the 
role of OmpA in adherence to surfaces, as well as itself. In all mutants, the biofilm 
appeared to be more fragile, however a marked decrease in the ability of the 
ompA2 and ompA1A2 mutants to form a biofilm was observed, both through 
qualitative and quantitative means. As the ompA1A2 mutant shows a vast 
difference in all aspects analysed throughout this thesis (membrane profile, 
membrane stability, vesicles, enzymatic assays etc.), it was interesting to observe a 
similar lack of biofilm formation in the ompA2 mutant, which portrayed the first 
indication that this protein subunit may have a greater role within the OmpA 
protein complex in interactions with its environment.  
  This is the first time that the OmpA protein has been shown to be involved in the 
interactions with oral epithelial cells, and in particular the data presented in this 
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thesis show a specific and significant role for the OmpA2 protein subunit. Through 
standard antibiotic protection assays, the ability of P. gingivalis wild-type and ompA 
mutants to adhere and invade oral epithelial cells was assessed. Whilst the ompA1 
and ompA2 mutants showed a 50 % reduction in adherence, whilst the ompA1A2 
mutant lost almost all ability to adhere to the cell. Interestingly, the intracellular 
count of ompA2 mutants resembled the ompA1A2 mutant with a significant 
reduction in the invasive capability whilst ∆ompA1 intracellular numbers were 
closer to wild-type. This result indicates that the OmpA2 protein the dominant 
subunit involved in the events leading to internalisation, whilst both subunits are 
required for effective adherence. 
 As the deletion of ompA2 appeared to show a greater effect in both biofilm and 
host cell interaction, a complement of this mutant was used to confirm the loss of 
biofilm formation and interaction with the host was due to the loss of the protein, 
not any downstream effects. The ∆ompA2 + pT-COW-A2 complement partially but 
significantly rescued the biofilm formation phenotype, whilst fully rescued the 
adherence and invasion phenotype, confirming the importance of the OmpA2 
subunit in these virulence factors.  
6.1.2 Chapter 4: Molecular Mechanism of OmpA Interaction with Host Epithelial Cells. 
This chapter focussed on the purification of the OmpA protein to determine the molecular 
mechanisms behind its interaction with the host cell. Despite numerous attempts at 
purifying soluble OmpA, including using solubilising agents, the use of binding proteins, 
truncated protein purification, making additions to the dialysis buffer, protein remained 
insoluble and therefore other methods of determining the molecular mechanism behind 
the host cell interactions were studied.  
 The structures of the OmpA proteins were determined using online prediction 
software, yielding a structure with high homology to the OmpA proteins found in E. 
coli and Klebsiella pneumoniae, with the classic two-domain structure of a β-barrel 
and a peptidoglycan-associated globular domain. This structure also indicated the 
presence of extracellular surface loops, which due to the predicted orientation of 
the protein; these would be exposed on the outside of the P. gingivalis cell. The 
hypothesis developed that these loops would be the part of the protein exposed 
and therefore involved in the interaction with the host cell. 
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 The extracellular loops were synthesised and used in place of recombinant OmpA 
protein in further experimental analysis. These loops, when included in a standard 
antibiotic protection assay with wild-type P. gingivalis successfully interrupted the 
adherence and invasion of the bacteria, indicating that these loops are binding to 
the host cell receptors, and efficiently preventing the binding of P. gingivalis.  
 Peptide 4 was especially effective at preventing the adherence and invasion of P. 
gingivalis to host cells, so a scrambled peptide was designed against this sequence, 
which when included in standard antibiotic protection assays as a negative control, 
showed no interruption of P. gingivalis interaction with the host, indicating a strong 
and specific interaction of peptide 4 of OmpA2 with human cells.  
 The synthesised peptides were designed with an N-terminal Biotin tag, which was 
used to bind the peptides to fluorescent microspheres. These peptide-coated 
microspheres were applied to monolayers of oral epithelial cells and the binding of 
the peptides to the cells analysed, which displayed a significant level of all peptides 
binding to the host cells, with peptide 4 displaying the greatest increase in binding, 
especially when compared to the control scrambled peptide.  
 These data together demonstrate the peptides are sufficient to allow direct binding 
to the host, and therefore greatly imply that there is a direct binding between 
OmpA2 and the host cell. This data also supports the hypothesis that the reduced 
invasion phenotype in Chapter 3 of the ∆ompA2 mutant is due specifically to the 
lack of the OmpA2 protein subunits. 
6.1.3 Chapter 5: Preliminary Characterisation of the Putative OmpH/Skp Locus of 
P. gingivalis. 
This chapter focussed on the characterisation of the putative outer membrane protein 
chaperone, OmpH, a protein whose gene transcript had previously been shown to be 
upregulated in P. gingivalis cells with a ‘hyperinvasive’ phenotype. The following major 
results and conclusions were drawn: 
 The generation of an ompH1H2 mutant allowed further development of the 
mutagenesis method of P. gingivalis. This involved the optimisation of the starting 
cultures and 24 hour incubation after the introduction of the DNA for both 
electroporation and natural competency methods. The optimisation of the method 
confirmed the efficiency of the natural competency versus electroporation, 
however within the natural competency method, liquid cultures proved to be the 
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most efficient mutagenesis method. This further optimisation over that in chapter 
3, has been further implemented as general lab practice for anaerobic bacterial 
mutagenesis within the Stafford group at The School of Clinical Dentistry.  
 Initial studies of the ompH1H2 mutant demonstrated a much larger colony size and 
a glossy, brown phenotype, suggesting an alteration to the outer membrane 
protein profile. This was confirmed through purification of the outer membrane 
proteins and analysis on SDS-PAGE gels, showing multiple absent protein bands, 
which at this stage have yet to be identified.  
 TEM imaging of the ompH1H2 mutant was performed, where a much higher 
proportion of the mutant population displayed the “wavy” membranes, indicating a 
higher level of membrane instability with the loss of various outer membrane 
proteins. This instability was supported by the significant increase in vesicle 
production observed in the mutant.  
 The presence of specific proteins was analysed through Western blot, which 
demonstrated the loss of the OmpA protein and the fimbrial proteins in the 
ompH1H2 mutant, indicating that these proteins may be clients of the OmpH 
chaperone system. The presence of other outer membrane proteins such as the 
sialidases and the gingipains were analysed through enzymatic assays. Sialidase 
activity was increased to similar levels observed for ompA1A2 mutants in chapter 3, 
which again were hypothesised to be due to the increase in the production of outer 
membrane vesicles. The gingipain activity, however, was significantly reduced in 
the omH1H2 mutant, suggesting that these proteins are also potential clients of the 
OmpH chaperone.  
 Similar to the ompA1A2 mutant phenotype in Chapter 3, the ompH1H2 mutant 
showed a complete abrogation of the ability to form a biofilm, with almost no 
bacteria adherent to the polystyrene plate surface. This loss of adherence was also 
observed in the standard antibiotic protection assay, whereby the mutant could no 
longer adhere to the oral epithelial cells, and very few were observed 
intracellularly. This data indicates that the outer membrane protein clients of the 
OmpH chaperone are crucial to the ability of P. gingivalis to interact with the host 
cell, and therefore to its ability to contribute to periodontal disease. 
 
229 
 
6.2 Host Cell Interaction of P. gingivalis with Human Cells: OmpA Surface Loops at 
the Host-Interface 
The data presented in this thesis has contributed to our understanding of the molecular 
determinants of host-cell interactions by P. gingivalis where previous studies have focussed 
chiefly on gingipains (Chen et al., 2001; Chen and Duncan, 2004), fimbriae (Hamada et al., 
1994; Weinberg et al., 1997; Njoroge et al., 1997) and haemagglutinin type proteins (Chen 
et al., 2001; Song et al., 2005; Bélanger et al., 2012). 
Specifically, my work has elucidated that the OmpA protein complex plays a key role in 
adhering to and invading the host epithelial cells, independent of existing mechanisms of 
host-cell interaction as shown by no change in the fimbriae expression and gingipain 
activities in the ompA1 and ompA2 mutants. This work has also provided novel data 
demonstrating the particular importance of the OmpA2 protein subunit extracellular loops 
in this interaction. However, one of the major aims when this work began was to eventually 
identify the host cellular target that OmpA interacts with. Due to the pitfalls of production 
of soluble outer membrane proteins, such as OmpA, this particular focal point of the 
project was never reached. Previous reporting into the identification of the host cell 
receptor engaged by P. gingivalis OmpA indicate a potential interaction with E-selectin on 
the cell surface of endothelial cells (Komatsu et al., 2012), however there is no evidence for 
this being the case for epithelial cells, and the presence of E-selectin on epithelial cells 
remains unclear (Moughal et al., 1992; Pietrzak et al., 1996). The OmpA of E. coli K1 has 
been shown to potentially interact with the gp96 receptor (Prasadarao et al., 1996), with 
the extracellular loops being of particular importance in this interaction (Mittal and 
Prasadarao, 2011; Mittal et al., 2011). The extracellular loops of E. coli OmpA show little 
homology to the extracellular loops determined in this project, however the observation 
that the peptides interrupted wild-type P. gingivalis from adhering and invading the host 
cell provides potential that these peptides could be used to identify the epithelial cell 
receptor for P. gingivalis OmpA. This would be achieved through immobilising the peptides 
on Avidin-coated resin by binding the biotin tag, and running host cell lysates over them, 
capturing any binding between host cell proteins and the OmpA2 extracellular loop 
peptides. Binding partners would then be purified and identified through mass 
spectrometry; however time constraints on this project have left this only as promising 
future work.  
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Identification of the host cell target would lead to the investigation of the molecular 
mechanisms behind invasion of the cell. Invasion of P. gingivalis using the fimbriae has 
been well documented, whereby the fimbriae engage the α5β1 integrins on the epithelial 
cell surface, leading to a kinase signalling cascade being triggered and the rearrangement of 
the cytoskeleton (Yilmaz, 2003). If similar host cell targets were identified for the OmpA 
protein, this would indicate a similar mechanism of invasion.  Alternatively without the 
identification of the host cell target, future work to investigate if this molecular mechanism 
is also triggered by the OmpA protein binding could be performed using fluorescent tagging 
of the actin filaments to determine if the cytoskeleton is rearranged in a similar fashion to 
the fimbrial FimA binding trigger.  
6.3 Periodontal Disease: A Targeted Approach?  
As this research has highlighted a role for OmpA in the adherence and invasion of the host, 
it is therefore a possibility to target this particular protein for therapeutic treatment 
development. This approach to targeted treatment of periodontal disease is a highly 
significant area for exploratory study, as the oral cavity contains a plethora of bacterial 
species with only a certain few that contribute to disease (Socransky et al., 1998; Aas et al., 
2005; Pennisi, 2005). The identification of the OmpA protein in the influence of the disease 
progression of the host by P. gingivalis coupled to the hypothesis of P. gingivalis being the 
keystone pathogen of periodontal disease (Hajishengallis et al., 2012), this targeted 
treatment is a realistic possibility of tackling the ever burdening issue of periodontal 
disease. As OmpA-like proteins can be found in all Gram-negatives (Beher et al., 1980), and 
Gram-negative bacteria have been implicated in the dysbiosis imbalance of the oral cavity 
and are heavily present in periodontal disease, using the OmpA as a target in periodontal 
treatment may allow a specific combat of the disease-causing periodontal pathogens. It 
would be interesting to determine the structural similarities of the OmpA proteins in the 
red complex bacteria, and any similarities of their extracellular loops for this specific 
approach. This area of future research is also interesting given that anti-OmpA1A2 protein 
serum can also bind the OmpA protein of T. forsythia (designated TF1331) (Imai et al., 2005; 
Veith et al., 2009; Abe et al., 2011), another oral pathogen found in severe cases of 
periodontal disease, this OmpA-targeted approach may have further benefits in patient 
treatment.  
The identification of the extracellular surface regions of OmpA2, leading to the generation 
of peptides yielded very exciting data on the ability of these extracellular loops to directly 
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bind the host cells and interrupt P. gingivalis interacting with the host. The possibility 
remains to further investigate these peptides, in altering the sequence to favour binding, or 
to identify particular residues necessary for the binding and eventually to allow 
development of novel anti-adhesive therapeutic agents to prevent P. gingivalis binding 
efficiently to the host. As adherence is one of the first steps of host colonisation, this would 
be advantageous as it could provide a block to a specific interaction between P. gingivalis 
(and possibly other periodontal pathogens binding through OmpA) and the host to prevent 
the adherence and invasion and therefore the progression to chronic periodontitis. Anti-
gingipain peptides have been previously developed for therapeutic use, specifically a study 
by Genco et al (1998) used the N-terminal sequence of the catalytic domain of the gingipain 
R1 which conferred resistance in mice against P. gingivalis infection (Genco et al., 1998), 
suggesting a possibility to use these peptides as therapeutic agents. Caution with the use of 
peptides in therapeutics would have to be considered as except for a general toxicity study 
in Figure 4.25, no data has been observed for the immunogenic effects of the OmpA 
peptides used in this study in the host. Traditionally, therapeutic peptides show poor 
physical stability and have a short half-life (Fosgerau and Hoffmann, 2015). However, if 
these peptides are incorporated into a topical preventative treatment such as a toothpaste, 
gel or a mouthwash, this would circumvent the short half-life but may also stimulate 
immunity, though this may prove to be potentially interesting in terms of vaccines.  
Previous reports have used the keystone-pathogen hypothesis to theorise that a 
vaccination of P. gingivalis-specific extracellular structures would reduce periodontal 
disease progression. Indeed, analysis of 14 clinical strains and isolates demonstrated a high 
level of conservation between P. gingivalis strains (Ross et al., 2001) so recombinant 
versions of OmpA proteins were used as a vaccine and provided protection in murine 
models (Ross et al., 2004). The protein provided some protection against development of 
oral lesions in the mouse model but showed no reduction in alveolar bone loss when orally 
challenged (Jong and van der Reijden, 2010), and therefore provides only partial protection 
against the development of periodontal disease. Issues with the OmpA protein solubility 
still remain, and would provide a great impracticality to use the whole or large sections of 
the OmpA protein as the sole determinant in the vaccine. Future work into the extracellular 
peptides of OmpA2 identified in this study may involve the investigation into generating an 
immune response from the peptides, and determine if they would be an appropriate 
vaccine candidate.  
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Outer membrane protein of P. gingivalis have been previously investigated as vaccine 
candidates, with moderate success (Maeba et al., 2005; Liu et al., 2010; Cai et al., 2013). 
The use of various outer membrane proteins in these studies showed protection against 
alveolar bone loss, both through introduction as an injection or nasally, and especially 
proved effective when introduced with a modified cholera toxin (Cai et al., 2013), displaying 
a potential path for using OmpA as a vaccine candidate.  
To use the peptides as a potential vaccine, the effects on the host immune system would 
have to be thoroughly investigated. Previous studies of the effect of OmpA, using the 
Klebsiella pneumoniae protein, on the host innate immune response have shown an 
importance of OmpA as a bacterial ligand which binds to and triggers internalisation by 
dendritic cells and macrophages, which activates them in a TLR2-dependant manner 
(Jeannin et al., 2002). The OmpA protein is then recognised by various scavenger receptors, 
resulting in the production in PTX3 (a pentraxin-related protein) which binds to OmpA and 
in turn, increases the inflammatory response (Mantovani et al., 2008). Investigations into 
the host cell response to OmpA2 alone and the extracellular peptides would therefore be 
critically important in determining if they would be suitable as a vaccine candidate. 
However, if it is possible to elicit a similar host response using only the peptides, this will 
elucidate potential epitopes in vaccine development, or be used in a combination with the 
OmpA protein to create a more effective vaccination to influence dysbiosis and result in a 
“re-biosis” of the oral microbiome (Curtis, 2015).  
6.4 The Role of OmpH Chaperone: Implications for Surface Proteome Involvement 
in P. gingivalis Biology 
The data presented in the final results chapter of this thesis gave a general characterisation 
to the relatively unknown OmpH protein of P. gingivalis. This protein was alluded to as 
being important in invasion when identified as an upregulated protein in a signature set of 
genes in the hyperinvasive subset of the P. gingivalis population (Suwannakul et al., 2010). 
It is currently unclear whether the OmpH1H2 protein complex functions as a trimer of 
OmpH1 and OmpH2 proteins, and in what composition (e.g. like OmpA is in a 2:1 
heterotrimeric structure of OmpA1:OmpA2) as this has not yet been determined. As little 
knowledge exists of the OmpH protein of P. gingivalis, a full knock out of the protein was 
created, with the intention to study the single mutations later. General analysis of a mutant 
lacking this chaperone indicated that strains lacking the OmpH complex have significantly 
altered physiology, with abrogated growth characteristics, colony morphology, biofilm 
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growth and viability in certain media conditions (e.g. tissue culture media during standard 
antibiotic protection assays). These observations can be explained largely in terms of its 
role as a periplasmic chaperone of outer membrane proteins. The ompH mutant in my work 
displays a drastically altered outer membrane protein profile, which is in stark contrast to 
the work of Taguchi et al., who described the phenotype of a mutant lacking only OmpH1, 
which largely seemed to lack proteins whose secretion to the OM is dependent on the Type 
IX PorSS system, including gingipains (Taguchi et al., 2016). It would therefore be an 
interesting prospect to complement the ompH1H2 mutant with the OmpH2 protein to 
determine if the mutant then behaves like the ompH1 single mutant demonstrated in the 
Taguchi et al work, i.e. the two subunits may have different client bases. The difference in 
the two mutants’ membrane profiles indicates the potential greater role for OmpH2 in the 
chaperoning of proteins, as a greater number of proteins are lost in the mutant lacking the 
entire operon, but may also indicate that it has a role in stabilisation of the potential 
OmpH1H2 complex. Analysis of the single mutants would form a large part of the ongoing 
work from this project.  
Although it is tempting to speculate that loss in virulence factors, such as the ability to form 
a biofilm, to adhere to and invade host cells, etc. is due at least in part to the loss of the 
OmpA protein in the ompH1H2 mutant as both mutants display very similar phenotypes. 
However, it is very difficult to dissect the effect of the OmpA protein missing in the outer 
membrane from the overall effect of all of the proteins lost from the outer membrane of 
the ompH1H2 mutant. It would therefore be very interesting for future work to determine 
which proteins are affected by the loss of the OmpH chaperone. This chapter has 
potentially identified three of these, the two gingipains, Kgp and Rgp (which were also 
identified by Taguchi et al), and the OmpA protein (a novel finding in this research) 
however further identification of outer membrane proteins that are clients of the OmpH 
protein would help to establish new proteins of P. gingivalis outer membrane that 
potentially could act as therapeutic targets for drugs to prevent the progression of 
periodontal disease. Some of these clients have been hinted at by the work performed by 
Taguchi et al, (2016) however this is still preliminary work as little is still known about P. 
gingivalis OmpH and therefore there is a great deal more to be defined and discovered.   
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6.5 Conclusion 
This body of work has identified a role for the OmpA in P. gingivalis virulence, contributing 
to the ability for the bacterium to form a biofilm as well as enabling the interaction with the 
host. In particular, these findings have demonstrated an increased role for the OmpA2 
subunit in the host cell interactions, with particular importance of the extracellular surface 
regions of the protein. There is promising potential to develop the extracellular loops 
derived from the peptides into potential anti-adhesive therapeutic agents or vaccines, 
whilst also using OmpA as a potential target for treatment of periodontal disease. This 
thesis has also developed a greater understanding of the OmpH chaperone protein of P. 
gingivalis and has provided evidence that the OmpA protein is a client of this chaperone 
system. The identification of other clients of OmpH would allow the further identification of 
targets for periodontal disease therapeutics. A schematic of how these proteins 
complement each other and fit into the larger picture of P. gingivalis interaction with the 
host can be seen in Figure 6.1.   
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Figure 6.1. Schematic diagram representing the surface proteins of P. gingivalis and their 
interactions with the host epithelial cell. The major mechanisms of adherence and invasion 
are indicated, with the addition of OmpH as a chaperone of the outer membrane proteins. 
The fimbriae (1) bind to the α5β1 integrins, triggering a signalling cascade causing 
cytoskeleton rearrangement and internalisation of the bacteria. The gingipains (2) modify 
and cleave host cell receptors to reveal cryptotopes and allow P. gingivalis adherence. 
Similarly, the sialidases (3) cleave the terminal sialic acid to increase P. gingivalis adherence 
to the host. The OmpA protein (4), specifically the OmpA2 subunit’s extracellular loops are 
involved in the binding of an unknown host cell receptor, and mediating invasion of the 
bacterium. The peptides designed to resemble these OmpA2 loops successfully reduce this 
adherence (4a). The OmpH protein (5) chaperones proteins to the outer membrane of the 
P. gingivalis cell, of which potentially include the OmpA protein, the fimbriae, and the 
gingipains, and other important proteins necessary for successful adherence and invasion 
of the host oral epithelial cells.  
 
Given that none of the mutations in these proteins needed for host cell interaction 
completely abrogate the ability of the bacteria to invade the host, merely that they severely 
reduce the capability, it would suggest that they are all needed in some form for maximal 
efficiency of host cell interaction and work synergistically. Particular mechanisms may be 
needed in different points of the adherence and invasion cycle, for example, gingipains are 
needed in adherence but not in invasion (Chen et al., 2001; Suwannakul et al., 2010), and 
they may be needed to reveal the receptors necessary for other molecular determinants to 
bind to facilitate invasion. It is evident from this study that OmpA plays a role in the host 
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cell interaction; however it should be seen with caution as an actual in vivo situation would 
employ a whole subset of virulence factors that would stimulate the cell in multiple 
different ways that a single virulence factor such as OmpA would not. It would be 
thoroughly interesting for future work to determine which are expressed at particular 
points of the host interaction cycle, and under what conditions they are necessary, and 
ultimately how the OmpA protein fits into this. In addition to this, periodontal disease is not 
the work of a single species; it is likely due to the interaction of P. gingivalis with multiple 
oral species and the host-related factors to thrive and cause disease, and therefore the 
effect of the OmpA protein in a multi-species environment would be an interesting area for 
follow up. 
With numerous studies already performed to determine the mechanism of virulence 
behind P. gingivalis and the cellular interaction with the host, there is still a substantial 
amount more work to be done. This study has hypothesised and confirmed the importance 
of OmpA in this interaction, and further exploration of this area will hopefully greatly 
contribute to the overall understanding of P. gingivalis virulence, and eventually lead to the 
development of effective therapies for controlling chronic P. gingivalis infections and help 
to prevent periodontal disease. 
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Appendix 
Appendix I 
Sequence of ∆ompA2 + pT-COW - A2 complement insert: 
GGATTCTGCTTACGAAGTAATTATGCATACAGGGAAAAAATTACCGGAGAATCTTCTTTGCAGCTCTGCAGATACA
CCACATGAAAAGCTCTACGAGATTCGCCAAAGGAATTATTTCTCCCAAGCGTTTTATAATAATACTCTATAATAAA
AAGACTGTTATTTGTTTTTGATCAATGGCTTTTTGAGAGGAGAACTAACGCTTTTCTCTCCTAATTATTTGGCTGT
TCAAATTTCTTACATTACATTTGTGTAGCGAATAGGCTATTGGTAAACGTATAAAAATACACTTAGAAAAGTAAAA
CTATGAAAGCTAAATCTTTATTATTAGCACTTGCGGGTCTCGCATGCACATTCAGTGCAACAGCCCAAGAAGCTAC
TACACAGAACAAAGCAGGGATGCACACCGCATTCCAACGTGATAAGGCCTCCGATCATTGGTTCATTGACATTGCA
GGTGGAGCAGGTATGGCTCTCTCGGGATGGAATAATGATGTAGACTTTGTAGATCGTCTAAGTATCGTTCCTACTT
TCGGTATCGGTAAATGGCATGAGCCTTATTTCGGTACTCGTCTCCAATTCACAGGATTCGACATCTATGGATTCCC
GCAAGGGAGCAAGGAGCGTAACCACAATTACTTTGGAAACGCCCACCTTGACTTCATGTTCGATCTGACGAACTAT
TTCGGTGTATACCGTCCCAATCGTGTCTTCCATATCATCCCATGGGCAGGTATAGGATTTGGTTATAAATTCCATA
GCGAAAACGCCAATGGTGAAAAAGTAGGAAGTAAAGATGATATGACCGGAACAGTTAATGTCGGTTTGATGCTGAA
ATTCCGCCTATCAAGAGTCGTAGACTTCAATATTGAAGGACAAGCTTTTGCCGGAAAGATGAACTTTATCGGGACA
AAGAGAGGAAAAGCAGACTTCCCTGTAATGGCTACAGCAGGTCTAACGTTCAACCTTGGCAAGACAGAGTGGACAG
AAATTGTTCCTATGGACTATGCTTTGGTCAATGACCTGAACAACCAAATCAACTCACTTCGCGGTCAAGTGGAAGA
GTTGAGCCGTCGTCCTGTTTCATGCCCTGAATGCCCTGAGCCTACACAGCCTACAGTTACTCGTGTAGTCGTTGAC
AATGTGGTTTACTTCCGTATCAATAGTGCAAAGATTGATCGTAATCAAGAAATCAATGTTTACAATACAGCTGAAT
ATGCGAAGACCAACAACGCACCGATCAAGGTAGTAGGTTACGCTGACGAAAAAACCGGTACTGCGGCCTATAACAT
GAAGCTTTCAGAGCGTCGTGCAAAAGCGGTAGCCAAGATGCTTGAAAAGTATGGTGTTTCTGCGGATCGCATTACA
ATTGAATGGAAGGGCTCATCAGAGCAAATCTATGAAGAGAACGCTTGGAATCGTATTGTAGTAATGACTGCAGCGG
AATAAGTCGAC 
 
The above details the sequence used to clone into pT-COW plasmid to generate a 
complement ∆ompA2 strain. Highlighted in teal are the two restriction enzyme sites 
(BamHI and SalI respectively) used to insert the sequence into the pT-COW plasmid. The 
grey highlighted section displays the 300 bp sequence upstream of the ompA1 gene which 
encodes the ompA operon promoter, whereas the section without highlighting denotes the 
ompA2 gene used to complement the ∆ompA2 mutant in trans.  
 
